<html lang="en" class="pb-page js" data-request-id="94d6a59084c8e7d5-SJC"><head data-pb-dropzone="head"><style type="text/css" nonce="94d6a59084c8e7d5-SJC">@font-face {font-family: "Source Sans Pro";src: url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.ttf) format("truetype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.woff) format("woff"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.otf) format("opentype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.eot) format("embedded-opentype");}.truste_cursor_pointer {cursor: pointer;}.truste_border_none {border: none;}.truste_accessible_link {font-family: "Source Sans Pro", sans-serif;color: #1D4ED8;font-size: 14px;font-weight: 600;text-decoration: underline;}.truste_accessible_link:hover {color: #1D4ED8;text-decoration: none !important;}.truste_accessible_link:focus-visible {outline: none;border-radius: 4px;box-shadow: 0 0 0 1px #FFFFFF, 0 0 0 4px #3699F1;}</style><script src="https://ssl-cdn.janraincapture.com/widget_data/flow.js:7h8bznq6j7bvyvzqcrwvyp8dfb:en-US:20240514181256512029:standard" type="text/javascript"></script><script src="https://cssjs.nejm.org/akamai/capture:login" type="text/javascript"></script><script src="https://ssl-widget-cdn.rpxnow.com/translations/login/en-US" type="text/javascript"></script><script type="text/javascript" id="janrainAuthWidget" src="https://cssjs.nejm.org/akamai/mms-prod.js"></script><script type="text/javascript" src="https://www.nejm.org/bR5qEdpD9yjmw9IF3vqAsG8AsZwDCto0uIGHb2wut39MWzUrOIDUYoWvNjYWPoasQUS4vGRkCDfH8lRaWBR7Vg=="></script>
            

<meta charset="UTF-8">






    
        
            
        
    
        
            
        
    
        
            
        
    
        
            
        
    
        
    
        
    
        
            
                
                
<title>Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | New England Journal of Medicine</title>





                
            
        
    







    
        
            
        
    
        
            
        
    
        
            
                
                



                
            
        
    
        
            
        
    
        
    
        
    
        
            
        
    











    








    

    
    

    
    
    
    
        
            
                <link rel="stylesheet" type="text/css" href="/wro/1125813~article-metrics.css">
            
            
            
        
    

    
    
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_nejm_1-994b0160d1eb33dc79517ef0295aab1b.ico" type="image/x-icon">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_16-4aa032aa775940f725817b7ff42f0e2c.png" type="image/png" sizes="16x16">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_32-0a94fa44823476ffa0bb15bdb320fb34.png" type="image/png" sizes="32x32">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_152-d6c3522864a8e483996b7e9c132c901a.png" sizes="152x152">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_180-f2538afc53a365d4cd3f10ab73c56aad.png" sizes="180x180">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_167-8e888012bbdd31a00c3e54bc5b8ca5b6.png" sizes="167x167">
        
    

    
    
            <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-5b89b331018866a4a965.css" media="all">
        <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/print-5b89b331018866a4a965.css" media="print">
           <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css" media="all" id="article-style-sheet">
    
        <script nonce="94d6a59084c8e7d5-SJC">
        try {
            document.documentElement.classList.add('js');
        } catch (e) {
        }
    </script>
     
    

















    
        
            
                
                
                
                    
                    <!-- TrustArc Scripts -->
<script async="async" src="https://consent.trustarc.com/notice?domain=nejm.com&amp;c=teconsent&amp;js=nj&amp;noticeType=bb&amp;gtm=1&amp;text=true&amp;pcookie" crossorigin="" id="truste_0.7962749005897285"></script>
<script src="https://consent.trustarc.com/autoblockasset/core.min.js?domain=nejm.com"></script>
<script src="https://consent.trustarc.com/autoblockoptout?domain=nejm.com"></script>
<!-- /TrustArc Scripts -->
<!-- BlueConic Scripts -->
<script src="https://bc.nejm.org/script.js"></script>
    <!-- /BlueConic Scripts -->
<!-- Printing Meta Tags -->
    <meta name="Specialties" content="Infectious Disease">
<meta name="articleType" content="Original Article">
<meta name="articleCategory" content="Research">
<meta name="topics" content="Vaccines|Coronavirus"><script type="text/javascript">var mmsData = {"access":{"isFreeCountry":"n"},"ad":{"category":"article"},"imageChallenge":{"id":null},"article":{"doi":"10.1056/NEJMoa2113017","title":"Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase","category":"Research","type":"Original Article","topics":"Vaccines|Coronavirus","specialties":"Infectious Disease","seriesTitle":"","viewType":"Full","age":"2Years-1990","issueDate":"2021-11-04T00:00Z","isFree":"y","broadTopics":"","perspectiveTopics":"","granularTopics":"","methodologicalArea":"","isOnlineFirst":"n","isCurrentIssue":"n","metaTags":"\u003cmeta name\u003d\"Specialties\" content\u003d\"Infectious Disease\"/\u003e\n\u003cmeta name\u003d\"articleType\" content\u003d\"Original Article\"/\u003e\n\u003cmeta name\u003d\"articleCategory\" content\u003d\"Research\"/\u003e\n\u003cmeta name\u003d\"topics\" content\u003d\"Vaccines|Coronavirus\"/\u003e"},"page":{"activity":"showFullText","url":"www.nejm.org/doi/full/10.1056/NEJMoa2113017","viewType":"desktop","journal":"NEJM"},"user":{"ucid":null,"audienceSegment":null,"specialtyGroupCode":null,"meterCountRemaining":null,"totalMeterCount":null},"object":[{"type":"Quick Take","title":"The mRNA-1273 SARS-CoV-2 Vaccine at 5 Months’ Follow-up","doi":"10.1056/NEJMdo006229","issueDate":"2021-11-04T00:00Z","age":"6Months-1990","isFree":"n","topics":"Vaccines|Coronavirus","viewType":"Full","specialties":"Infectious Disease"},{"type":"Research Summary","title":"Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase","doi":"10.1056/NEJMdo006230","issueDate":"2021-11-04T00:00Z","age":"6Months-1990","isFree":"n","topics":"Vaccines|Coronavirus","viewType":"Full","specialties":"Infectious Disease"},{"type":"Visual Abstract","title":"Efficacy of mRNA-1273 SARS-CoV-2 Vaccine","doi":"10.1056/NEJMdo006254","issueDate":"2021-11-04T00:00Z","age":"6Months-1990","isFree":"y","topics":"Vaccines|Coronavirus","viewType":"Full","specialties":"Infectious Disease"}]};</script>
    <script type="text/javascript">var mmsDataAdd = {"user":{"customerType":"null","accessInstitutionID":"null"}};</script>
    <!-- Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- placeholder id=null, description=Adobe-Target-Prehiding-Snippet --><!--
  Adobe Target - Prehiding Snippet
  v2.0.0
-->
<script nonce="94d6a59084c8e7d5-SJC">
function tgtNoFlicker(e,n,t,o,i,c,l,r){function d(){return n.getElementsByTagName("head")[0]}function a(e,t){if(e){var o=n.getElementById(t);o&&e.removeChild(o)}}function f(e,o){!function(e,t,o){if(e){var i=n.createElement("style");i.id=t,i.innerHTML=o,e.appendChild(i)}}(d(),t,e),setTimeout(function(){a(d(),t)},o)}var m;n.location.href.indexOf(c)>-1?f(l,r):f(o,i),n.location.href.indexOf("mboxDisable")>-1?(a(d(),t),console.log("[TARGET] - Disabled, removing prehiding style")):(m=function(e){e&&(a(d(),t),console.log("[TARGET] - Blocked, removing prehiding style"))},fetch("//cdn.tt.omtrdc.net/cdn/target-vec.js",{method:"HEAD",mode:"no-cors"}).then(e=>m(!1)).catch(e=>m(!0)))}

tgtNoFlicker(window, document, 'at-body-style', 'div[data-location-name="Anonymous Module"], div[data-location-name="Anonymous Banner"], main > div.page-body > div > div > div > div.col-md-2-3.o-col.o-col--primary > div[class*="u-hide"], main > div.page-body > div > div > div > div.col-md-1-3.o-col.o-col--secondary > aside, header > h1#mainContent, a.m-article__link[href*="/10.1056/NEJMoa2116747"] > span.m-article__blurb > p, li.g-nejm-group__user-tool-secondary {opacity: 0 !important}', 3000);

tgtNoFlicker(window, document, 'at-mbox-style', '.N-ad-global-top-right, #N-ad-myNEJM-contextual-top, .N-ad-recentArticles, #N-ad-article-rightRail-1, #N-ad-siteWide-rightRail-1, #N-ad-imageChallenge-rightRail-2 {opacity: 0 !important}', 3000);
</script><!-- /Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- Launch Header Embed Code -->
    <script src="//assets.adobedtm.com/launch-ENcd6450fae3ae4870becbe6a2b01ab2e1.min.js" async="" type="ta-blocked" data-ta-blocked="1"></script>
    <!-- /Launch Header Embed Code -->

                    
                
            
        
    
        
            
                
                
                
                    
                    <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="New England Journal of Medicine"><meta name="dc.Title" content="Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase"><meta name="dc.Creator" content="Hana M. El Sahly"><meta name="dc.Creator" content="Lindsey R. Baden"><meta name="dc.Creator" content="Brandon Essink"><meta name="dc.Creator" content="Susanne Doblecki-Lewis"><meta name="dc.Creator" content="Judith M. Martin"><meta name="dc.Creator" content="Evan J. Anderson"><meta name="dc.Creator" content="Thomas B. Campbell"><meta name="dc.Creator" content="Jesse Clark"><meta name="dc.Creator" content="Lisa A. Jackson"><meta name="dc.Creator" content="Carl J. Fichtenbaum"><meta name="dc.Creator" content="Marcus Zervos"><meta name="dc.Creator" content="Bruce Rankin"><meta name="dc.Creator" content="Frank Eder"><meta name="dc.Creator" content="Gregory Feldman"><meta name="dc.Creator" content="Christina Kennelly"><meta name="dc.Creator" content="Laurie Han-Conrad"><meta name="dc.Creator" content="Michael Levin"><meta name="dc.Creator" content="Kathleen M. Neuzil"><meta name="dc.Creator" content="Lawrence Corey"><meta name="dc.Creator" content="Peter Gilbert"><meta name="dc.Creator" content="Holly Janes"><meta name="dc.Creator" content="Dean Follmann"><meta name="dc.Creator" content="Mary Marovich"><meta name="dc.Creator" content="Laura Polakowski"><meta name="dc.Creator" content="John R. Mascola"><meta name="dc.Creator" content="Julie E. Ledgerwood"><meta name="dc.Creator" content="Barney S. Graham"><meta name="dc.Creator" content="Allison August"><meta name="dc.Creator" content="Heather Clouting"><meta name="dc.Creator" content="Weiping Deng"><meta name="dc.Creator" content="Shu Han"><meta name="dc.Creator" content="Brett Leav"><meta name="dc.Creator" content="Deb Manzo"><meta name="dc.Creator" content="Rolando Pajon"><meta name="dc.Creator" content="Florian Schödel"><meta name="dc.Creator" content="Joanne E. Tomassini"><meta name="dc.Creator" content="Honghong Zhou"><meta name="dc.Creator" content="Jacqueline Miller"><meta name="dc.Description" content="At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 (Covid-19). After emergency..."><meta name="Description" content="At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 (Covid-19). After emergency..."><meta name="dc.Publisher" content="Massachusetts Medical Society"><meta name="dc.Date" scheme="WTN8601" content="2021-11-04"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1056/NEJMoa2113017"><meta name="dc.Identifier" scheme="publisher-id" content="NJ202111043851908"><meta name="dc.Language" content="EN"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="Copyright © 2021 Massachusetts Medical Society. All rights reserved.">




<link rel="meta" type="application/atom+xml" href="https://doi.org/10.1056%2FNEJMoa2113017">
<link rel="meta" type="application/rdf+json" href="https://doi.org/10.1056%2FNEJMoa2113017">
<link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1056%2FNEJMoa2113017">


                    
                
            
        
    
        
            
                
                
                
                
                
            
        
    
        
            
                
                
                
                    
                    





<meta name="robots" content="noarchive">





    





    
    
        
        <meta name="twitter:title" content="Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM">
        <meta property="og:title" content="Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM">
    


    <meta property="og:type" content="article">


    
    
        <meta property="og:url" content="https://www.nejm.org/doi/full/10.1056/NEJMoa2113017">
    
    


    
    
        <meta property="og:image" content="https://www.nejm.org/cms/asset/cd9a6d07-b425-4d9f-8d58-c18c4c45e968/nejmoa2113017_f0.jpg">
        <meta name="twitter:image" content="https://www.nejm.org/cms/asset/cd9a6d07-b425-4d9f-8d58-c18c4c45e968/nejmoa2113017_f0.jpg">
    



    <meta property="og:site_name" content="The New England Journal of Medicine">


    
    
        
        <meta property="og:description" content="At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial,
the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019
(Covid-19). After emergency...">
        <meta name="twitter:description" content="At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial,
the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019
(Covid-19). After emergency...">
    


    
    
        <meta property="og:image:width" content="2640">
    


    
    
        <meta property="og:image:height" content="3416">
    


    <meta name="twitter:card" content="summary">


    <meta name="twitter:site" content="@NEJM">


<meta name="viewport" content="width=device-width,initial-scale=1"><meta name="citation_fulltext_world_readable" content="">
    <meta name="publication_doi" content="10.1056/NEJMoa2113017">


    















                    
                
            
        
    
        
    
        
    
        
            
                
                
                
                
                
            
        
    




<meta name="format-detection" content="telephone=no">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
    




    
        
        
        <link rel="canonical" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2113017">
    
    







<meta name="pbContext" content=";requestedJournal:journal:nejm;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:MMS NextGen Website Group;issue:issue:doi\:10.1056/nejm_2021.385.issue-19;article:article:doi\:10.1056/NEJMoa2113017;pageGroup:string:Publication Pages;subPage:string:Full Text;website:website:mms-site;journal:journal:nejms">
        <script id="altmetric-embed-js" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-288192a491f0ad9cc434f05ea175659426f5ab0cfd6befb3f3592f96bb90b0d1.js"></script><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-933-8e181dff8b36ea01dc4c.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-34-6ea546d794fb7a1cea52.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-743-ddd329e1530654ec0846.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-305-9eee37798fdfe5196307.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-388-bb098c62445f518c0b46.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-556-8e58ca05fb5497e541ef.css"><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/0-dfd243c732a07d3608f6.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/7-10d355ba95f7ec1fddf2.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/11-04bf2a0da30146b4a5d0.js"></script><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><link rel="preconnect" href="https://use.typekit.net"><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><link rel="stylesheet" href="https://quilt-cdn.janrain.com/HEAD/providers.css" type="text/css"><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css"></head>
    

    



    
        
        
        
            <body class="pb-ui website-mms-site loaded">
            






    
    
        





    
    
        
        
    
    
    







<input type="hidden" id="isRoMode" name="isRoMode" value="false">

        <div id="pb-page-content" data-ng-non-bindable="">
                
            <div data-pb-dropzone="main" data-pb-dropzone-name="Main">
                
                    
                        



        
        <header data-sticky="false" class="ng-header js_stickyAd"><a href="#mainContent" class="ng-skipToMainContent">Skip to main content</a><div class="ng-header_topAd"><div class="ng-header_topAd-content d-flex justify-content-center align-items-center">



        
        <div id="DTM_Position_Topbanner" class="ad">
 <!--emptycomment-->
</div>
</div></div><div class="ng-header_journal-navbar"><div class="ng-header_journal-navbar-content"><div class="container-fluid"><div class="row"><div class="ng-header_journal-navbar_left col-lg-8 col-sm-12 pr-lg-0 d-flex align-items-center"><div data-location="nejm_group_product_nav" class="ng-header_journalNavMenu">



        
        <nav data-location="nejm_group_product_nav" role="navigation" class="ng-journalNavMenu">
<ul class="ng-journalNavMenu_list">
<li class="ng-journalNavMenu_list-item"><a href="/" class="ng-journalNavMenu_mainLink active" aria-current="page" aria-label="The New England Journal of Medicine selected item"><span class="ng-journalNavMenu_mainLink-text d-lg-block d-none">The New England Journal of Medicine</span><span class="ng-journalNavMenu_mainLink-text d-lg-none d-block">NEJM</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://evidence.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Evidence</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://ai.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> AI</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://catalyst.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Catalyst</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://www.jwatch.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Journal Watch</span></a></li>
</ul>
</nav>

</div></div><div class="ng-header_journal-navbar_right col-lg-4 pl-lg-0 d-none d-xl-flex align-items-center justify-content-end"><div class="ng-header_loginBar d-xl-flex align-items-lg-center">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2113017" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div></div><div class="ng-header_instBanner d-none d-lg-block"></div><div class="ng-header_logoBar"><div class="container-fluid"><div class="row"><div data-location="logo" class="ng-header_logoBar_left col-lg-4 col-6 d-flex align-items-center justify-content-start"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-logo-166667e91992a5212bc723b03e45d39f.svg" alt="The New England Journal of Medicine homepage" width="366" height="58" class="ng-header_logo-image"></a></div><div class="ng-header_logoBar_right ng-header_navBar col-lg-8 col-sm-12 p-lg-0 align-items-center justify-content-end"><div class="ng-header_navBar-content"><div class="container-fluid"><div class="row"><div class="ng-header_instBanner-md col-12 d-block d-lg-none"></div><div class="ng-header_loginBar-md col-12 d-block d-xl-none">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2113017" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div><div class="ng-header_navBar_left col-lg-8 col-sm-12 d-flex align-items-center"><div class="ng-header_stickyLogo mr-32"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-small-logo-070df7a3f4d8cfa2e71c3c45bb4b172f.svg" alt="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-image"></a></div><div class="ng-header_mainMenu">









    
    
        <div data-widget-def="menuWidget" data-widget-id="97fb3983-db63-4b0b-97dd-d9bb7929fce1" data-location="main_nav">
        



        
        <nav class="ng-menu"><ul class="ng-menu_list ng-simple-menu"><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/toc/nejm/current" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">current issue</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/toc/nejm/current" class="ng-simple-menu_list-link">VIEW CURRENT ISSUE</a></li><li class="ng-simple-menu_list-item"><a href="/toc/nejm/recently-published" class="ng-simple-menu_list-link">BROWSE RECENTLY PUBLISHED</a></li><li class="ng-simple-menu_list-item"><a href="/loi/nejm" class="ng-simple-menu_list-link">BROWSE ALL ISSUES</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/medical-specialties" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">SPECIALTIES</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/browse/specialty/cardiology" class="ng-simple-menu_list-link">Cardiology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/clinical-medicine" class="ng-simple-menu_list-link">Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/endocrinology" class="ng-simple-menu_list-link">Endocrinology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/gastroenterology" class="ng-simple-menu_list-link">Gastroenterology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/hematology-oncology" class="ng-simple-menu_list-link">Hematology/Oncology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/infectious-disease" class="ng-simple-menu_list-link">Infectious Disease</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/nephrology" class="ng-simple-menu_list-link">Nephrology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/neurology-neurosurgery" class="ng-simple-menu_list-link">Neurology/Neurosurgery</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/obstetrics-gynecology" class="ng-simple-menu_list-link">Obstetrics/Gynecology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pediatrics" class="ng-simple-menu_list-link">Pediatrics</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pulmonary-critical-care" class="ng-simple-menu_list-link">Pulmonary/Critical Care</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/surgery" class="ng-simple-menu_list-link">Surgery</a></li><li class="ng-simple-menu_list-item"><a href="/medical-specialties" class="ng-simple-menu_list-link">View All Specialties</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/topics" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">TOPICS</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/ai-in-medicine" class="ng-simple-menu_list-link">AI in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/climate-change" class="ng-simple-menu_list-link">Climate Change</a></li><li class="ng-simple-menu_list-item"><a href="/coronavirus" class="ng-simple-menu_list-link">Coronavirus</a></li><li class="ng-simple-menu_list-item"><a href="/equity" class="ng-simple-menu_list-link">Efforts toward Equity</a></li><li class="ng-simple-menu_list-item"><a href="/firearm-injury-prevention" class="ng-simple-menu_list-link">Firearm Injury Prevention</a></li><li class="ng-simple-menu_list-item"><a href="/nam" class="ng-simple-menu_list-link">From the National Academy of Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/fundamentals-of-medical-ethics" class="ng-simple-menu_list-link">Fundamentals of Medical Ethics</a></li><li class="ng-simple-menu_list-item"><a href="/gray-matters" class="ng-simple-menu_list-link">Gray Matters</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/health-policy" class="ng-simple-menu_list-link">Health Policy</a></li><li class="ng-simple-menu_list-item"><a href="/medicine-and-society" class="ng-simple-menu_list-link">Medicine and Society</a></li><li class="ng-simple-menu_list-item"><a href="/nutrition-in-medicine" class="ng-simple-menu_list-link">Nutrition in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/outbreaks" class="ng-simple-menu_list-link">Outbreaks Center</a></li><li class="ng-simple-menu_list-item"><a href="/race-and-medicine" class="ng-simple-menu_list-link">Race and Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/recognizing-historical-injustices" class="ng-simple-menu_list-link">Recognizing Historical Injustices and the Journal</a></li><li class="ng-simple-menu_list-item"><a href="/tobacco-use-reduction" class="ng-simple-menu_list-link">Tobacco Use Reduction</a></li><li class="ng-simple-menu_list-item"><a href="/topics" class="ng-simple-menu_list-link">View All Topics</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/multimedia" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">MULTIMEDIA</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/rss-feed" class="ng-simple-menu_list-link">Podcasts</a></li><li class="ng-simple-menu_list-item"><a href="/double-take" class="ng-simple-menu_list-link">Double Takes</a></li><li class="ng-simple-menu_list-item"><a href="https://illustrated-glossary.nejm.org/" class="ng-simple-menu_list-link">Illustrated Glossary</a></li><li class="ng-simple-menu_list-item"><a href="/image-challenge" class="ng-simple-menu_list-link">Image Challenge</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/images-in-clinical-medicine" class="ng-simple-menu_list-link">Images in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/interactive-medical-case" class="ng-simple-menu_list-link">Interactive Medical Cases</a></li><li class="ng-simple-menu_list-item"><a href="/plain-language-research-summaries" class="ng-simple-menu_list-link">Plain Language/Research Summaries</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia/quick-take-video" class="ng-simple-menu_list-link">Quick Takes</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/videos-in-clinical-medicine" class="ng-simple-menu_list-link">Videos in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia" class="ng-simple-menu_list-link">View All Multimedia</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/learning" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">LEARNING/CME</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/continuing-medical-education" class="ng-simple-menu_list-link">Weekly CME</a></li><li class="ng-simple-menu_list-item"><a href="/cme-ce/obesity" class="ng-simple-menu_list-link">Obesity CME/CE</a></li><li class="ng-simple-menu_list-item"><a href="/learning" class="ng-simple-menu_list-link">VIEW ALL LEARNING/CME</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item"><a href="/author-center/home" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">AUTHOR CENTER</span></a></li></ul></nav>

        </div>
    

</div><button aria-label="Search" class="ng-header_searchBtn searchBtnNav d-block ml-24"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button></div><div class="ng-header_loginBar ng-header_loginBar-sticky col-4">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2113017" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div><div class="ng-header_logoBar_right-lg col-lg-8 col-6 d-flex align-items-center justify-content-end d-xl-none"><button aria-label="Search" class="ng-header_searchBtn d-flex justify-content-end"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><div class="ng-header_openCloseBtns d-flex align-items-center justify-content-end"><button aria-label="Open" class="ng-header_openBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#burger"></use></svg></span></button><button aria-label="Close" class="ng-header_closeBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></button></div></div><div class="ng-header_quickSearch col-12"><div class="ng-header_quickSearch-content">



        
        <div class="ng-quick-search js-ng-quick-search"><form action="/search" method="get" class="ng-quick-search_form js-form"><div class="ng-quick-search_inputArea js-inputArea"><input type="search" name="q" placeholder="Enter keyword, author, title or citation" autocomplete="off" value="" required="required" class="ng-quick-search_allField ng-large-text-input js-allField js-allField-def-tmpl ui-autocomplete-input"><button type="submit" aria-label="Search Button" class="ng-quick-search_iconBtn d-xl-none d-block js-submitBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" style="display: none;"></ul></div><div class="ng-quick-search_btnsArea d-none d-xl-flex align-items-center justify-content-end"><a href="/search/advanced" class="ng-quick-search_advSearchLink ng-btn_link js-advancedSearchLink">Advanced Search</a><button type="submit" class="ng-quick-search_textBtn ng-btn_secondary ng-btn_iconRight js-submitBtn"><span class="ng-btn_text">SEARCH</span><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-right"></use></svg></span></button></div></form></div>
</div></div></div></div></div></header><div class="ng-header_overlay"></div><div class="ng-header_after">









    
    
        <div data-widget-def="literatumAd" data-widget-id="4931ddbd-d46e-4597-b4fd-92549e9847ca" id="ad-global-banner-FULLx64-1">
        



        
        



    

    

    
        
    



        </div>
    

</div>

                    
                        



        
        <div>









    
    
        <main data-widget-def="axelPublicationContent" data-widget-id="fcdb5261-d6a2-4a9c-81d5-3a3e2304e9c1" id="mainContent">
        



        
        <div class="article-tools__savePopup"><div class="ng-save"><input type="hidden" value="/action/getSavedTags" class="getKeywordsServiceUrl"><input type="hidden" value="/action/mmsSaveItemsService?itemType=article" class="saveServiceUrl"><input type="hidden" value="article" class="saveType"><input type="hidden" value="10.1056/NEJMoa2113017" class="inputDoi"><input type="hidden" value="H.M. El Sahly and Others" class="inputAuthor"><input type="hidden" value="N Engl J Med 2021;385:1774-1785" class="inputCitation"><input type="hidden" value="09-22-2021" class="inputEPubDate"><input type="hidden" value="November 2021" class="inputCoverDate"><input type="hidden" value="Original Article" class="inputContentType"><input type="hidden" value="Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase" class="inputArticleTitle"><input type="hidden" value="/browse/nejm-article-type/original-article" class="inputContentTypeUrl"><button type="button" id="saveArticleShowPopupBtn" aria-hidden="true" tabindex="-1" class="ng-save-btn ng-btn_secondary isLoggedOut">Save</button></div></div><div class="article-tools__articleAlertPopup"><div id="articleAlertModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="articleAlertModalTitle" class="ng-modal_title modal-title">Create an E-mail Alert for This Article</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><div class="ng-do-media_popup modal-lg"><div id="doPopup" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" data-type="research-article" vocab="http://schema.org/" typeof="ScholarlyArticle" lang="en" dir="ltr"><header data-extent="frontmatter" data-location="header_article"><div class="core-container"><div data-article-access="free" data-article-access-type="free" class="meta-panel"><div class="meta-panel__left-content"><div class="meta-panel__type"><a href="/browse/nejm-article-type/original-article">Original Article</a></div></div><div class="meta-panel__right-content"><div class="meta-panel__share">









    
    
        <div data-widget-def="UX3share" data-widget-id="eee5f139-16f2-48f8-97ea-1b114367da16" data-location="share_tools_article">
        



        
        <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js" nonce="94d6a59084c8e7d5-SJC"></script><div class="share"><div class="share__block share__inline-links"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="d-flex list-unstyled a2a a2a_kit a2a_default_style mb-0 a2a_kit_size_32" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Facebook" data-interactiontype="social" class="share__link a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-facebook"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="X (formerly Twitter)" data-interactiontype="social" class="share__link a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-twitter"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Linked In" data-interactiontype="social" class="share__link a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-linkedin"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Email" data-interactiontype="content_email_click" class="share__link a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-email"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" data-interactiontype="social" class="share__link a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-bluesky"></use></svg></span></a></li></ul></div></div>

        </div>
    

</div></div></div><h1 property="name">Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase</h1><div class="core-relations my-3"></div><div class="contributors"><span class="authors"><span class="heading">Authors</span>: <span role="list"><span property="author" typeof="Person" role="listitem"><span property="givenName">Hana M.</span> <span property="familyName">El Sahly</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-0489-0074" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-0489-0074</a></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Lindsey R.</span> <span property="familyName">Baden</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Brandon</span> <span property="familyName">Essink</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Susanne</span> <span property="familyName">Doblecki-Lewis</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Judith M.</span> <span property="familyName">Martin</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Evan J.</span> <span property="familyName">Anderson</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-1576-4420" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-1576-4420</a></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Thomas B.</span> <span property="familyName">Campbell</span>, <span property="honorificSuffix">M.D.</span></span><span data-displayed-on="all">, <span data-action="reveal" tabindex="0" role="listitem">+31</span> </span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Jesse</span> <span property="familyName">Clark</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0001-5862-6530" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0001-5862-6530</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Lisa A.</span> <span property="familyName">Jackson</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-1785-0218" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-1785-0218</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Carl J.</span> <span property="familyName">Fichtenbaum</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Marcus</span> <span property="familyName">Zervos</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Bruce</span> <span property="familyName">Rankin</span>, <span property="honorificSuffix">D.O.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Frank</span> <span property="familyName">Eder</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Gregory</span> <span property="familyName">Feldman</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Christina</span> <span property="familyName">Kennelly</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Laurie</span> <span property="familyName">Han-Conrad</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Michael</span> <span property="familyName">Levin</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Kathleen M.</span> <span property="familyName">Neuzil</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Lawrence</span> <span property="familyName">Corey</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-2179-2436" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-2179-2436</a></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Peter</span> <span property="familyName">Gilbert</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Holly</span> <span property="familyName">Janes</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Dean</span> <span property="familyName">Follmann</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Mary</span> <span property="familyName">Marovich</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Laura</span> <span property="familyName">Polakowski</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">John R.</span> <span property="familyName">Mascola</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Julie E.</span> <span property="familyName">Ledgerwood</span>, <span property="honorificSuffix">D.O.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Barney S.</span> <span property="familyName">Graham</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Allison</span> <span property="familyName">August</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Heather</span> <span property="familyName">Clouting</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Weiping</span> <span property="familyName">Deng</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Shu</span> <span property="familyName">Han</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Brett</span> <span property="familyName">Leav</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Deb</span> <span property="familyName">Manzo</span>, <span property="honorificSuffix">M.Sc.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Rolando</span> <span property="familyName">Pajon</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Florian</span> <span property="familyName">Schödel</span>, <span property="honorificSuffix">M.D., Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Joanne E.</span> <span property="familyName">Tomassini</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Honghong</span> <span property="familyName">Zhou</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, and <span property="author" typeof="Person" role="listitem"><span property="givenName">Jacqueline</span> <span property="familyName">Miller</span>, <span property="honorificSuffix">M.D.</span></span></span>, for <span property="author" typeof="Person" role="listitem">the COVE Study Group<sup><a href="#fn1" role="doc-noteref">*</a></sup></span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">-31</span></span></span></span><a href="#tab-contributors" class="to-authors-affiliations" data-id="article-authors-viewall">Author Info &amp; Affiliations</a></div><div class="core-self-citation"><div class="core-date-published">Published <span property="datePublished">September 22, 2021</span></div><div property="isPartOf" typeof="Periodical"><span property="name">N Engl J Med</span> 2021<span property="isPartOf" typeof="PublicationVolume">;<span property="volumeNumber">385</span></span>:<span property="pageStart">1774</span>-<span property="pageEnd">1785</span></div><div class="doi">DOI: 10.1056/NEJMoa2113017</div><div class="core-enumeration"><a href="/toc/nejm/385/19"><span property="isPartOf" typeof="PublicationVolume">VOL. <span property="volumeNumber">385</span></span> <span property="isPartOf" typeof="PublicationIssue">NO. <span property="issueNumber">19</span></span></a></div><div><a href="#tab-information">Copyright © 2021</a></div></div><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__metrics info-panel__item"></div></div><div data-location="tools_article" class="info-panel__right-content"><div class="info-panel__article_tools info-panel__item">



        
        <div data-permission="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DHana%2BM.%2BEl%2BSahly%252C%2BLindsey%2BR.%2BBaden%252C%2BBrandon%2BEssink%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D385%26issueNum%3D19%26contentID%3D10.1056%252FNEJMoa2113017%26title%3DEfficacy%2Bof%2Bthe%2BmRNA-1273%2BSARS-CoV-2%2BVaccine%2Bat%2BCompletion%2Bof%2BBlinded%2BPhase%26publicationDate%3D11%252F04%252F2021" class="article-tools"><button id="articleToolsAlertBtn" data-url="/action/addCitationAlert?doi=10.1056%2FNEJMoa2113017" data-toggle="" data-target="#articleAlertModal" aria-label="Sign in or create account to add an article alert" data-interactiontype="article_alert" class="article-tools__citation btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to add an article alert"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#alerts"></use></svg></span></span></button><button id="articleToolsSaveBtn" data-toggle="modal" data-target="#saveArticle" aria-label="Sign in or create account to save this article" data-interactiontype="article_tools_save_click" class="article-tools__favorite btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to save this article"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#bookmarkFilled"></use></svg></span></span></button><a href="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DHana%2BM.%2BEl%2BSahly%252C%2BLindsey%2BR.%2BBaden%252C%2BBrandon%2BEssink%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D385%26issueNum%3D19%26contentID%3D10.1056%252FNEJMoa2113017%26title%3DEfficacy%2Bof%2Bthe%2BmRNA-1273%2BSARS-CoV-2%2BVaccine%2Bat%2BCompletion%2Bof%2BBlinded%2BPhase%26publicationDate%3D11%252F04%252F2021" target="_blank" title="" data-toggle="tooltip" aria-label="Permissions" data-interactiontype="article_tools_permissions_click" class="article-tools__permissions btn btn--slim" data-original-title="Permissions"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#permissions"></use></svg></span></a><a href="/about-nejm/reprints" title="" data-toggle="tooltip" aria-label="Reprints" data-interactiontype="article_tools_reprints_click" class="article-tools__reprints btn btn--slim" data-original-title="Reprints"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#reprints"></use></svg></span></a><a href="/cms/asset/6876a126-2328-4c8f-8809-3ef41341e6e5/nejmoa2113017.pptx" target="_blank" title="" data-toggle="tooltip" aria-label="Download Slides" data-interactiontype="article_tools_slide_set_download" data-multimedia-type="Article Slideset" data-multimedia-filename="nejmoa2113017.pptx" class="article-tools__downloadSlides btn btn--slim" data-original-title="Download Slides"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#download"></use></svg></span></a><div class="article-tools__permissionsPopup"><div id="permissionsModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="permissionsModalTitle" class="ng-modal_title modal-title">Permissions</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body">For permission requests, please contact NEJM Reprints at <a href="mailto:reprints@nejm.org">reprints@nejm.org</a></div></div></div></div></div></div>
</div><div class="info-panel__citations info-panel__item"><a href="#tab-citations" class="btn btn--slim" aria-label="View Citations" data-toggle="tooltip" data-original-title="View Citations" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><i aria-hidden="true" class="icon-format_quote"></i></a></div><div class="info-panel__formats info-panel__item"><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2113017" class="btn btn--pdf btn--slim" aria-label="View PDF" data-toggle="tooltip" data-original-title="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2113017" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2113017.pdf"><i aria-hidden="true" class="icon-PDF"></i></a></div></div></div></div></header><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Contents</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><ul><li><a href="#summary-abstract" aria-current="true">Abstract</a></li><li><a href="#sec-1" aria-current="false">Methods</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li class="bordered"><a href="#backnotes" aria-current="false">Notes</a></li><li><a href="#supplementary-materials" aria-current="false">Supplementary Material</a></li><li><a href="#bibliography" aria-current="false">References</a></li></ul></nav></div><nav id="article_collateral_menu"><ul data-core-nav="collateral" class="collateral-pill" style="margin-top: 0px;"><li><a href="#core-collateral-info" data-id="article-nav-menubar-info" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Information &amp; Authors"><i aria-hidden="true" class="icon-info"></i><span class="sr-only">Information &amp; Authors</span></a></li><li><a href="#core-collateral-metrics" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Metrics &amp; Citations"><i aria-hidden="true" class="icon-timeline"></i><span class="sr-only">Metrics &amp; Citations</span></a></li><li><a href="#core-collateral-fulltext-options" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="View Options"><i aria-hidden="true" class="icon-eye"></i><span class="sr-only">View Options</span></a></li><li><a href="#core-collateral-references" data-id="article-nav-menubar-references" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="References"><i aria-hidden="true" class="icon-references"></i><span class="sr-only">References</span></a></li><li><a href="#core-collateral-media" data-id="article-nav-menubar-media" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Media"><i aria-hidden="true" class="icon-photo"></i><span class="sr-only">Media</span></a></li><li title="No tables available"><a href="#core-collateral-tables" data-id="article-nav-menubar-tables" disabled="true" aria-disabled="true" title="" tabindex="-1" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Tables"><i aria-hidden="true" class="icon-tables"></i><span class="sr-only">Tables</span></a></li><li><a href="#core-collateral-share" data-id="article-nav-menubar-share" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Share"><i aria-hidden="true" class="icon-share"></i><span class="sr-only">Share</span></a></li></ul></nav></div></div><div data-core-wrapper="content"><div id="abstracts" data-extent="frontmatter" data-location="articleTab_article"><div class="core-container"><section id="summary-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Abstract</h2><section id="abs-sec-1"><h3>Background</h3><div role="paragraph">At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 (Covid-19). After emergency use of the vaccine was authorized, the protocol was amended to include an open-label phase. Final analyses of efficacy and safety data from the blinded phase of the trial are reported.</div></section><section id="abs-sec-2"><h3>Methods</h3><div role="paragraph">We enrolled volunteers who were at high risk for Covid-19 or its complications; participants were randomly assigned in a 1:1 ratio to receive two intramuscular injections of mRNA-1273 (100 μg) or placebo, 28 days apart, at 99 centers across the United States. The primary end point was prevention of Covid-19 illness with onset at least 14 days after the second injection in participants who had not previously been infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The data cutoff date was March 26, 2021.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><!-- There is no content. --><nav><a href="#f0" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f0.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f0" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f0.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/cd9a6d07-b425-4d9f-8d58-c18c4c45e968/assets/images/large/nejmoa2113017_f0.jpg" height="3416" width="2640" aria-labelledby="f0" loading="lazy"></a><figcaption>Download a PDF of the <a href="#ap0">Research Summary</a>.</figcaption></figure></div></section><section id="abs-sec-3"><h3>Results</h3><div role="paragraph">The trial enrolled 30,415 participants; 15,209 were assigned to receive the mRNA-1273 vaccine, and 15,206 to receive placebo. More than 96% of participants received both injections, 2.3% had evidence of SARS-CoV-2 infection at baseline, and the median follow-up was 5.3 months in the blinded phase. Vaccine efficacy in preventing Covid-19 illness was 93.2% (95% confidence interval [CI], 91.0 to 94.8), with 55 confirmed cases in the mRNA-1273 group (9.6 per 1000 person-years; 95% CI, 7.2 to 12.5) and 744 in the placebo group (136.6 per 1000 person-years; 95% CI, 127.0 to 146.8). The efficacy in preventing severe disease was 98.2% (95% CI, 92.8 to 99.6), with 2 cases in the mRNA-1273 group and 106 in the placebo group, and the efficacy in preventing asymptomatic infection starting 14 days after the second injection was 63.0% (95% CI, 56.6 to 68.5), with 214 cases in the mRNA-1273 group and 498 in the placebo group. Vaccine efficacy was consistent across ethnic and racial groups, age groups, and participants with coexisting conditions. No safety concerns were identified.</div></section><section id="abs-sec-4"><h3>Conclusions</h3><div role="paragraph">The mRNA-1273 vaccine continued to be efficacious in preventing Covid-19 illness and severe disease at more than 5 months, with an acceptable safety profile, and protection against asymptomatic infection was observed. (Funded by the Biomedical Advanced Research and Development Authority and the National Institute of Allergy and Infectious Diseases; COVE ClinicalTrials.gov number, <a href="http://clinicaltrials.gov/show/NCT04470427" target="_blank">NCT04470427</a>.)</div></section></section><div class="core-digital-object visual-abstract">
<div class="ng-page_separator pt-24"></div>
<div class="ng-do-media">
    <button data-toggle="modal" data-target="#doPopup" class="ng-do-media_btn" modal-size="lg"></button>
    <div data-ajaxurl="/do/10.1056/NEJMdo006254/full/?ajaxRequest=true" class="ng-do-media_item">
        <div class="ng-do-media_item-left">
            <a href="#" class="ng-do-media_item-img-link" data-interactiontype="multimedia_click" data-multimedia-type="Visual Abstract" data-multimedia-contentid="10.1056/NEJMdo006254" data-multimedia-filename="NEJMdo006254_600x400.jpg">
                <img src="/cms/asset/301ef819-ff78-4791-bdc4-054078cd1ff5/media/NEJMdo006254_300x200.jpg" class="ng-do-media_item-img">
                <span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#tooltip-visual"></use></svg></span>
            </a>
        </div>
        <div class="ng-do-media_item-right">
            <div class="ng-do-media_item-type">
                <a href="/browse/nejm-media-type/visual-abstract" class="ng-do-media_item-type-link">Visual Abstract</a>
            </div>
            <h6 class="ng-do-media_item-title">
                <a href="#" class="ng-do-media_item-title-link" data-interactiontype="multimedia_click" data-multimedia-type="Visual Abstract" data-multimedia-contentid="10.1056/NEJMdo006254" data-multimedia-filename="NEJMdo006254_600x400.jpg">Efficacy of mRNA-1273 SARS-CoV-2 Vaccine</a>
            </h6>
        </div>
    </div>
</div>

</div><div class="core-digital-object quick-take">
<div class="ng-do-media" style="border-top: 1px solid #e5e5e5; padding-top: 1.5rem;" data-location="inlineArticlePreview">
    <div class="ng-do-media_item">
        <div class="ng-do-media_item-left">
            <a href="/do/10.1056/NEJMdo006229/full/" class="ng-do-media_item-img-link">
                <img src="/cms/asset/1cb6014d-840d-41d3-a3f6-f12e4ff987af/media/NEJMdo006229_300x200.jpg" class="ng-do-media_item-img">
                <span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#tooltip-video"></use></svg></span>
            </a>
        </div>
        <div class="ng-do-media_item-right">
            <div class="ng-do-media_item-type">
                <a href="/browse/nejm-media-type/quick-take" class="ng-do-media_item-type-link">Quick Take</a>
            </div>
            <h6 class="ng-do-media_item-title">
                <a href="/do/10.1056/NEJMdo006229/full/" class="ng-do-media_item-title-link">The mRNA-1273 SARS-CoV-2 Vaccine at 5 Months’ Follow-up</a>
            </h6>
            <div class="ng-do-media_item-duration">1m 53s</div>
        </div>
    </div>
</div>
</div></div></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text" data-location="articleTab_article"><div class="core-container"><div role="paragraph">The global morbidity, mortality, and societal disruption caused by the coronavirus disease 2019 (Covid-19) pandemic prompted accelerated clinical vaccine development and regulatory interventions to mitigate some of its consequences. Between December 2020 and February 2021, three vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) on the basis of data from observer-blinded, randomized, controlled trials demonstrating safety and efficacy against Covid-19 after a median follow-up of 2 months after vaccination.<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1 r2 r3 r4" id="body-ref-r4" href-manipulated="true">1-4</a></sup> The short-term efficacy of the vaccines observed in the clinical trials was also observed after vaccine deployment in the general population.<sup><a href="#core-r5" role="doc-biblioref" data-xml-rid="r5 r6 r7 r8 r9 r10" id="body-ref-r10" href-manipulated="true">5-10</a></sup> Longer-term safety and efficacy of the vaccines have remained open questions of public health import.</div><div role="paragraph">The phase 3 trial of mRNA-1273, a lipid nanoparticle–encapsulated mRNA expressing the prefusion-stabilized spike glycoprotein of SARS-CoV-2,<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11" id="body-ref-r11" href-manipulated="true" aria-label="Reference 11">11</a></sup> showed a 94.1% vaccine efficacy against Covid-19, with an acceptable safety and side-effect profile after a median follow-up of 64 days.<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-2" href-manipulated="true" aria-label="Reference 1">1</a></sup> These early findings supported the issuance of the EUA, after which the <a href="#ap1">protocol</a> was amended to offer participants the option of having the group assignments unblinded and, for those who had received placebo, the option to receive the mRNA-1273 vaccine. Here we report the vaccine efficacy and safety results of the final analysis of the blinded phase of the trial, ending 5.3 months after the second dose, and in additional analyses in important subgroups of interest, as well as findings on the effect of vaccination on asymptomatic infection and on efficacy at various time intervals since vaccination.</div><section id="sec-1" data-type="methods"><h2>Methods</h2><section id="sec-1-1"><h3>Trial Oversight</h3><div role="paragraph">In this phase 3, observer-blinded, randomized, placebo-controlled trial, adults in medically stable condition were enrolled at 99 sites in the United States.<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-3" href-manipulated="true" aria-label="Reference 1">1</a></sup> After the FDA issued an EUA for the use of mRNA-1273 in December 2020, the protocol was amended to include two parts (A and B; see Figs. S1 and S2 in the <a href="#ap2">Supplementary Appendix</a>, available together with the protocol with the full text of this article at NEJM.org). Part A, the observer-blinded phase of the trial, concluded when participants were informed of their group assignments; those in the placebo group were offered the opportunity to receive mRNA-1273 (the participant-decision visit). Part B, the open-label phase of the trial, is currently ongoing. Participants will continue to be followed for up to 2 years, as originally planned.</div><div role="paragraph">The trial is being conducted in accordance with the Good Clinical Practice guidelines of the International Council Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, and applicable government regulations. The central institutional review board approved the protocol and the consent forms. All participants provided written informed consent.</div></section><section id="sec-1-2"><h3>Participants, Randomization, and Data Blinding</h3><div role="paragraph">Part A of the trial was a stratified, observer-blinded, randomized, placebo-controlled evaluation of the efficacy, safety, and immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine as compared with placebo in eligible participants who were at least 18 years old and had no known history of SARS-CoV-2 infection and whose locations or circumstances put them at appreciable risk of acquiring SARS-CoV-2 infection or who were at high risk for severe disease (or both).<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-4" href-manipulated="true" aria-label="Reference 1">1</a></sup> Participants were randomly assigned in a 1:1 ratio to receive two doses of the mRNA-1273 vaccine (100 μg) or placebo and were stratified according to age and Covid-19 complications risk criteria (≥18 to &lt;65 years and not at risk, ≥18 to &lt;65 years and at risk, and ≥65 years). The trial design, efficacy assessments, and vaccine have been described previously.<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-5" href-manipulated="true" aria-label="Reference 1">1</a></sup></div></section><section id="sec-1-3"><h3>Safety Assessments</h3><div role="paragraph">Safety measures included solicited local and systemic adverse events with onset during the 7 days after each injection; unsolicited adverse events with onset during the 28 days after each injection; adverse events leading to discontinuation from receiving injections, participating in the trial, or both; medically attended and serious adverse events occurring during the trial; and severity of the events, which were graded as described in the protocol. Safety data, all Covid-19 cases, and severe Covid-19 cases were continuously monitored by the data and safety monitoring board.</div></section><section id="sec-1-4"><h3>Efficacy Assessments</h3><div role="paragraph">Participants provided nasopharyngeal swab and blood samples before the first and second injections of vaccine or placebo and before the unblinding of the group assignments at the participant-decision visit. Efficacy assessments included surveillance for Covid-19 symptoms from enrollment throughout the trial. Efficacy end points were adjudicated by an independent adjudication committee whose members were unaware of group assignments.</div><div role="paragraph">For the primary end point, mRNA-1273 vaccine efficacy in preventing a first occurrence of Covid-19 with onset at least 14 days after the second injection, Covid-19 cases were defined by at least two systemic symptoms (temperature ≥38°C, chills, myalgia, headache, sore throat, or new olfactory or taste disorders), or at least one respiratory sign or symptom (cough, shortness of breath, or clinical or radiologic evidence of pneumonia), and were confirmed by positive SARS-CoV-2 reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay of nasopharyngeal swab, nasal, or saliva samples. Participants were monitored daily for at least 14 days after diagnosis or until symptoms resolved. Severe Covid-19 was defined as confirmed Covid-19 plus one clinical sign of severe systemic illness (Tables S1 and S2). Secondary end points include the efficacy of the mRNA-1273 vaccine in preventing severe Covid-19, Covid-19 after the first dose, Covid-19 regardless of prior SARS-CoV-2 infection, Covid-19 according to a secondary definition (the Centers for Disease Control and Prevention definition, requiring only one symptom), serologically confirmed SARS-CoV-2 infection (positive binding antibody against SARS-CoV-2 nucleocapsid protein in participants who were SARS-CoV-2–negative at baseline), SARS-CoV-2 infection (positive RT-PCR assay) regardless of symptom status, and asymptomatic SARS-CoV-2 infection (absence of symptoms, with infections starting at least 14 days after the second injection, including seroconversion at day 57 or at the participant-decision visit, or a positive RT-PCR assay at the participant-decision visit).</div></section><section id="sec-1-5"><h3>Statistical Analysis</h3><div role="paragraph">Determination of the sample size (30,000 participants) and aspects of the statistical analysis designed to demonstrate the efficacy of the mRNA-1273 vaccine as compared with placebo for the primary end point, prevention of Covid-19 starting at 14 days after the second dose, were described previously<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-6" href-manipulated="true" aria-label="Reference 1">1</a></sup> and are also provided in the protocol. Analysis populations included the randomization population; the full analysis population, comprising participants who had undergone randomization and received at least one dose of mRNA-1273 or placebo; the modified intention-to-treat population, consisting of participants in the full analysis population who had no immunologic or virologic evidence of SARS-CoV-2 infection before the first dose; the per-protocol population, consisting of participants in the modified intention-to-treat population who received two doses, with no major protocol deviations; and the solicited safety and safety populations (described in Table S3).</div><div role="paragraph">The prespecified primary efficacy analysis was performed in the per-protocol data set, starting 14 days after the second dose of vaccine or placebo. The efficacy of the mRNA-1273 vaccine was estimated with a stratified Cox proportional-hazards model. Incidence rates and vaccine efficacy were estimated by 1 minus the hazard ratio (mRNA-1273 vs. placebo), and the corresponding 95% confidence interval was based on the total number of cases adjusted according to total person-time. Additional details of the primary and secondary efficacy analyses are provided in Table S4 and in Supplementary Methods. The final efficacy analysis presented herein is based on cleaned data through the completion of the blinded phase, Part A, with a data cutoff date of March 26, 2021, when 95.0% of the trial participants had completed the participant-decision visit or had discontinued participation in the trial.</div></section></section><section id="sec-2" data-type="results"><h2>Results</h2><section id="sec-2-1"><h3>Trial Population</h3><div role="paragraph">From July 27 to October 23, 2020, a total of 30,415 participants underwent randomization; 15,206 were assigned to the placebo group and 15,209 to the mRNA-1273 group (<a href="#f1">Figure 1</a> and Fig. S2).<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-7" href-manipulated="true" aria-label="Reference 1">1</a></sup> More than 96% of participants (14,727 in the placebo group and 14,635 in the mRNA-1273 group) received second injections. A total of 531 participants (3.5%) in the placebo group and 453 (3.0%) in the mRNA-1273 group did not receive the second injection, mainly owing to confirmed SARS-CoV-2 infection or withdrawal of consent. Trial discontinuations in the placebo group (691 participants [4.5%]) and the mRNA-1273 group (440 participants [2.9%]) were most commonly due to protocol deviations, withdrawal of consent, or loss to follow-up. The imbalance of discontinuations between the placebo and mRNA-1273 groups coincided with the FDA issuance of the EUAs for Covid-19 vaccines and reflected the intent of placebo recipients to receive a vaccine under EUA as it became available (Fig. S3). By the data cutoff date (March 26, 2021), 27,109 participants had been informed of their group assignments at a participant-decision visit, and 1855 had been informed before the participant-decision visit because they intended to receive a vaccine under EUA through their provider. A total of 28,964 participants entered the open-label phase of the trial.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 1</div><nav><a href="#f1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f1" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f1.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/1a7b1e11-6e57-48e5-9a1e-f2f1c9e8b5be/assets/images/large/nejmoa2113017_f1.jpg" height="2115" width="2640" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Randomization and Analysis Populations.</div><div class="notes"><div role="doc-footnote">Eight participants, including six with major protocol deviations and two who erroneously underwent randomization twice, were excluded from the original randomization population (30,423 participants) and from all analysis sets. The full analysis population comprised all participants who had undergone randomization and received at least one injection; the modified intention-to-treat population included participants in the full analysis population who had no immunologic or virologic evidence of previous Covid-19 (i.e., had both a negative nasopharyngeal swab specimen and a negative anti-nucleocapsid antibody test result) at day 1 before the first injection; and the per-protocol population consisted of all participants in the modified intent-to-treat population who received planned injections according to the schedule and had no major protocol deviations that affected key trial data. The safety population included all participants who had undergone randomization and received at least one injection; this population was used for all safety analyses except the analysis for solicited adverse events. For safety analyses, participants were evaluated according to the injection received. Three participants assigned to the mRNA-1273 group received two doses of placebo and were included in the placebo safety population, and seven participants assigned to the placebo group received one or two doses of mRNA-1273 and were included in the mRNA-1273 safety population. The data cutoff date was March 26, 2021.</div></div></figcaption></figure></div><div role="paragraph">Vaccine safety was assessed among 30,346 participants in the safety population (<a href="#f1">Figure 1</a>). The prespecified primary efficacy analysis was performed in the per-protocol population, which included 28,451 participants who were SARS-CoV-2–negative at baseline and had received two doses of vaccine by the final analysis in the blinded phase. The median duration of follow-up from randomization to data cutoff or trial discontinuation was 212 days (interquartile range, 193 to 225), the duration from the second dose to data cutoff or discontinuation was 183 days (interquartile range, 165 to 194), and the duration from randomization to unblinding was 148 days (interquartile range, 131 to 162). Baseline demographic and clinical characteristics were balanced between the placebo group and the mRNA-1273 group (Table S5).<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-8" href-manipulated="true" aria-label="Reference 1">1</a></sup></div></section><section id="sec-2-2"><h3>Safety</h3><div role="paragraph">At the end of the blinded phase, the frequencies of solicited local and systemic adverse events were consistent with those reported previously,<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1-9" href-manipulated="true" aria-label="Reference 1">1</a></sup> with such events occurring less frequently in the placebo group (in 48% and 43% of participants after the first and second injections, respectively) than in the mRNA-1273 group (88% and 92%) (Fig. S4 and Tables S6 through S13). Women were slightly more likely than men to have grade 3 solicited adverse events after the first and second injections (Table S8). Occurrences of solicited adverse events were generally similar with the two injections, regardless of severe Covid-19 risk status (Table S9), and were less common after both doses among participants with previous SARS-CoV-2 infection than among those without previous SARS-CoV-2 infection, with the exception of systemic adverse events after the first dose of mRNA-1273, which occurred more often in participants previously infected with SARS-CoV-2 (62% vs. 55%, respectively) (Tables S11 and S12). The incidence of local adverse events with delayed onset starting on day 8 after an injection was higher after the first injection (80 participants [0.5%]) than after the second injection (10 participants [&lt;0.1%]), and the most common local adverse event reported on or after day 8 was erythema in the mRNA-1273 group after the first (68 participants [0.4%]) and second (6 [&lt;0.1%]) injections (Table S13).</div><div role="paragraph">The frequencies of unsolicited, severe, and serious adverse events reported during the 28 days after either injection were generally similar in the two groups in the overall safety population, regardless of age or risk factors for severe Covid-19 (Tables S14 through S18). The frequency of grade 3 and medically attended adverse events that were considered to be related to injection of placebo or vaccine was lower in the placebo group (0.2% and 0.6%, respectively) than in the mRNA-1273 group (0.5% and 1.3%) (Table S14). Overall, 0.6% of placebo recipients and 0.4% of vaccine recipients had adverse events that resulted in their not receiving the second dose, and less than 0.1% in both groups discontinued trial participation because of adverse events after either injection. Adverse events that were considered to be related to the injections were reported by 8.5% of placebo recipients and 13.9% of mRNA-1273 recipients during the observation period of the study and were generally similar to those reported previously regardless of age (Tables S19 through S21). Serious injection-related adverse events occurred in 4 placebo recipients (&lt;0.1%) and in 12 mRNA-1273 recipients (&lt;0.1%).</div><div role="paragraph">Hypersensitivity reactions were reported in 1.8% of placebo recipients and in 2.2% of vaccine recipients, with anaphylaxis occurring in 2 participants (&lt;0.1%) in each group (Table S22). Dermal filler reactions were reported in 14 placebo recipients (&lt;0.1%) and in 20 mRNA-1273 recipients (0.1%) with a history of dermal filler injections (Table S23). Three cases of Bell’s palsy (&lt;0.1%) were reported in the placebo group and 8 in the mRNA-1273 group (&lt;0.1%); no case was considered to be related to the placebo or the vaccine (Table S24). Thromboembolic events were observed in 43 placebo recipients (0.3%) and in 47 mRNA-1273 recipients (0.3%) (Table S25). No cases of myocarditis were reported. Pericarditis events occurred in 2 participants each (&lt;0.1%) in the placebo and mRNA-1273 groups (both events &gt;28 days after the second dose) and were considered serious (Tables S20 and S21). A total of 32 deaths had occurred by completion of the blinded phase, with 16 deaths each (0.1%) in the placebo and mRNA-1273 groups; no deaths were considered to be related to injections of placebo or vaccine, and 4 were attributed to Covid-19 (3 in the placebo group and 1 in the mRNA-1273 group) (Tables S19 and S26). The Covid-19 death in the mRNA-1273 group occurred in a participant who had received only one dose; Covid-19 was diagnosed 119 days after the first dose, and the participant died of complications 56 days after diagnosis.</div></section><section id="sec-2-3"><h3>Efficacy Analyses</h3><div role="paragraph">A total of 799 adjudicated cases of Covid-19 in the per-protocol population were included in the primary efficacy analysis; 744 cases (5.3%) were in the placebo group and 55 (0.4%) were in the mRNA-1273 group (<a href="#f2">Figure 2</a> and <a href="#f3">Figure 3</a> and Tables S27 and S28). The vaccine efficacy was 93.2% for the prevention of Covid-19 starting at least 14 days after the second dose, with incidences of 136.6 cases per 1000 person-years (95% confidence interval [CI], 127.0 to 146.8) in the placebo group and 9.6 cases per 1000 person-years (95% CI, 7.2 to 12.5) in the mRNA-1273 group. The vaccine efficacy for adjudicated cases in the modified intention-to-treat population was 92.3% (95% CI, 90.1 to 93.9). Vaccine efficacy in preventing severe Covid-19, a key secondary end point, was 98.2% (95% CI, 92.8 to 99.6) in the per-protocol population, with 106 severe cases in the placebo group and 2 in the mRNA-1273 group. Vaccine efficacy was consistently high in subgroups, including participants 65 years of age or older and 75 years of age or older, those with coexisting conditions, those belonging to various racial and ethnic groups, and those with various categories of occupational risk exposures (<a href="#f4">Figure 4</a> and Table S29). When examined by specific time interval since completion of vaccination over the duration of follow-up, the efficacy of the mRNA-1273 vaccine in preventing Covid-19 remained consistent, with efficacy greater than 90% observed 4 months or more after the second injection (<a href="#f5">Figure 5</a>, Fig. S5, and Table S30). Symptoms most commonly reported in the adjudicated Covid-19 cases in both groups were cough, fatigue, headaches, and nasal congestion; severe obesity and diabetes were contributing risk factors for severe Covid-19 (Tables S31 and S32).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 2</div><nav><a href="#f2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f2" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f2.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/4652d527-7163-470e-8421-106217b707e0/assets/images/large/nejmoa2113017_f2.jpg" height="3438" width="2629" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Efficacy of the mRNA-1273 Vaccine in Preventing Covid-19.</div><div class="notes"><div role="doc-footnote">In Panels A and C, the dashed vertical line denotes the adjudicated assessment beginning at day 42 (14 days after the second injection of vaccine or placebo). Tick marks in all three panels indicate censored data. Vaccine efficacy was defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional-hazards model with Efron’s method of tie handling and with treatment group as a covariate, adjusted for stratification factor. The data cutoff date was March 26, 2021.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 3</div><nav><a href="#f3" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f3.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f3" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f3.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/4657f5e8-6a33-4d2f-8dd2-1b050955e2b2/assets/images/large/nejmoa2113017_f3.jpg" height="1015" width="2640" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Vaccine Efficacy for Primary and Secondary End Points.</div><div class="notes"><div role="doc-footnote">Vaccine efficacy was defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo), and 95% confidence intervals were estimated using a stratified Cox proportional-hazards model with Efron’s method of tie handling and with the treatment group as a covariate, adjusted for stratification factor. The P value for the vaccine efficacy against Covid-19 (upper right corner) is P&lt;0.001. The dashed vertical line represents a vaccine efficacy of 30%, based on the null hypothesis that the primary efficacy of the mRNA-1273 vaccine is 30% or less. In the Covid-19 rows, censoring rules for efficacy analyses (Covid-19 cases based on eligible symptoms and positive reverse-transcriptase–polymerase-chain-reaction [RT-PCR] assay within 14 days before the second injection) were applied, except for deaths from Covid-19. If a participant had a positive RT-PCR assay at the visit before the second dose (day 29) without eligible symptoms within the previous 14 days, or a positive anti-nucleocapsid antibody test at a scheduled visit before Covid-19 was diagnosed, the participant’s data were censored at the date of the positive RT-PCR assay or anti-nucleocapsid antibody test. Covid-19 diagnoses were based on adjudication committee assessments. The data for Covid-19 regardless of previous SARS-CoV-2 status were based on the number of participants in the full analysis population (15,166 participants in the placebo group and 15,180 participants in the mRNA-1273 group). Data for the asymptomatic subgroup include data from the participant-decision visit. Asymptomatic was defined as the absence of symptoms (according to either the primary efficacy end point of Covid-19 or the secondary definition of Covid-19 [the Centers for Disease Control and Prevention definition, requiring only one symptom]) and of infection as detected by RT-PCR assay (at scheduled visits) or seroconversion (anti-nucleocapsid antibody test). In the primary approach, documented asymptomatic infection was counted beginning 14 days after the second injection, which required seroconversion at month 2 (day 57 through the participant-decision visit). Asymptomatic seroconversion excludes infections confirmed by RT-PCR assay only and includes infections confirmed by seroconversion and those confirmed by both RT-PCR and seroconversion (Table S28). Vaccine efficacy and 95% confidence intervals for asymptomatic SARS-CoV-2 infection were estimated with Fine and Gray’s subdistribution hazard model, with disease cases as competing events and with treatment group as a covariate, adjusted for stratification factor. Results for additional end points are summarized in Table S27. The data cutoff date was March 26, 2021. NE indicates that the lower bound of the 95% confidence interval could not be estimated.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 4</div><nav><a href="#f4" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f4.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f4" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f4" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f4.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/19887e6e-08b6-4722-af2e-661850da3213/assets/images/large/nejmoa2113017_f4.jpg" height="3084" width="2640" aria-labelledby="f4" loading="lazy"></a><figcaption><div class="caption">Efficacy of the mRNA-1273 Vaccine in Preventing Covid-19 in Subgroups.</div><div class="notes"><div role="doc-footnote">Analysis of the vaccine efficacy of mRNA-1273 in the prevention of Covid-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the second injection. Vaccine efficacy, defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional-hazards model with Efron’s method of tie-handling and with the treatment group as a covariate, adjusted for stratification factor if applicable. The total number of events for race includes 38 placebo recipients and 3 mRNA-1273 recipients who were in “Multiple,” “Other,” or not reported or unknown categories, and the total number for ethnicity includes 4 placebo recipients and no mRNA-1273 recipients who were in not reported or unknown categories (not shown). Race and ethnic group were reported by the participant. The body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters. Additional subgroup data are provided in Table S29. The data cutoff date was March 26, 2021. HIV denotes human immunodeficiency virus.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 5</div><nav><a href="#f5" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f5.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f5" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f5" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f5.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/53b693ff-6179-441a-bf13-001595ad6b83/assets/images/large/nejmoa2113017_f5.jpg" height="1135" width="2640" aria-labelledby="f5" loading="lazy"></a><figcaption><div class="caption">Incidence of Covid-19 According to Time Periods in the Per-Protocol Population.</div><div class="notes"><div role="doc-footnote">The incidence rate based on adjudicated Covid-19 cases was defined as the number of participants with an event during the period divided by the number of participants at risk at the beginning of each period and adjusted by person-years (total time at risk) in each treatment group. The dashed vertical line represents a vaccine efficacy of 30% based on the null hypothesis that the primary efficacy of the mRNA-1273 vaccine is 30% or less. The number of person-years was calculated from randomization to the date of onset of Covid-19, the end of each time period, the last date of participation in the trial, or the efficacy data cutoff date, whichever date was the earliest. For the analysis of time intervals starting from 14 days after the first injection, starting from the second injection, and starting 14 days after the second injection, assessed every 2 months, person-years for each time period were defined starting from the beginning of each time interval and truncating at the end of the interval (if there was an ending time). Vaccine efficacy was defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo). The 95% confidence interval for the ratio was calculated with the exact method, conditional on the total number of cases and adjusted for person-years for the time period. The data cutoff date was March 26, 2021.</div></div></figcaption></figure></div><div role="paragraph">Secondary end points (<a href="#f3">Figure 3</a> and Table S27) also included vaccine efficacy according to the secondary definition of Covid-19 (the Centers for Disease Control and Prevention definition, requiring only one symptom) starting 14 days after the second injection in the per-protocol population; according to the secondary definition, the vaccine efficacy was 93.4% (95% CI, 91.4 to 94.9). Among participants who were SARS-CoV-2–negative at baseline, a total of 712 participants (498 in the placebo group and 214 in the mRNA-1273 group) were found to be SARS-CoV-2–positive by RT-PCR assay or anti-nucleocapsid antibody test in the absence of symptoms starting 14 days after the second injection, through and including the participant-decision visit, and were considered to have asymptomatic infection (<a href="#f3">Figure 3</a> and Tables S27 and S28). Vaccine efficacy in preventing asymptomatic SARS-CoV-2 infection, based on the hazard ratio using the competing risk method, was 63.0% (95% CI, 56.6 to 68.5). In an analysis of asymptomatic infections after randomization, with data accrued up to and including the participant-decision visit, 157 participants in the placebo group and 153 in the mRNA-1273 group were RT-PCR–positive only; 306 participants in the placebo group and 48 in the mRNA-1273 group showed seroconversion by anti-nucleocapsid antibodies, and 115 participants in the placebo group and 7 in the mRNA-1273 group tested positive in both anti-nucleocapsid antibody testing and RT-PCR assay in the absence of symptoms. Findings for asymptomatic infection were similar in the modified intention-to-treat population (Table S28). For the secondary end point of prevention of SARS-CoV-2 infection (regardless of symptom or severity), the vaccine efficacy was 82.0% (95% CI, 79.5 to 84.2) beginning 14 days after the second injection in the per-protocol population, with 1339 participants in the placebo group and 280 in the mRNA-1273 group who had documented infection, defined as a positive result on RT-PCR assay at 14 days or more after the second injection or seroconversion at day 57 or later, through the participant-decision visit.</div><div role="paragraph">For the secondary end point of Covid-19 with onset at least 14 days after the first injection, the vaccine efficacy, based on adjudicated cases of Covid-19 in the per-protocol population among participants who received both injections (769 in the placebo group and 56 in the mRNA-1273 group), was 93.3% (95% CI, 91.1 to 94.9). In an exploratory analysis performed in a modified intention-to-treat subpopulation of 425 participants in the placebo group and 334 in the mRNA-1273 group who had no evidence of SARS-CoV-2 infection at baseline and who received only one injection, adjudicated Covid-19 cases were observed in 45 participants (10.6%) in the placebo group and in 4 participants (1.2%) in the mRNA-1273 group (Table S33). Six severe Covid-19 cases occurred in recipients of a single injection of placebo (1.4%), and one severe case occurred in a recipient of a single injection of the mRNA-1273 vaccine (0.3%).</div></section></section><section id="sec-3" data-type="discussion"><h2>Discussion</h2><div role="paragraph">The data compiled through the completion of the blinded phase of the COVE trial provide further evidence of the safety and efficacy of mRNA-1273 in preventing symptomatic Covid-19 as well as preventing SARS-CoV-2 infection regardless of symptom and severity in adults, including those 65 years of age or older and those with coexisting conditions, and across various ethnic and racial groups. These findings are based on a median follow-up of 148 days in the blinded phase and are similar to those observed previously at a median follow-up of 64 days, indicating that the high efficacy of the mRNA-1273 vaccine is maintained in the medium term. Of importance, the vaccine provided substantial protection against asymptomatic infection (63%; 95% CI, 56.6 to 68.5), though at a lower vaccine efficacy than that for symptomatic infection. The efficacy of the mRNA-1273 vaccine did not wane up to 4 months after the second injection and beyond. It is notable that the efficacies found in phase 3 trials of Covid-19 vaccines have thus far translated into high effectiveness in the general population, including effectiveness against variants of concern that are associated with reductions in neutralization, such as the B.1.351 (beta) and B.1.617.2 (delta) variants.<sup><a href="#core-r8" role="doc-biblioref" data-xml-rid="r8 r12 r13 r14 r15" id="body-ref-r15" href-manipulated="true">8,12–15</a></sup> Additional data gathered from regions with current and potential surges in transmission of variants of concern are important toward informing strategies for administering additional doses of vaccine.</div><div role="paragraph">No safety concerns were identified in this trial. However, robust safety surveillance systems have identified rare events during the global distribution of Covid-19 vaccines that the phase 3 studies were not powered to detect; thus, continued vigilance is warranted, including monitoring for anaphylactic reactions, especially in persons with allergic phenotypes, and for other potential unexpected reactions, such as myocarditis in adolescents and young adults.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16" id="body-ref-r16" href-manipulated="true" aria-label="Reference 16">16</a></sup> Given the high efficacies of the vaccines<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1 r3 r17" id="body-ref-r17" href-manipulated="true">1,3,17</a></sup> and the burden of the pandemic, the risk–benefit ratio remains strongly in favor of broad deployment of the vaccines. Despite differences in the definitions of disease severity, the vaccine efficacy is supported by real-world data: vaccination has been shown to be highly effective in preventing severe Covid-19, associated hospitalizations, and deaths, as well as mild or asymptomatic infection, regardless of race and age.<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9 r12 r18 r19 r20" id="body-ref-r20" href-manipulated="true">9,12,18–20</a></sup></div><div role="paragraph">Several important limitations of the trial should be considered. At the trial design stage in early 2020, the efficacy and safety of the mRNA-1273 vaccine were unknown; for that reason, certain key populations such as pregnant women, children, and immunocompromised persons were not included in the trial. Studies in these populations are currently ongoing, and the data that are emerging in adolescents and pregnant women are reassuring.<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21 r22 r23 r24" id="body-ref-r24" href-manipulated="true">21-24</a></sup> Although no safety concerns associated with the mRNA vaccines have been identified in immunocompromised persons, these vaccines appear to be less immunogenic in such persons.<sup><a href="#core-r25" role="doc-biblioref" data-xml-rid="r25 r26" id="body-ref-r26" href-manipulated="true">25,26</a></sup> Given the period during which the blinded phase of the trial was conducted, assessment of vaccine efficacy in preventing Covid-19 caused by SARS-CoV-2 variants of concern is limited, since circulation of the variants was low. Future exploratory analyses are needed to probe this question. It should also be noted that the sensitivity of detection of asymptomatic infection in this trial was somewhat limited by the assessment of seroconversion at fixed time points, the kinetics of seroconversion of anti-nucleocapsid antibodies (which may take weeks to emerge after an initial infection and then wane relatively quickly), as well as the possible diminished detection of SARS-CoV-2 by RT-PCR, owing to a reduced duration of infection in vaccine recipients and the infrequent collection of samples from asymptomatic participants in the trial.</div><div role="paragraph">We found that the efficacy of the mRNA-1273 vaccine against Covid-19 and severe Covid-19 was maintained for more than 5 months after the second dose among all subgroups in the trial, including those at risk for severe complications. Asymptomatic SARS-CoV-2 infections were also reduced. No safety concerns were identified in this trial. The interplay of viral evolution with vaccine distribution in the next months will determine the trajectory of the pandemic, which continues to evade predictions and shape much of the social and economic life in the United States and worldwide.</div></section>



        
        
</div></section><section id="backmatter" data-extent="backmatter" data-location="articleTab_article"><div class="core-container"><section id="backnotes" data-location="notes_article"><h2>Notes</h2><div data-type="published/updated" role="paragraph">This article was published on September 22, 2021, and updated on October 1, 2021, at NEJM.org.</div><div data-type="data-sharing" role="paragraph">A <a href="#ap4">data sharing statement</a> provided by the authors is available with the full text of this article at NEJM.org.</div><div role="paragraph">Supported by the Office of the Assistant Secretary for Preparedness and Response, <span class="named-content" data-type="funder">Biomedical Advanced Research and Development Authority</span> (contract 75A50120C00034), and by the National Institute of Allergy and Infectious Diseases (<span class="named-content" data-type="funder">NIAID</span>). The <span class="named-content" data-type="funder">NIAID</span> provides grant funding to the HIV Vaccine Trials Network (HVTN) Leadership and Operations Center (UM1 AI 68614HVTN), the Statistics and Data Management Center (UM1 AI 68635), the HVTN Laboratory Center (UM1 AI 68618), the HIV Prevention Trials Network Leadership and Operations Center (UM1 AI 68619), the AIDS Clinical Trials Group Leadership and Operations Center (UM1 AI 68636), and the Infectious Diseases Clinical Research Consortium leadership group 5 (UM1 AI148684-03).</div><div role="paragraph"><a href="#ap3">Disclosure forms</a> provided by the authors are available with the full text of this article at NEJM.org.</div><div role="paragraph">We thank the participants in the trial and the members of the data and safety monitoring board (Richard J. Whitley, chair, University of Alabama School of Medicine; Abdel Babiker, MRC Clinical Trials Unit at University College, London; Lisa Angeline Cooper, Johns Hopkins University School of Medicine and Bloomberg School of Public Health; Susan Smith Ellenberg, University of Pennsylvania; Alan Fix, Vaccine Development Global Program Center for Vaccine Innovation and Access PATH; Marie Griffin, Vanderbilt University Medical Center; Steven Joffe, Perelman School of Medicine, University of Pennsylvania; Jorge Kalil, Clinics Hospital (HC-FMUSP), Universidade de São Paulo, Brazil; Myron M. Levine, University of Maryland School of Medicine; Malegapuru William Makgoba, University of KwaZulu-Natal; Anastasios A. Tsiatis, North Carolina State University; and Renee H. Moore, Emory University) and the adjudication committee (Richard J. Hamill, chair, Baylor College of Medicine; Lewis Lipsitz, Harvard Medical School; Eric S. Rosenberg, Massachusetts General Hospital; and Anthony Faugno, Tufts Medical Center) for their critical and timely review of the trial data. We also acknowledge the contribution from the mRNA-1273 Product Coordination Team from the Biomedical Advanced Research and Development Authority (BARDA) (Robert Bruno, Richard Gorman, Holli Hamilton, Gary Horwith, Chuong Huynh, Nutan Mytle, Corrina Pavetto, Xiaomi Tong, and John Treanor), as well as Frank J. Dutko (Moderna consultant) for editorial support and Katherine Kacena for input on statistics.</div></section><section id="supplementary-materials" class="core-supplementary-materials"><h2>Supplementary Material</h2><div role="list"><div id="ap0" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Research Summary</span> <span class="core-filename">(nejmoa2113017_research-summary.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2113017/suppl_file/nejmoa2113017_research-summary.pdf" download="nejmoa2113017_research-summary.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2113017_research-summary.pdf" data-doi="10.1056/NEJMoa2113017">Download</a></li><li>574.35 KB</li></ul></div></div><div id="ap1" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Protocol</span> <span class="core-filename">(nejmoa2113017_protocol.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2113017/suppl_file/nejmoa2113017_protocol.pdf" download="nejmoa2113017_protocol.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2113017_protocol.pdf" data-doi="10.1056/NEJMoa2113017">Download</a></li><li>3.93 MB</li></ul></div></div><div id="ap2" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Supplementary Appendix</span> <span class="core-filename">(nejmoa2113017_appendix.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2113017/suppl_file/nejmoa2113017_appendix.pdf" download="nejmoa2113017_appendix.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2113017_appendix.pdf" data-doi="10.1056/NEJMoa2113017">Download</a></li><li>1.59 MB</li></ul></div></div><div id="ap3" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Disclosure Forms</span> <span class="core-filename">(nejmoa2113017_disclosures.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2113017/suppl_file/nejmoa2113017_disclosures.pdf" download="nejmoa2113017_disclosures.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2113017_disclosures.pdf" data-doi="10.1056/NEJMoa2113017">Download</a></li><li>1.09 MB</li></ul></div></div><div id="ap4" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Data Sharing Statement</span> <span class="core-filename">(nejmoa2113017_data-sharing.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2113017/suppl_file/nejmoa2113017_data-sharing.pdf" download="nejmoa2113017_data-sharing.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2113017_data-sharing.pdf" data-doi="10.1056/NEJMoa2113017">Download</a></li><li>75.04 KB</li></ul></div></div></div></section><section id="bibliography" class="core-reference-list" role="doc-bibliography" data-location="references_article"><h2>References</h2><div role="list" data-method="clamp" id="collapsible-text"><div role="listitem" data-has="label"><div class="label">1.</div><div id="r1" class="citations"><div class="citation"><div class="citation-content">Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. <em>N Engl J Med</em> 2021;384:403-416.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r1" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_2_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2035389&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33378609/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000629333200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+the+mRNA-1273+SARS-CoV-2+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=403-416&amp;doi=10.1056%2FNEJMoa2035389&amp;pmid=33378609" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r1" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] follow-up of 2 months after vaccination. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] after a median follow-up of 64 days. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] enrolled at 99 sites in the United States. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] at high risk for severe disease (or both). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] and vaccine have been described previously. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] the second dose, were described previously </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] and Fig. S2). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>h [...] group and the mRNA-1273 group (Table S5). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-9" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>i [...] consistent with those reported previously, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r17" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>j [...] Given the high efficacies of the vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="r2" class="citations"><div class="citation"><div class="citation-content">Johnson &amp; Johnson COVID-19 vaccine authorized by U.S. FDA for emergency use — first single-shot vaccine in fight against global pandemic. New Brunswick, NJ: <em>Johnson &amp; Johnson</em>, February 27, 2021 (<a href="https://www.jnj.com/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic">https://www.jnj.com/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Johnson+%26+Johnson+COVID-19+vaccine+authorized+by+U.S.+FDA+for+emergency+use+%E2%80%94+first+single-shot+vaccine+in+fight+against+global+pandemic&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="r3" class="citations"><div class="citation"><div class="citation-content">Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <em>N Engl J Med</em> 2020;383:2603-2615.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2034577&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33301246/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000605648000010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2603-2615&amp;doi=10.1056%2FNEJMoa2034577&amp;pmid=33301246" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] follow-up of 2 months after vaccination. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r17" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] Given the high efficacies of the vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="r4" class="citations"><div class="citation"><div class="citation-content">Sadoff J, Le Gars M, Shukarev G, et al. Interim results of a phase 1–2a trial of Ad26.COV2.S Covid-19 vaccine. <em>N Engl J Med</em> 2021;384:1824-1835.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_5_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2034201&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33440088/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640382300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+results+of+a+phase+1%E2%80%932a+trial+of+Ad26.COV2.S+Covid-19+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1824-1835&amp;doi=10.1056%2FNEJMoa2034201&amp;pmid=33440088" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="r5" class="citations"><div class="citation"><div class="citation-content">Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. <em>N Engl J Med</em> 2021;384:1412-1423.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_6_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2101765&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33626250/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640554500008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BNT162b2+mRNA+Covid-19+vaccine+in+a+nationwide+mass+vaccination+setting.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1412-1423&amp;doi=10.1056%2FNEJMoa2101765&amp;pmid=33626250" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="r6" class="citations"><div class="citation"><div class="citation-content">Maternal, neonatal, and child health services during COVID-19. Atlanta: Centers for Disease Control and Prevention, November 5, 2020 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/pregnancy-services.html">https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/pregnancy-services.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Maternal%2C+neonatal%2C+and+child+health+services+during+COVID-19&amp;publication_year=2020" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="r7" class="citations"><div class="citation"><div class="citation-content">Thompson MG, Burgess JL, Naleway AL, et al. Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines. <em>N Engl J Med</em> 2021;385:320-329.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_8_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2107058&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34192428/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000669589200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Prevention+and+attenuation+of+Covid-19+with+the+BNT162b2+and+mRNA-1273+vaccines.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=320-329&amp;doi=10.1056%2FNEJMoa2107058&amp;pmid=34192428" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="r8" class="citations"><div class="citation"><div class="citation-content">Thompson MG, Burgess JL, Naleway AL, et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers — eight U.S. locations, December 2020–March 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:495-500.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r8" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7013e3" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33793460/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000636784900007" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+estimates+of+vaccine+effectiveness+of+BNT162b2+and+mRNA-1273+COVID-19+vaccines+in+preventing+SARS-CoV-2+infection+among+health+care+personnel%2C+first+responders%2C+and+other+essential+and+frontline+workers+%E2%80%94+eight+U.S.+locations%2C+December+2020%E2%80%93March+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=495-500&amp;doi=10.15585%2Fmmwr.mm7013e3&amp;pmid=33793460" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r8" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] deployment in the general population. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] (beta) and B.1.617.2 (delta) variants. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="r9" class="citations"><div class="citation"><div class="citation-content">Tenforde MW, Olson SM, Self WH, et al. Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged ≥65 years — United States, January–March 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:674-679.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7018e1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33956782/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647643800003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Pfizer-BioNTech+and+Moderna+vaccines+against+COVID-19+among+hospitalized+adults+aged+%E2%89%A565+years+%E2%80%94+United+States%2C+January%E2%80%93March+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=674-679&amp;doi=10.15585%2Fmmwr.mm7018e1&amp;pmid=33956782" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] deployment in the general population. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r20" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] infection, regardless of race and age. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="r10" class="citations"><div class="citation"><div class="citation-content">Pawlowski C, Lenehan P, Puranik A, et al. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. <em>Med (N Y)</em> 2021;2(8):979-992.e8.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.medj.2021.06.007" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34223401/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000686159800011" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=FDA-authorized+mRNA+COVID-19+vaccines+are+effective+per+real-world+evidence+synthesized+across+a+multi-state+health+system.&amp;publication_year=2021&amp;journal=Med+%28N+Y%29&amp;pages=979-992.e8&amp;doi=10.1016%2Fj.medj.2021.06.007&amp;pmid=34223401" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="r11" class="citations"><div class="citation"><div class="citation-content">Corbett KS, Edwards D, Leist SR, et al. SARS-CoV-2 mRNA vaccine development enabled by prototype pathogen preparedness. June 11, 2020 (<a href="https://www.biorxiv.org/content/10.1101/2020.06.11.145920v1">https://www.biorxiv.org/content/10.1101/2020.06.11.145920v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+mRNA+vaccine+development+enabled+by+prototype+pathogen+preparedness.&amp;publication_year=2020" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="r12" class="citations"><div class="citation"><div class="citation-content">Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. <em>Lancet</em> 2021;397:1819-1829.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r12" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)00947-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33964222/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000651041900028" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Impact+and+effectiveness+of+mRNA+BNT162b2+vaccine+against+SARS-CoV-2+infections+and+COVID-19+cases%2C+hospitalisations%2C+and+deaths+following+a+nationwide+vaccination+campaign+in+Israel%3A+an+observational+study+using+national+surveillance+data.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=1819-1829&amp;doi=10.1016%2FS0140-6736%2821%2900947-8&amp;pmid=33964222" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r12" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r15" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] (beta) and B.1.617.2 (delta) variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r20" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] infection, regardless of race and age. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="r13" class="citations"><div class="citation"><div class="citation-content">Planas D, Bruel T, Grzelak L, et al. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. <em>Nat Med</em> 2021;27:917-924.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-021-01318-5" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33772244/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000633281900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Sensitivity+of+infectious+SARS-CoV-2+B.1.1.7+and+B.1.351+variants+to+neutralizing+antibodies.&amp;publication_year=2021&amp;journal=Nat+Med&amp;pages=917-924&amp;doi=10.1038%2Fs41591-021-01318-5&amp;pmid=33772244" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="r14" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Butt AA. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. <em>N Engl J Med</em> 2021;385:187-189.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_15_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMc2104974&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33951357/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647808600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+BNT162b2+Covid-19+vaccine+against+the+B.1.1.7+and+B.1.351+variants.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=187-189&amp;doi=10.1056%2FNEJMc2104974&amp;pmid=33951357" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="r15" class="citations"><div class="citation"><div class="citation-content">Bernal JL, Andrews N, Gower C, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant. May 24, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.05.22.21257658v1">https://www.medrxiv.org/content/10.1101/2021.05.22.21257658v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+COVID-19+vaccines+against+the+B.1.617.2+variant.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="r16" class="citations"><div class="citation"><div class="citation-content">Marshall M, Ferguson ID, Lewis P, et al. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. <em>Pediatrics</em> 2021;148(3):e2021052478-e2021052478.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1542/peds.2021-052478" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34088762/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000755048000072" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Symptomatic+acute+myocarditis+in+7+adolescents+after+Pfizer-BioNTech+COVID-19+vaccination.&amp;publication_year=2021&amp;journal=Pediatrics&amp;pages=e2021052478-e2021052478&amp;doi=10.1542%2Fpeds.2021-052478&amp;pmid=34088762" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="r17" class="citations"><div class="citation"><div class="citation-content">Thomas SJ, Moreira ED, Kitchin N, et al. Six month safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. July 28, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1">https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Six+month+safety+and+efficacy+of+the+BNT162b2+mRNA+COVID-19+vaccine.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="r18" class="citations"><div class="citation"><div class="citation-content">Tenforde MW, Patel MM, Ginde AA, et al. Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States. <em>Clin Infect Dis</em> 2021 August 6 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34358310/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000756472600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+SARS-CoV-2+mRNA+vaccines+for+preventing+Covid-19+hospitalizations+in+the+United+States.&amp;publication_year=2021&amp;journal=Clin+Infect+Dis&amp;pmid=34358310" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="r19" class="citations"><div class="citation"><div class="citation-content">Jones NK, Rivett L, Seaman S, et al. Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection. <em>Elife</em> 2021;10:e68808-e68808.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.68808" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33830018/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000644424200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Single-dose+BNT162b2+vaccine+protects+against+asymptomatic+SARS-CoV-2+infection.&amp;publication_year=2021&amp;journal=Elife&amp;pages=e68808-e68808&amp;doi=10.7554%2FeLife.68808&amp;pmid=33830018" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="r20" class="citations"><div class="citation"><div class="citation-content">Tande AJ, Pollock BD, Shah ND, et al. Impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening. <em>Clin Infect Dis</em> 2021 March 10 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/cid/ciab229" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33704435/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000780096300009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Impact+of+the+COVID-19+vaccine+on+asymptomatic+infection+among+patients+undergoing+pre-procedural+COVID-19+molecular+screening.&amp;publication_year=2021&amp;journal=Clin+Infect+Dis&amp;doi=10.1093%2Fcid%2Fciab229&amp;pmid=33704435" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="r21" class="citations"><div class="citation"><div class="citation-content">Collier AY, McMahan K, Yu J, et al. Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. <em>JAMA</em> 2021;325:2370-2380.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jama.2021.7563" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33983379/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000650215800001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+COVID-19+mRNA+vaccines+in+pregnant+and+lactating+women.&amp;publication_year=2021&amp;journal=JAMA&amp;pages=2370-2380&amp;doi=10.1001%2Fjama.2021.7563&amp;pmid=33983379" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="r22" class="citations"><div class="citation"><div class="citation-content">Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. <em>N Engl J Med</em> 2021;384:2273-2282.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_23_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2104983&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33882218/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000642261100001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Preliminary+findings+of+mRNA+Covid-19+vaccine+safety+in+pregnant+persons.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=2273-2282&amp;doi=10.1056%2FNEJMoa2104983&amp;pmid=33882218" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="r23" class="citations"><div class="citation"><div class="citation-content">Ali K, Berman G, Zhou H, et al. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. <em>N Engl J Med</em>.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_24_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2109522&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34379915/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000685294300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Evaluation+of+mRNA-1273+SARS-CoV-2+vaccine+in+adolescents.&amp;journal=N+Engl+J+Med&amp;doi=10.1056%2FNEJMoa2109522&amp;pmid=34379915" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="r24" class="citations"><div class="citation"><div class="citation-content">Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. <em>N Engl J Med</em> 2021;385:239-250.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_25_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2107456&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34043894/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000657049900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety%2C+immunogenicity%2C+and+efficacy+of+the+BNT162b2+Covid-19+vaccine+in+adolescents.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=239-250&amp;doi=10.1056%2FNEJMoa2107456&amp;pmid=34043894" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="r25" class="citations"><div class="citation"><div class="citation-content">Haidar G, Agha M, Lukanski A, et al. Immunogenicity of COVID-19 vaccination in immunocompromised patients: an observational, prospective cohort study interim analysis. June 30, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.06.28.21259576v1">https://www.medrxiv.org/content/10.1101/2021.06.28.21259576v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+COVID-19+vaccination+in+immunocompromised+patients%3A+an+observational%2C+prospective+cohort+study+interim+analysis.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="r26" class="citations"><div class="citation"><div class="citation-content">Hadjadj J, Planas D, Ouedrani A, et al. Immunogenicity of BNT162b2 vaccine against the alpha and delta variants in immunocompromised patients. August 9, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.08.21261766v1">https://www.medrxiv.org/content/10.1101/2021.08.08.21261766v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+BNT162b2+vaccine+against+the+alpha+and+delta+variants+in+immunocompromised+patients.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div></div><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary" aria-expanded="false" aria-controls="collapsible-text"><span>Show all references</span></button></div></section></div></section></div><div class="core-collateral"><div id="core-collateral-info" role="tabpanel" data-core-tabs="core-collateral-info" tabindex="-1" aria-labelledby="pane-core-collateral-info"><header><h2 id="pane-core-collateral-info"><i class="icon-info" aria-hidden="true"></i>Information &amp; Authors</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-information" role="tab" id="tab-information-label" aria-selected="true" class="active">Information</button><button aria-controls="tab-contributors" role="tab" id="tab-contributors-label" tabindex="-1" aria-selected="false">Authors</button></div><section id="tab-information" aria-labelledby="tab-information-label" role="tabpanel" tabindex="0"><h3>Information</h3><section class="core-self-citation"><h4>Published In</h4><div class="core-journal-presentation"><div class="core-journal-description"><div property="isPartOf" typeof="Periodical"><span property="name">New England Journal of Medicine</span></div><div class="core-enumeration"><a href="/toc/nejm/385/19"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">385</span></span> • <span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">19</span></span> • <span property="datePublished">November 4, 2021</span></a></div><div class="core-pagination"><span class="heading">Pages</span>: <span class="content"><span property="pageStart">1774</span>-<span property="pageEnd">1785</span></span></div></div></div></section><section class="core-copyright"><h4>Copyright</h4><div role="paragraph">Copyright © 2021 Massachusetts Medical Society. All rights reserved.</div><div>For personal use only. Any commercial reuse of NEJM Group content requires <a href="mailto:permissions@nejm.org">permission</a>.</div></section><section class="core-history"><h4>History</h4><div><b class="core-label">Published online</b>: September 22, 2021</div><div><b class="core-label">Published in issue</b>: November 4, 2021</div></section><section data-location="recirc_topics_article" class="core-classifications"><h4>Topics</h4><div class="keywords"><ol><li><a href="/browse/topic/coronavirus" alt="View article keyword Coronavirus" data-interactiontype="article_recirculation_click">Coronavirus</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="/browse/topic/vaccines" alt="View article keyword Vaccines" data-interactiontype="article_recirculation_click">Vaccines</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li></ol></div></section></section><section id="tab-contributors" aria-labelledby="tab-contributors-label" role="tabpanel" tabindex="-1"><h3>Authors</h3><section class="core-authors"><h4>Authors</h4><div role="paragraph"><span property="author" typeof="Person"><span property="givenName">Hana M.</span> <span property="familyName">El Sahly</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-0489-0074" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-0489-0074</a></span>, <span property="author" typeof="Person"><span property="givenName">Lindsey R.</span> <span property="familyName">Baden</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Brandon</span> <span property="familyName">Essink</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Susanne</span> <span property="familyName">Doblecki-Lewis</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Judith M.</span> <span property="familyName">Martin</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Evan J.</span> <span property="familyName">Anderson</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-1576-4420" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-1576-4420</a></span>, <span property="author" typeof="Person"><span property="givenName">Thomas B.</span> <span property="familyName">Campbell</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Jesse</span> <span property="familyName">Clark</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0001-5862-6530" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0001-5862-6530</a></span>, <span property="author" typeof="Person"><span property="givenName">Lisa A.</span> <span property="familyName">Jackson</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-1785-0218" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-1785-0218</a></span>, <span property="author" typeof="Person"><span property="givenName">Carl J.</span> <span property="familyName">Fichtenbaum</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Marcus</span> <span property="familyName">Zervos</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Bruce</span> <span property="familyName">Rankin</span>, <span property="honorificSuffix">D.O.</span></span>, <span property="author" typeof="Person"><span property="givenName">Frank</span> <span property="familyName">Eder</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Gregory</span> <span property="familyName">Feldman</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Christina</span> <span property="familyName">Kennelly</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Laurie</span> <span property="familyName">Han-Conrad</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Michael</span> <span property="familyName">Levin</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Kathleen M.</span> <span property="familyName">Neuzil</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Lawrence</span> <span property="familyName">Corey</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-2179-2436" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-2179-2436</a></span>, <span property="author" typeof="Person"><span property="givenName">Peter</span> <span property="familyName">Gilbert</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Holly</span> <span property="familyName">Janes</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Dean</span> <span property="familyName">Follmann</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Mary</span> <span property="familyName">Marovich</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Laura</span> <span property="familyName">Polakowski</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">John R.</span> <span property="familyName">Mascola</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Julie E.</span> <span property="familyName">Ledgerwood</span>, <span property="honorificSuffix">D.O.</span></span>, <span property="author" typeof="Person"><span property="givenName">Barney S.</span> <span property="familyName">Graham</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Allison</span> <span property="familyName">August</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Heather</span> <span property="familyName">Clouting</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Weiping</span> <span property="familyName">Deng</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Shu</span> <span property="familyName">Han</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Brett</span> <span property="familyName">Leav</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Deb</span> <span property="familyName">Manzo</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Rolando</span> <span property="familyName">Pajon</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Florian</span> <span property="familyName">Schödel</span>, <span property="honorificSuffix">M.D., Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Joanne E.</span> <span property="familyName">Tomassini</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Honghong</span> <span property="familyName">Zhou</span>, <span property="honorificSuffix">Ph.D.</span></span>, and <span property="author" typeof="Person"><span property="givenName">Jacqueline</span> <span property="familyName">Miller</span>, <span property="honorificSuffix">M.D.</span></span>, for <span property="author" typeof="Person">the COVE Study Group<sup><a href="#fn1" role="doc-noteref">*</a></sup></span></div></section><section class="core-affiliations"><h4>Affiliations</h4><div property="affiliation" typeof="Organization"><span property="name">From Baylor College of Medicine, Houston (H.M.E.S.), and Javara, The Woodlands (C.K.) — both in Texas; Brigham and Women’s Hospital, Boston (L.R.B.), and Moderna, Cambridge (A.A., H.C., W.D., S.H., B.L., D.M., R.P., F.S., J.E.T., H.Z., J.M.) — both in Massachusetts; Meridian Clinical Research, Baton Rouge, LA (B.E., F.E.); University of Miami, Miami (S.D.-L.), and DeLand Clinical Research Unit, DeLand (B.R.) — both in Florida; University of Pittsburgh School of Medicine, Pittsburgh (J.M.M.); Emory University School of Medicine, Atlanta (E.J.A.); University of Colorado School of Medicine, Aurora (T.B.C.); University of California, Los Angeles (J.C.), and Wake Research–Medical Center for Clinical Research, San Diego (L.H.-C.) — both in California; Kaiser Permanente Washington Health Research Institute (L.A.J.), and Fred Hutchinson Cancer Research Center (L.C., P.G., H.J.) — both in Seattle; University of Cincinnati, Cincinnati (C.J.F.); Henry Ford Health System, Detroit (M.Z.); Vitalink Research, Greenville, SC (G.F.); Clinical Research Center of Nevada, Wake Research, Las Vegas (M.L.); and the University of Maryland, College Park (K.M.N.), and the Vaccine Research Center (J.R.M., J.E.L., B.S.G.), National Institute of Allergy and Infectious Diseases (D.F., M.M., L.P.), National Institutes of Health, Bethesda — both in Maryland.</span></div></section><section class="core-authors-notes"><h4>Notes</h4><div role="doc-footnote">Dr. El Sahly can be contacted at <a href="mailto:hana.elsahly@bcm.edu">hana.elsahly@bcm.edu</a>, or at 1 Baylor Plaza, Departments of Molecular Virology and Microbiology and Medicine, BCM-MS280, Houston, TX, 77030. Dr. Baden can be contacted at <a href="mailto:lbaden@bwh.harvard.edu">lbaden@bwh.harvard.edu</a>, or at the Division of Infectious Diseases, Brigham and Women’s Hospital, 15 Francis St., PBB-A4, Boston, MA 02115.</div><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="fn1" role="paragraph">The members of the COVE Study Group are listed in the <a href="#ap2">Supplementary Appendix</a>, available at NEJM.org.</div></div><div role="doc-footnote"><div id="fn2" role="paragraph">Drs. El Sahly and Baden contributed equally to this article.</div></div></section></section></div><div id="core-collateral-metrics" role="tabpanel" data-core-tabs="core-collateral-metrics" tabindex="-1" aria-labelledby="pane-core-collateral-metrics"><header><h2 id="pane-core-collateral-metrics"><i class="icon-timeline" aria-hidden="true"></i>Metrics &amp; Citations</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-metrics-inner" role="tab" id="tab-metrics-inner-label" aria-selected="true" class="active" data-interactiontype="article_tab" data-tabname="metricsWindow">Metrics</button><button aria-controls="tab-citations" role="tab" id="tab-citations-label" tabindex="-1" aria-selected="false" data-interactiontype="article_tab" data-tabname="metricsWindow">Citations<span class="citations-count">440</span></button></div><section id="tab-metrics-inner" aria-labelledby="tab-metrics-inner-label" role="tabpanel" tabindex="0"><h3>Metrics</h3><section>









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="95ea9f58-ec0e-4db2-b2ab-280fc876af53" data-location="article_metrics_article">
        



        
            <h4 class="">
                Altmetrics
            </h4>
        
        <div data-badge-details="right" data-badge-type="large-donut" data-doi="10.1056/NEJMoa2113017" data-hide-no-mentions="true" data-link-target="_blank" class="altmetric-embed" data-uuid="8bf5c6c4-a4ab-beb7-8f81-cace3f96c3ab"><div style="overflow:hidden;">
    <div class="altmetric-normal-legend">
        <a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136" style="display:inline-block;">
                <img alt="Article has an altmetric score of 3501" src="https://badges.altmetric.com/?size=320&amp;score=3501&amp;types=mabrtwfd" width="180" height="180" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el_8bf5c6c4-a4ab-beb7-8f81-cace3f96c3ab" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136&amp;tab=news">
          Picked up by <b>32</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136&amp;tab=blogs">
          Blogged by <b>7</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #9f79f2;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136&amp;tab=policy-documents">
          Referenced in <b>3</b> policy sources
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136&amp;tab=twitter">
          Posted by <b>5727</b> X users
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #f27700;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136&amp;tab=patents">
          Referenced in <b>1</b> patents
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136&amp;tab=facebook">
          On <b>7</b> Facebook pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #958899;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136&amp;tab=wikipedia">
          Referenced in <b>1</b> Wikipedia pages
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #D5E8F0;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=113886136&amp;tab=reddit">
          Reddited by <b>5</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>527</b> readers on Mendeley
          </div>
    </div>

                </div>
            </div>
        </div>
    </div>
</div></div>
<script async="" type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" nonce="94d6a59084c8e7d5-SJC"></script>

        </div>
    

</section></section><section id="tab-citations" aria-labelledby="tab-citations-label" role="tabpanel" tabindex="-1"><h3>Citations</h3><section>



        
            <h4 class="">
                Export citation
            </h4>
        
        <div class="citation-download cd-sec">
<p class="citation-download_msg">Select the format you want to export the citation of this publication.</p>
<form action="/action/downloadCitation" name="frmCitmgr" method="post" target="_self" class="citation-download_form"><input type="hidden" name="doi" value="10.1056/NEJMoa2113017"> <input type="hidden" name="downloadFileName" value="csp_385_"> <input type="hidden" name="include" value="abs">
<div class="dropdown dropdown-selectable dropdown-selectable--form-control"><input type="hidden" name="format" value=""> <label class="form-label">Format*</label> <button id="slct_format" type="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="btn dropdown-toggle d-flex align-items-center justify-content-between">Please Select </button>
<div aria-labelledby="slct_format" role="listbox" class="dropdown-menu"><a href="#" data-value="ris" class="dropdown-item">RIS (ProCite, Reference Manager)</a><a href="#" data-value="endnote" class="dropdown-item">EndNote</a><a href="#" data-value="bibtex" class="dropdown-item">BibTex</a><a href="#" data-value="medlars" class="dropdown-item">Medlars</a><a href="#" data-value="refworks" class="dropdown-item">RefWorks</a></div>
<div class="invalid-feedback">Please select an item in the list</div>
</div>
<div class="citation-download_checkbox"><label class="checkbox--primary"><input type="checkbox" name="direct" value="true"><span class="checkbox--primary-icons"><span class="checkbox--primary-unchecked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxUnchecked"></use></svg></span></span><span class="checkbox--primary-checked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxChecked"></use></svg></span></span></span><span class="checkbox--primary-label"><span class="checkbox--primary-label-text">Direct Import</span></span></label></div>
<div class="citation-download_btn"><button type="submit" name="submit" value="Download" class="ng-btn_default ng-btn_iconLeft" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#citations"></use></svg></span><span class="ng-btn_text">Export citation</span></button></div>
</form></div>
</section><section>









    
    
        <div data-widget-def="UX3CitedByWidget" data-widget-id="efb4df9a-8e1a-47f9-bfb7-271959277a9f" data-location="citedby_article">
        



        
            <h4 class="">
                Cited by
            </h4>
        
        <section id="cited-by" class="cited-by"><div class="cited-by__wrapper"><div id="cited-by__content" class="cited-by__content"><ol data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2021.385.issue-19%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2113017%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" data-lazyload="false" data-total="440" class="cited-by__list list-unstyled"><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Gregg Hartvigsen, </li><li class="list-inline-item cited-by__entry__author">Yannis Dimitroff, </li></ul><span class="cited-by__entry__title">Modeling the SARS-CoV-2 epidemic and the efficacy of different vaccines across different network structures, </span><span class="cited-by__entry__series-title">PLOS One, </span><span class="cited-by__entry__volume"><strong>20</strong>, </span><span class="cited-by__entry__issue">6, </span><span class="cited-by__entry__page-range">(e0325129), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1371/journal.pone.0325129" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1371/journal.pone.0325129</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1371/journal.pone.0325129" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Jeffrey M. Adelglass, </li><li class="list-inline-item cited-by__entry__author">Paul Bradley, </li><li class="list-inline-item cited-by__entry__author">Miranda R. Cai, </li><li class="list-inline-item cited-by__entry__author">Gordon Chau, </li><li class="list-inline-item cited-by__entry__author">Raj Kalkeri, </li><li class="list-inline-item cited-by__entry__author">Shane Cloney-Clark, </li><li class="list-inline-item cited-by__entry__author">Mingzhu Zhu, </li><li class="list-inline-item cited-by__entry__author">Zhaohui Cai, </li><li class="list-inline-item cited-by__entry__author">Mark Eickhoff, </li><li class="list-inline-item cited-by__entry__author">Joyce S. Plested, </li><li class="list-inline-item cited-by__entry__author">Raburn M. Mallory, </li><li class="list-inline-item cited-by__entry__author">Lisa M. Dunkle, </li></ul><span class="cited-by__entry__title">Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine doses, </span><span class="cited-by__entry__series-title">Journal of Allergy and Clinical Immunology, </span><span class="cited-by__entry__volume"><strong>155</strong>, </span><span class="cited-by__entry__issue">6, </span><span class="cited-by__entry__page-range">(2063-2074.e6), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.jaci.2025.03.015" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.jaci.2025.03.015</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.jaci.2025.03.015" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Leah I. B. Andrews, </li><li class="list-inline-item cited-by__entry__author">M. Elizabeth Halloran, </li><li class="list-inline-item cited-by__entry__author">Kathleen M. Neuzil, </li><li class="list-inline-item cited-by__entry__author">Lars van der Laan, </li><li class="list-inline-item cited-by__entry__author">Yunda Huang, </li><li class="list-inline-item cited-by__entry__author">Jessica Andriesen, </li><li class="list-inline-item cited-by__entry__author">Mayur Patel, </li><li class="list-inline-item cited-by__entry__author">Leigh H. Fisher, </li><li class="list-inline-item cited-by__entry__author">Holly Janes, </li><li class="list-inline-item cited-by__entry__author">Nadine Rouphael, </li><li class="list-inline-item cited-by__entry__author">Stephen R. Walsh, </li><li class="list-inline-item cited-by__entry__author">Deborah A. Theodore, </li><li class="list-inline-item cited-by__entry__author">Hong-Van Tieu, </li><li class="list-inline-item cited-by__entry__author">Magdalena Sobieszczyk, </li><li class="list-inline-item cited-by__entry__author">Hana M. El Sahly, </li><li class="list-inline-item cited-by__entry__author">Lindsey R. Baden, </li><li class="list-inline-item cited-by__entry__author">Ann R. Falsey, </li><li class="list-inline-item cited-by__entry__author">Thomas B. Campbell, </li><li class="list-inline-item cited-by__entry__author">Colleen F. Kelley, </li><li class="list-inline-item cited-by__entry__author">Catherine Mary Healy, </li><li class="list-inline-item cited-by__entry__author">Lilly Immergluck, </li><li class="list-inline-item cited-by__entry__author">Benjamin Luft, </li><li class="list-inline-item cited-by__entry__author">Ian Hirsch, </li><li class="list-inline-item cited-by__entry__author">Guy de Bruyn, </li><li class="list-inline-item cited-by__entry__author">Carla Truyers, </li><li class="list-inline-item cited-by__entry__author">Frances Priddy, </li><li class="list-inline-item cited-by__entry__author">Kelsey M. Sumner, </li><li class="list-inline-item cited-by__entry__author">Brendan Flannery, </li><li class="list-inline-item cited-by__entry__author">Dean Follmann, </li><li class="list-inline-item cited-by__entry__author">Peter B. Gilbert, </li><li class="list-inline-item cited-by__entry__author">Vanessa Abad, </li><li class="list-inline-item cited-by__entry__author">Karina Abalos, </li><li class="list-inline-item cited-by__entry__author">Getahun Abate, </li><li class="list-inline-item cited-by__entry__author">Anum Abbas, </li><li class="list-inline-item cited-by__entry__author">Jose Accini, </li><li class="list-inline-item cited-by__entry__author">Ronald Ackerman, </li><li class="list-inline-item cited-by__entry__author">Jamie Ackerman, </li><li class="list-inline-item cited-by__entry__author">Jeremy Ackermann, </li><li class="list-inline-item cited-by__entry__author">Atoya Adams, </li><li class="list-inline-item cited-by__entry__author">Michael R. Adams, </li><li class="list-inline-item cited-by__entry__author">Mark S. Adams, </li><li class="list-inline-item cited-by__entry__author">Michael Adams, </li><li class="list-inline-item cited-by__entry__author">Jeffrey M. Adelglass, </li><li class="list-inline-item cited-by__entry__author">Sarah Afework, </li><li class="list-inline-item cited-by__entry__author">Nina Ahmad, </li><li class="list-inline-item cited-by__entry__author">Christine Akamine, </li><li class="list-inline-item cited-by__entry__author">Julie A. Ake, </li><li class="list-inline-item cited-by__entry__author">Gary Albert, </li><li class="list-inline-item cited-by__entry__author">Maria L. Alcaide, </li><li class="list-inline-item cited-by__entry__author">Nathan Alderson, </li><li class="list-inline-item cited-by__entry__author">Lily Aleman, </li><li class="list-inline-item cited-by__entry__author">José O. Alemán, </li><li class="list-inline-item cited-by__entry__author">Mohamed S. Al-Ibrahim, </li><li class="list-inline-item cited-by__entry__author">Mohammed Allaw, </li><li class="list-inline-item cited-by__entry__author">Leland N. Allen, </li><li class="list-inline-item cited-by__entry__author">Mary Allen, </li><li class="list-inline-item cited-by__entry__author">Naveena Aloysia, </li><li class="list-inline-item cited-by__entry__author">Hilario Alvarado, </li><li class="list-inline-item cited-by__entry__author">Winniberg Stephany Alvarez León, </li><li class="list-inline-item cited-by__entry__author">Carmen Amador, </li><li class="list-inline-item cited-by__entry__author">John Humphrey Amuasi, </li><li class="list-inline-item cited-by__entry__author">James Andersen, </li><li class="list-inline-item cited-by__entry__author">Evan J. Anderson, </li><li class="list-inline-item cited-by__entry__author">Corey G. Anderson, </li><li class="list-inline-item cited-by__entry__author">Victoria R. Anderson, </li><li class="list-inline-item cited-by__entry__author">David R. Andes, </li><li class="list-inline-item cited-by__entry__author">Michele P. Andrasik, </li><li class="list-inline-item cited-by__entry__author">Stephanie Andree, </li><li class="list-inline-item cited-by__entry__author">Jeb Andrews, </li><li class="list-inline-item cited-by__entry__author">Jessica G. Andriesen, </li><li class="list-inline-item cited-by__entry__author">Victoria Andriulis, </li><li class="list-inline-item cited-by__entry__author">Germán Áñez, </li><li class="list-inline-item cited-by__entry__author">Maria Angeles&nbsp;Ceregido, </li><li class="list-inline-item cited-by__entry__author">Nana Akosua Ansah, </li><li class="list-inline-item cited-by__entry__author">Jessica L. Ansel, </li><li class="list-inline-item cited-by__entry__author">Codi M. Anthony, </li><li class="list-inline-item cited-by__entry__author">Johannes Antony, </li><li class="list-inline-item cited-by__entry__author">Mohammed Antwi, </li><li class="list-inline-item cited-by__entry__author">Roberto C. Arduino, </li><li class="list-inline-item cited-by__entry__author">Florida Aristy, </li><li class="list-inline-item cited-by__entry__author">Valerie K. Arnold, </li><li class="list-inline-item cited-by__entry__author">Alicia Arrazcaeta, </li><li class="list-inline-item cited-by__entry__author">Hugo Macareno Arroyo, </li><li class="list-inline-item cited-by__entry__author">Kwaku Poku Asante, </li><li class="list-inline-item cited-by__entry__author">Robert L. Atmar, </li><li class="list-inline-item cited-by__entry__author">Allison August, </li><li class="list-inline-item cited-by__entry__author">Ayoade Avworo, </li><li class="list-inline-item cited-by__entry__author">Christina Bacher, </li><li class="list-inline-item cited-by__entry__author">Martín Bäcker, </li><li class="list-inline-item cited-by__entry__author">Lindsay R. Baden, </li><li class="list-inline-item cited-by__entry__author">Diana Badillo, </li><li class="list-inline-item cited-by__entry__author">Emma Bainbridge, </li><li class="list-inline-item cited-by__entry__author">Michele Baka, </li><li class="list-inline-item cited-by__entry__author">Sherrie Baker, </li><li class="list-inline-item cited-by__entry__author">Bindu Balani, </li><li class="list-inline-item cited-by__entry__author">Brandy Ball, </li><li class="list-inline-item cited-by__entry__author">Mira Baron, </li><li class="list-inline-item cited-by__entry__author">Dan H. Barouch, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Barranco-Santana, </li><li class="list-inline-item cited-by__entry__author">Alejandro Quintín Barrat Hernández, </li><li class="list-inline-item cited-by__entry__author">Darlene Bartilucci, </li><li class="list-inline-item cited-by__entry__author">Jennifer Bashour, </li><li class="list-inline-item cited-by__entry__author">Teresa A. Batteiger, </li><li class="list-inline-item cited-by__entry__author">Clarisse Baudelaire, </li><li class="list-inline-item cited-by__entry__author">George H. Bauer, </li><li class="list-inline-item cited-by__entry__author">Jose A. Bazan, </li><li class="list-inline-item cited-by__entry__author">Maria G. Becerra, </li><li class="list-inline-item cited-by__entry__author">Cynthia Becher Strout, </li><li class="list-inline-item cited-by__entry__author">Teresa Becker, </li><li class="list-inline-item cited-by__entry__author">David Beckmann, </li><li class="list-inline-item cited-by__entry__author">Roger J. Bedimo, </li><li class="list-inline-item cited-by__entry__author">Linda R. Belhorn, </li><li class="list-inline-item cited-by__entry__author">Genevieve Beninati, </li><li class="list-inline-item cited-by__entry__author">Jorge A. Benitez, </li><li class="list-inline-item cited-by__entry__author">David Benkeser, </li><li class="list-inline-item cited-by__entry__author">Annette R. Bennett, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Bennett, </li><li class="list-inline-item cited-by__entry__author">Tatiana Beresnev, </li><li class="list-inline-item cited-by__entry__author">Aude Berge, </li><li class="list-inline-item cited-by__entry__author">Megan Berman, </li><li class="list-inline-item cited-by__entry__author">Maria I. Bermudez, </li><li class="list-inline-item cited-by__entry__author">Marcia Bernard, </li><li class="list-inline-item cited-by__entry__author">David I. Bernstein, </li><li class="list-inline-item cited-by__entry__author">Jennifer Berry, </li><li class="list-inline-item cited-by__entry__author">Andrea Berry, </li><li class="list-inline-item cited-by__entry__author">Vladimir Berthaud, </li><li class="list-inline-item cited-by__entry__author">Hanna Beyko, </li><li class="list-inline-item cited-by__entry__author">Kristin Bialobok, </li><li class="list-inline-item cited-by__entry__author">Joanne L. Billings, </li><li class="list-inline-item cited-by__entry__author">Oleksandra Bilotkach, </li><li class="list-inline-item cited-by__entry__author">Zachary Bittner, </li><li class="list-inline-item cited-by__entry__author">Jeanne Blevins, </li><li class="list-inline-item cited-by__entry__author">Jill Blumenthal, </li><li class="list-inline-item cited-by__entry__author">Rebecca Boas, </li><li class="list-inline-item cited-by__entry__author">Joseph Bocchini, </li><li class="list-inline-item cited-by__entry__author">Tyler D. Bold, </li><li class="list-inline-item cited-by__entry__author">Matthew I. Bonaparte, </li><li class="list-inline-item cited-by__entry__author">Alison Bondell, </li><li class="list-inline-item cited-by__entry__author">Paul Bondy, </li><li class="list-inline-item cited-by__entry__author">Alberto Cadena Bonfanti, </li><li class="list-inline-item cited-by__entry__author">Judith Borger, </li><li class="list-inline-item cited-by__entry__author">Scott Borgetti, </li><li class="list-inline-item cited-by__entry__author">Joseph Boscia, </li><li class="list-inline-item cited-by__entry__author">Dean M. Boswell, </li><li class="list-inline-item cited-by__entry__author">Tana Bourgeois, </li><li class="list-inline-item cited-by__entry__author">Maggie Bowers, </li><li class="list-inline-item cited-by__entry__author">Paul S Bradley, </li><li class="list-inline-item cited-by__entry__author">Judith Brady, </li><li class="list-inline-item cited-by__entry__author">Riemke Brakema, </li><li class="list-inline-item cited-by__entry__author">Andres Bran, </li><li class="list-inline-item cited-by__entry__author">Angela R. Branche, </li><li class="list-inline-item cited-by__entry__author">Boerries Brandenburg, </li><li class="list-inline-item cited-by__entry__author">Donald M. Brandon, </li><li class="list-inline-item cited-by__entry__author">Eric Bravo, </li><li class="list-inline-item cited-by__entry__author">Thomas Breuer, </li><li class="list-inline-item cited-by__entry__author">Margaret Brewinski Isaacs, </li><li class="list-inline-item cited-by__entry__author">Liz Briesemeister, </li><li class="list-inline-item cited-by__entry__author">Toby Briskin, </li><li class="list-inline-item cited-by__entry__author">Gail Broder, </li><li class="list-inline-item cited-by__entry__author">Adam B. Brosz, </li><li class="list-inline-item cited-by__entry__author">David Browder, </li><li class="list-inline-item cited-by__entry__author">Lesley Browder, </li><li class="list-inline-item cited-by__entry__author">Jeremy Brown, </li><li class="list-inline-item cited-by__entry__author">Cynthia Brown, </li><li class="list-inline-item cited-by__entry__author">Robert Brownlee, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Bruce, </li><li class="list-inline-item cited-by__entry__author">Susan Buchbinder, </li><li class="list-inline-item cited-by__entry__author">Cynthia Bueno, </li><li class="list-inline-item cited-by__entry__author">Elisabeth Bukusi, </li><li class="list-inline-item cited-by__entry__author">Delia Bullock, </li><li class="list-inline-item cited-by__entry__author">Catherine A. Bunce, </li><li class="list-inline-item cited-by__entry__author">Cortney Burch, </li><li class="list-inline-item cited-by__entry__author">Michelle L. Burgett, </li><li class="list-inline-item cited-by__entry__author">Abram Burgher, </li><li class="list-inline-item cited-by__entry__author">Larry Bush, </li><li class="list-inline-item cited-by__entry__author">Michael B. Butcher, </li><li class="list-inline-item cited-by__entry__author">Robert J. Buynak, </li><li class="list-inline-item cited-by__entry__author">LaShondra Cade, </li><li class="list-inline-item cited-by__entry__author">Rafael Calderon, </li><li class="list-inline-item cited-by__entry__author">Richard Calderone, </li><li class="list-inline-item cited-by__entry__author">Amy Caldwell, </li><li class="list-inline-item cited-by__entry__author">Cornell Calinescu, </li><li class="list-inline-item cited-by__entry__author">Robert S. Call, </li><li class="list-inline-item cited-by__entry__author">Jim Callis, </li><li class="list-inline-item cited-by__entry__author">Laura Julia Camacho Choza, </li><li class="list-inline-item cited-by__entry__author">Andres Camacho-Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Thomas B. Campbell, </li><li class="list-inline-item cited-by__entry__author">Wesley Campbell, </li><li class="list-inline-item cited-by__entry__author">Michael Cancilla, </li><li class="list-inline-item cited-by__entry__author">Kevin D. Cannon, </li><li class="list-inline-item cited-by__entry__author">Karina Cano Martínez, </li><li class="list-inline-item cited-by__entry__author">Richard Canter, </li><li class="list-inline-item cited-by__entry__author">Valeria D. Cantos, </li><li class="list-inline-item cited-by__entry__author">Vicky Cárdenas, </li><li class="list-inline-item cited-by__entry__author">Martha Carmen Medina, </li><li class="list-inline-item cited-by__entry__author">Ellie Carmody, </li><li class="list-inline-item cited-by__entry__author">Christopher Carpenter, </li><li class="list-inline-item cited-by__entry__author">Melissa Carr, </li><li class="list-inline-item cited-by__entry__author">Monica B. Carrascal, </li><li class="list-inline-item cited-by__entry__author">Jaime Augusto Carrillo, </li><li class="list-inline-item cited-by__entry__author">Steven E. Carsons, </li><li class="list-inline-item cited-by__entry__author">Marianela Carvajal, </li><li class="list-inline-item cited-by__entry__author">Denise Casey, </li><li class="list-inline-item cited-by__entry__author">Jorge Caso, </li><li class="list-inline-item cited-by__entry__author">Flora Castellino, </li><li class="list-inline-item cited-by__entry__author">Marvin Castellon, </li><li class="list-inline-item cited-by__entry__author">Jose Castillo Mancilla, </li><li class="list-inline-item cited-by__entry__author">Mario Castro, </li><li class="list-inline-item cited-by__entry__author">Hannah Catan, </li><li class="list-inline-item cited-by__entry__author">Nancy Cauwenberghs, </li><li class="list-inline-item cited-by__entry__author">Winston Cavert, </li><li class="list-inline-item cited-by__entry__author">Médéric Celle, </li><li class="list-inline-item cited-by__entry__author">Jorge A. Chacón, </li><li class="list-inline-item cited-by__entry__author">Mesha M. Chadwick, </li><li class="list-inline-item cited-by__entry__author">Amy Chamberlain, </li><li class="list-inline-item cited-by__entry__author">Austin Chan, </li><li class="list-inline-item cited-by__entry__author">Jennifer Chang, </li><li class="list-inline-item cited-by__entry__author">Danaya Chansinghakul, </li><li class="list-inline-item cited-by__entry__author">Mouna G. Chebib, </li><li class="list-inline-item cited-by__entry__author">Corey M. Chen, </li><li class="list-inline-item cited-by__entry__author">Aiying Chen, </li><li class="list-inline-item cited-by__entry__author">Margaret Cheng, </li><li class="list-inline-item cited-by__entry__author">Roman M. Chicz, </li><li class="list-inline-item cited-by__entry__author">Iksung Cho, </li><li class="list-inline-item cited-by__entry__author">Karin Choquette, </li><li class="list-inline-item cited-by__entry__author">R. Michelle Chouteau, </li><li class="list-inline-item cited-by__entry__author">Brian D. W. Chow, </li><li class="list-inline-item cited-by__entry__author">Lisa Chrisley, </li><li class="list-inline-item cited-by__entry__author">Shane G. Christensen, </li><li class="list-inline-item cited-by__entry__author">Laurence Chu, </li><li class="list-inline-item cited-by__entry__author">Hanh Chu, </li><li class="list-inline-item cited-by__entry__author">Waseem Chughtai, </li><li class="list-inline-item cited-by__entry__author">Michael Chung, </li><li class="list-inline-item cited-by__entry__author">Annie Ciambruschini, </li><li class="list-inline-item cited-by__entry__author">Cristina Cicogna, </li><li class="list-inline-item cited-by__entry__author">Alexander Clark, </li><li class="list-inline-item cited-by__entry__author">Jesse L. Clark, </li><li class="list-inline-item cited-by__entry__author">Phillip Claybrook, </li><li class="list-inline-item cited-by__entry__author">Andrea Clement, </li><li class="list-inline-item cited-by__entry__author">Lauren Clement, </li><li class="list-inline-item cited-by__entry__author">Steve Clemons, </li><li class="list-inline-item cited-by__entry__author">Heather Clouting, </li><li class="list-inline-item cited-by__entry__author">Lisa Cohen, </li><li class="list-inline-item cited-by__entry__author">Stuart H. Cohen, </li><li class="list-inline-item cited-by__entry__author">Jacob Coleman, </li><li class="list-inline-item cited-by__entry__author">Joseph P. Connor, </li><li class="list-inline-item cited-by__entry__author">James H. Conway, </li><li class="list-inline-item cited-by__entry__author">Erin Cooksey, </li><li class="list-inline-item cited-by__entry__author">Robert W. Coombs, </li><li class="list-inline-item cited-by__entry__author">Maureen Cooney, </li><li class="list-inline-item cited-by__entry__author">Deanna Cooper, </li><li class="list-inline-item cited-by__entry__author">Paul Coplan, </li><li class="list-inline-item cited-by__entry__author">Lawrence Corey, </li><li class="list-inline-item cited-by__entry__author">Raymond Cornelison, </li><li class="list-inline-item cited-by__entry__author">Barbara Corral, </li><li class="list-inline-item cited-by__entry__author">Jordan Coslet, </li><li class="list-inline-item cited-by__entry__author">Erin Coston, </li><li class="list-inline-item cited-by__entry__author">Michael J. Cotugno, </li><li class="list-inline-item cited-by__entry__author">Florence Coux, </li><li class="list-inline-item cited-by__entry__author">Jessica Cowden, </li><li class="list-inline-item cited-by__entry__author">Paul Cramer, </li><li class="list-inline-item cited-by__entry__author">Clarence B. Creech, </li><li class="list-inline-item cited-by__entry__author">Charnell Cromer, </li><li class="list-inline-item cited-by__entry__author">Marshall A. Cross, </li><li class="list-inline-item cited-by__entry__author">Aurelio Cruz-Valdez, </li><li class="list-inline-item cited-by__entry__author">Marcel Curlin, </li><li class="list-inline-item cited-by__entry__author">LaKondria Curry, </li><li class="list-inline-item cited-by__entry__author">Jerome Custers, </li><li class="list-inline-item cited-by__entry__author">Erika A. Cutz, </li><li class="list-inline-item cited-by__entry__author">Eric S. Daar, </li><li class="list-inline-item cited-by__entry__author">Michelle DallaPiazza, </li><li class="list-inline-item cited-by__entry__author">Dima Dandachi, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Danford, </li><li class="list-inline-item cited-by__entry__author">Lyly Dang, </li><li class="list-inline-item cited-by__entry__author">Stephen Daniels, </li><li class="list-inline-item cited-by__entry__author">Chandan Das, </li><li class="list-inline-item cited-by__entry__author">Santa Kumar Das, </li><li class="list-inline-item cited-by__entry__author">Matthew Davies, </li><li class="list-inline-item cited-by__entry__author">Yvonne Davis, </li><li class="list-inline-item cited-by__entry__author">Joseph D. Davis, </li><li class="list-inline-item cited-by__entry__author">William S. Davis, </li><li class="list-inline-item cited-by__entry__author">William B. Davis, </li><li class="list-inline-item cited-by__entry__author">Matthew G. Davis, </li><li class="list-inline-item cited-by__entry__author">Rajesh K. Davit, </li><li class="list-inline-item cited-by__entry__author">Gustavo H. Dayan, </li><li class="list-inline-item cited-by__entry__author">Anne Marit de Groot, </li><li class="list-inline-item cited-by__entry__author">Luis I. De La Cruz, </li><li class="list-inline-item cited-by__entry__author">Claudia De La Matta Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Ian De Proost, </li><li class="list-inline-item cited-by__entry__author">Christopher Dedon, </li><li class="list-inline-item cited-by__entry__author">Jon F. Dedon, </li><li class="list-inline-item cited-by__entry__author">Teresa Deese, </li><li class="list-inline-item cited-by__entry__author">Emily Degan, </li><li class="list-inline-item cited-by__entry__author">Elliot DeHaan, </li><li class="list-inline-item cited-by__entry__author">Edwin DeJesus, </li><li class="list-inline-item cited-by__entry__author">Carlos del Rio, </li><li class="list-inline-item cited-by__entry__author">Michael Delgado, </li><li class="list-inline-item cited-by__entry__author">Mike Delgado, </li><li class="list-inline-item cited-by__entry__author">Ernesto Delgado, </li><li class="list-inline-item cited-by__entry__author">David Dellaero, </li><li class="list-inline-item cited-by__entry__author">Weiping Deng, </li><li class="list-inline-item cited-by__entry__author">Douglas S. Denham, </li><li class="list-inline-item cited-by__entry__author">Chinar Desai, </li><li class="list-inline-item cited-by__entry__author">Parul Desai, </li><li class="list-inline-item cited-by__entry__author">Michael Desjardins, </li><li class="list-inline-item cited-by__entry__author">Karen Deutsch, </li><li class="list-inline-item cited-by__entry__author">Michael E. Dever, </li><li class="list-inline-item cited-by__entry__author">Naomi Devine, </li><li class="list-inline-item cited-by__entry__author">Louis Devlin, </li><li class="list-inline-item cited-by__entry__author">Carlos A. Diazgranados, </li><li class="list-inline-item cited-by__entry__author">Secia Díaz-Miralrio, </li><li class="list-inline-item cited-by__entry__author">Michelle Dickey, </li><li class="list-inline-item cited-by__entry__author">David J. Diemert, </li><li class="list-inline-item cited-by__entry__author">Craig Dietz, </li><li class="list-inline-item cited-by__entry__author">Susanne Doblecki-Lewis, </li><li class="list-inline-item cited-by__entry__author">Dmytro Dobrianskyi, </li><li class="list-inline-item cited-by__entry__author">Jennifer L Dong, </li><li class="list-inline-item cited-by__entry__author">Tambra Dora, </li><li class="list-inline-item cited-by__entry__author">Brenda Dorcely, </li><li class="list-inline-item cited-by__entry__author">Macaya Douoguih, </li><li class="list-inline-item cited-by__entry__author">Matthew W. Doust, </li><li class="list-inline-item cited-by__entry__author">Frances Downing, </li><li class="list-inline-item cited-by__entry__author">Michael P. Dube, </li><li class="list-inline-item cited-by__entry__author">Filip Dubovsky, </li><li class="list-inline-item cited-by__entry__author">Pete Ducheneaux, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Dugas, </li><li class="list-inline-item cited-by__entry__author">Aeiress Duhart, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Duke, </li><li class="list-inline-item cited-by__entry__author">Debora Dunbar, </li><li class="list-inline-item cited-by__entry__author">Haoua Dunbar, </li><li class="list-inline-item cited-by__entry__author">Daniel M. Duncanson, </li><li class="list-inline-item cited-by__entry__author">Lisa M. Dunkle, </li><li class="list-inline-item cited-by__entry__author">Hillary Dunlevy, </li><li class="list-inline-item cited-by__entry__author">Anna Durbin, </li><li class="list-inline-item cited-by__entry__author">Amy Dye, </li><li class="list-inline-item cited-by__entry__author">Carmel B. Dyer, </li><li class="list-inline-item cited-by__entry__author">Sarah Dzigiel, </li><li class="list-inline-item cited-by__entry__author">Mary Easley, </li><li class="list-inline-item cited-by__entry__author">Niles Eaton, </li><li class="list-inline-item cited-by__entry__author">Valentine M. Ebuh, </li><li class="list-inline-item cited-by__entry__author">Georgette Ebuh, </li><li class="list-inline-item cited-by__entry__author">Lynn Eckert, </li><li class="list-inline-item cited-by__entry__author">Benjamin Eckhardt, </li><li class="list-inline-item cited-by__entry__author">Frank S. Eder, </li><li class="list-inline-item cited-by__entry__author">Srilatha Edupuganti, </li><li class="list-inline-item cited-by__entry__author">Leslie A. Edwards, </li><li class="list-inline-item cited-by__entry__author">Mark Eickhoff, </li><li class="list-inline-item cited-by__entry__author">Hana M. El Sahly, </li><li class="list-inline-item cited-by__entry__author">Edward Ellerbeck, </li><li class="list-inline-item cited-by__entry__author">Grant Ellsworth, </li><li class="list-inline-item cited-by__entry__author">Elwaleed Elnagar, </li><li class="list-inline-item cited-by__entry__author">Victoria Engler, </li><li class="list-inline-item cited-by__entry__author">Kendra Enright, </li><li class="list-inline-item cited-by__entry__author">David J. Ensz, </li><li class="list-inline-item cited-by__entry__author">Sally Eppenbach, </li><li class="list-inline-item cited-by__entry__author">Sandra Erickson, </li><li class="list-inline-item cited-by__entry__author">Joseph Eron, </li><li class="list-inline-item cited-by__entry__author">Joseph J. Eron, </li><li class="list-inline-item cited-by__entry__author">Tiffany Esinhart, </li><li class="list-inline-item cited-by__entry__author">Claudia Espinosa, </li><li class="list-inline-item cited-by__entry__author">Luis Espinoza, </li><li class="list-inline-item cited-by__entry__author">Brandon J. Essink, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Everette, </li><li class="list-inline-item cited-by__entry__author">Evan C. Ewers, </li><li class="list-inline-item cited-by__entry__author">Beverly Ewing, </li><li class="list-inline-item cited-by__entry__author">Amy Falk, </li><li class="list-inline-item cited-by__entry__author">Ann R. Falsey, </li><li class="list-inline-item cited-by__entry__author">Norberto Fas, </li><li class="list-inline-item cited-by__entry__author">Michael Fay, </li><li class="list-inline-item cited-by__entry__author">Szheckera Fearon, </li><li class="list-inline-item cited-by__entry__author">Brittany Feijoo, </li><li class="list-inline-item cited-by__entry__author">Gregory J. Feldman, </li><li class="list-inline-item cited-by__entry__author">Uriel R. Felsen, </li><li class="list-inline-item cited-by__entry__author">Hein Fennema, </li><li class="list-inline-item cited-by__entry__author">Carl J. Fichtenbaum, </li><li class="list-inline-item cited-by__entry__author">Tom Fiel, </li><li class="list-inline-item cited-by__entry__author">Carlos A. Fierro, </li><li class="list-inline-item cited-by__entry__author">Kenneth Finkelstein, </li><li class="list-inline-item cited-by__entry__author">Jon Finley, </li><li class="list-inline-item cited-by__entry__author">Suzanne Fiorillo, </li><li class="list-inline-item cited-by__entry__author">David Fitz-Patrick, </li><li class="list-inline-item cited-by__entry__author">Diana F. Florescu, </li><li class="list-inline-item cited-by__entry__author">Patrick Flume, </li><li class="list-inline-item cited-by__entry__author">Charles M. Fogarty, </li><li class="list-inline-item cited-by__entry__author">Jennifer Foley, </li><li class="list-inline-item cited-by__entry__author">Dean Follmann, </li><li class="list-inline-item cited-by__entry__author">Pink Folmar, </li><li class="list-inline-item cited-by__entry__author">Lyndsea Folsom, </li><li class="list-inline-item cited-by__entry__author">Youyi Fong, </li><li class="list-inline-item cited-by__entry__author">Stacy Ford, </li><li class="list-inline-item cited-by__entry__author">Lina M. Forero, </li><li class="list-inline-item cited-by__entry__author">Les B. Forgosh, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Formentini, </li><li class="list-inline-item cited-by__entry__author">Rhodna Fouts, </li><li class="list-inline-item cited-by__entry__author">Carina Frago, </li><li class="list-inline-item cited-by__entry__author">Veronica G. Fragoso, </li><li class="list-inline-item cited-by__entry__author">Doris Franco-Vitteri, </li><li class="list-inline-item cited-by__entry__author">Ian Frank, </li><li class="list-inline-item cited-by__entry__author">George H. Freeman, </li><li class="list-inline-item cited-by__entry__author">Lena R. Freese, </li><li class="list-inline-item cited-by__entry__author">Robert W. Frenck, </li><li class="list-inline-item cited-by__entry__author">Karen Freudemann, </li><li class="list-inline-item cited-by__entry__author">Sharon E. Frey, </li><li class="list-inline-item cited-by__entry__author">David L. Fried, </li><li class="list-inline-item cited-by__entry__author">Luke Friesen, </li><li class="list-inline-item cited-by__entry__author">James Fry, </li><li class="list-inline-item cited-by__entry__author">Bo Fu, </li><li class="list-inline-item cited-by__entry__author">Hiroyuki Fukase, </li><li class="list-inline-item cited-by__entry__author">Dawn Furey, </li><li class="list-inline-item cited-by__entry__author">Christopher Galloway, </li><li class="list-inline-item cited-by__entry__author">Sarah Galloway, </li><li class="list-inline-item cited-by__entry__author">Edgar Garcia, </li><li class="list-inline-item cited-by__entry__author">Jenina Garcia, </li><li class="list-inline-item cited-by__entry__author">Iris García, </li><li class="list-inline-item cited-by__entry__author">Sebastian Garcia Escallon, </li><li class="list-inline-item cited-by__entry__author">Veronica Garcia-Fragoso, </li><li class="list-inline-item cited-by__entry__author">Agnes Garinga, </li><li class="list-inline-item cited-by__entry__author">Janet Garvey, </li><li class="list-inline-item cited-by__entry__author">Cynthia L. Gay, </li><li class="list-inline-item cited-by__entry__author">Bruce C. Gebhardt, </li><li class="list-inline-item cited-by__entry__author">Grant Geiger, </li><li class="list-inline-item cited-by__entry__author">Huub G. Gelderblom, </li><li class="list-inline-item cited-by__entry__author">Georgettea Geuss, </li><li class="list-inline-item cited-by__entry__author">Elham Ghadishah, </li><li class="list-inline-item cited-by__entry__author">Elie Gharib, </li><li class="list-inline-item cited-by__entry__author">Suzanne Gharib, </li><li class="list-inline-item cited-by__entry__author">Richard L. Gibson, </li><li class="list-inline-item cited-by__entry__author">Peter B. Gilbert, </li><li class="list-inline-item cited-by__entry__author">Alfredo Gilberto Guerreros Benavides, </li><li class="list-inline-item cited-by__entry__author">Teletha Gipson, </li><li class="list-inline-item cited-by__entry__author">Eneyda Giuvanela Llerena Zegarra, </li><li class="list-inline-item cited-by__entry__author">Gregory M. Glenn, </li><li class="list-inline-item cited-by__entry__author">Richard M. Glover, </li><li class="list-inline-item cited-by__entry__author">Erin A. Goecker, </li><li class="list-inline-item cited-by__entry__author">Paul A. Goepfert, </li><li class="list-inline-item cited-by__entry__author">James N. Goldenberg, </li><li class="list-inline-item cited-by__entry__author">Blanca Gomez, </li><li class="list-inline-item cited-by__entry__author">Martha Cecilia Gómora Madrid, </li><li class="list-inline-item cited-by__entry__author">Jose Gonzales-Zamora, </li><li class="list-inline-item cited-by__entry__author">Celia Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Lazaro Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Viviana Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Claudia Gonzalez, </li><li class="list-inline-item cited-by__entry__author">Luis H. González, </li><li class="list-inline-item cited-by__entry__author">Denisse Alejandra González Estrada, </li><li class="list-inline-item cited-by__entry__author">Antonio Gonzalez-Lopez, </li><li class="list-inline-item cited-by__entry__author">Sarah Gordon, </li><li class="list-inline-item cited-by__entry__author">Bryan Gordon, </li><li class="list-inline-item cited-by__entry__author">Richard Gorman, </li><li class="list-inline-item cited-by__entry__author">Gregory M. Gottschlich, </li><li class="list-inline-item cited-by__entry__author">Melissa Gottschlich, </li><li class="list-inline-item cited-by__entry__author">Shanda Gower, </li><li class="list-inline-item cited-by__entry__author">Daniel S. Graciaa, </li><li class="list-inline-item cited-by__entry__author">Barney S. Graham, </li><li class="list-inline-item cited-by__entry__author">Irene Graham, </li><li class="list-inline-item cited-by__entry__author">Maria Angelica Granados, </li><li class="list-inline-item cited-by__entry__author">Amber Grant, </li><li class="list-inline-item cited-by__entry__author">Brett Gray, </li><li class="list-inline-item cited-by__entry__author">Glenda Gray, </li><li class="list-inline-item cited-by__entry__author">Roni Gray, </li><li class="list-inline-item cited-by__entry__author">Sinikka L. Green, </li><li class="list-inline-item cited-by__entry__author">Allison Green, </li><li class="list-inline-item cited-by__entry__author">Justin A. Green, </li><li class="list-inline-item cited-by__entry__author">Rusty Greene, </li><li class="list-inline-item cited-by__entry__author">Caroline Greene, </li><li class="list-inline-item cited-by__entry__author">Cathy Greiwe, </li><li class="list-inline-item cited-by__entry__author">Alex Greninger, </li><li class="list-inline-item cited-by__entry__author">Carl P. Griffin, </li><li class="list-inline-item cited-by__entry__author">Marie-Helene Grillet, </li><li class="list-inline-item cited-by__entry__author">Joseph Grillo, </li><li class="list-inline-item cited-by__entry__author">Beatriz Grinsztejn, </li><li class="list-inline-item cited-by__entry__author">Robert M. Grossberg, </li><li class="list-inline-item cited-by__entry__author">Nicole Grunenberg, </li><li class="list-inline-item cited-by__entry__author">Bernard Grunstra, </li><li class="list-inline-item cited-by__entry__author">Juan V. Guanira-Carranza, </li><li class="list-inline-item cited-by__entry__author">Sonia Guerrero, </li><li class="list-inline-item cited-by__entry__author">Lea Guillery, </li><li class="list-inline-item cited-by__entry__author">Clint C. Guillory, </li><li class="list-inline-item cited-by__entry__author">Caitlin J. Guiney, </li><li class="list-inline-item cited-by__entry__author">Catherine Q. Gular, </li><li class="list-inline-item cited-by__entry__author">Shauna H. Gunaratne, </li><li class="list-inline-item cited-by__entry__author">Sanjay Gurunathan, </li><li class="list-inline-item cited-by__entry__author">Milton Haber, </li><li class="list-inline-item cited-by__entry__author">Greg Hachigian, </li><li class="list-inline-item cited-by__entry__author">Amina Z. Haggag, </li><li class="list-inline-item cited-by__entry__author">William Hahn, </li><li class="list-inline-item cited-by__entry__author">Evelyn Hall, </li><li class="list-inline-item cited-by__entry__author">Jessicalee Hall, </li><li class="list-inline-item cited-by__entry__author">David Halpert, </li><li class="list-inline-item cited-by__entry__author">Holli Hamilton, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Hammershaimb, </li><li class="list-inline-item cited-by__entry__author">Shu Han, </li><li class="list-inline-item cited-by__entry__author">Laurie J. Han-Conrad, </li><li class="list-inline-item cited-by__entry__author">Kate Harden, </li><li class="list-inline-item cited-by__entry__author">Karin Hardt, </li><li class="list-inline-item cited-by__entry__author">Esther L. Harmon, </li><li class="list-inline-item cited-by__entry__author">Wayne L. Harper, </li><li class="list-inline-item cited-by__entry__author">Charles Harper, </li><li class="list-inline-item cited-by__entry__author">Nicole Harrell, </li><li class="list-inline-item cited-by__entry__author">Hannah Harrington, </li><li class="list-inline-item cited-by__entry__author">Tavane Harrison, </li><li class="list-inline-item cited-by__entry__author">Kristina Harrison, </li><li class="list-inline-item cited-by__entry__author">Shana Harshell, </li><li class="list-inline-item cited-by__entry__author">William R. Hartman, </li><li class="list-inline-item cited-by__entry__author">Robyn Hartvickson, </li><li class="list-inline-item cited-by__entry__author">Michael Hassman, </li><li class="list-inline-item cited-by__entry__author">Timothy J. Hatlen, </li><li class="list-inline-item cited-by__entry__author">Kirsten Hauge, </li><li class="list-inline-item cited-by__entry__author">Lynne A. Haughey, </li><li class="list-inline-item cited-by__entry__author">Michelle Haynes, </li><li class="list-inline-item cited-by__entry__author">Gary Headden, </li><li class="list-inline-item cited-by__entry__author">C. Mary Healy, </li><li class="list-inline-item cited-by__entry__author">Parke Hedges, </li><li class="list-inline-item cited-by__entry__author">Dirk Heerwegh, </li><li class="list-inline-item cited-by__entry__author">Theresa Hegmann, </li><li class="list-inline-item cited-by__entry__author">Jessica Heimonen, </li><li class="list-inline-item cited-by__entry__author">Destiny S. Heinzig-Cartwright, </li><li class="list-inline-item cited-by__entry__author">Sheryl L. Henderson, </li><li class="list-inline-item cited-by__entry__author">Jeffrey A. Henderson, </li><li class="list-inline-item cited-by__entry__author">Renea Henderson, </li><li class="list-inline-item cited-by__entry__author">Jenny Hendriks, </li><li class="list-inline-item cited-by__entry__author">Gayle D. Hennekes, </li><li class="list-inline-item cited-by__entry__author">Matthew Hepburn, </li><li class="list-inline-item cited-by__entry__author">Ramin Herati, </li><li class="list-inline-item cited-by__entry__author">Erica Herc, </li><li class="list-inline-item cited-by__entry__author">Will Hernandez, </li><li class="list-inline-item cited-by__entry__author">Laura Hernandez Guarin, </li><li class="list-inline-item cited-by__entry__author">Maria Hernandez Moran, </li><li class="list-inline-item cited-by__entry__author">Robin Hilder, </li><li class="list-inline-item cited-by__entry__author">John M. Hill, </li><li class="list-inline-item cited-by__entry__author">Janet Hill, </li><li class="list-inline-item cited-by__entry__author">Ian Hirsch, </li><li class="list-inline-item cited-by__entry__author">Ken Ho, </li><li class="list-inline-item cited-by__entry__author">Alejandro Hoberman, </li><li class="list-inline-item cited-by__entry__author">Daniel Hoft, </li><li class="list-inline-item cited-by__entry__author">Leila Hojat, </li><li class="list-inline-item cited-by__entry__author">Troy Holdeman, </li><li class="list-inline-item cited-by__entry__author">Ripley R. Hollister, </li><li class="list-inline-item cited-by__entry__author">Lisa Holloway, </li><li class="list-inline-item cited-by__entry__author">Gregory Holt, </li><li class="list-inline-item cited-by__entry__author">Matthew Hong, </li><li class="list-inline-item cited-by__entry__author">Stephan Hong, </li><li class="list-inline-item cited-by__entry__author">Rosamond Hong, </li><li class="list-inline-item cited-by__entry__author">Amanda Horn, </li><li class="list-inline-item cited-by__entry__author">Manisha Horton, </li><li class="list-inline-item cited-by__entry__author">Gary Horwith, </li><li class="list-inline-item cited-by__entry__author">Sybil G. Hosek, </li><li class="list-inline-item cited-by__entry__author">Cyrus Hoseyni, </li><li class="list-inline-item cited-by__entry__author">Patty Howenstine, </li><li class="list-inline-item cited-by__entry__author">Yunda Huang, </li><li class="list-inline-item cited-by__entry__author">Ying Huang, </li><li class="list-inline-item cited-by__entry__author">Kathy Hudzina, </li><li class="list-inline-item cited-by__entry__author">Cory J. Huffine, </li><li class="list-inline-item cited-by__entry__author">Esther S. Huffine, </li><li class="list-inline-item cited-by__entry__author">Christine Hull, </li><li class="list-inline-item cited-by__entry__author">Julie Hunt, </li><li class="list-inline-item cited-by__entry__author">John Hural, </li><li class="list-inline-item cited-by__entry__author">James W. Hurst, </li><li class="list-inline-item cited-by__entry__author">Shamika Huskey, </li><li class="list-inline-item cited-by__entry__author">Mary Hussain, </li><li class="list-inline-item cited-by__entry__author">Julie Hussey, </li><li class="list-inline-item cited-by__entry__author">Morgan Hussey, </li><li class="list-inline-item cited-by__entry__author">Mark Hutchens, </li><li class="list-inline-item cited-by__entry__author">Tanya Hutchins, </li><li class="list-inline-item cited-by__entry__author">Julia Hutter, </li><li class="list-inline-item cited-by__entry__author">Vincent Huynh, </li><li class="list-inline-item cited-by__entry__author">Jessica Ibarra, </li><li class="list-inline-item cited-by__entry__author">Lilly Immergluck, </li><li class="list-inline-item cited-by__entry__author">Dilek Ince, </li><li class="list-inline-item cited-by__entry__author">Sarah M. Ingalsbe-Geno, </li><li class="list-inline-item cited-by__entry__author">Asha Inniss, </li><li class="list-inline-item cited-by__entry__author">Farah Irani, </li><li class="list-inline-item cited-by__entry__author">Mashrur Islam Majumder, </li><li class="list-inline-item cited-by__entry__author">Ryan Israelsen, </li><li class="list-inline-item cited-by__entry__author">Leslie Iverson, </li><li class="list-inline-item cited-by__entry__author">Genevieve Iwuala, </li><li class="list-inline-item cited-by__entry__author">Lisa A. Jackson, </li><li class="list-inline-item cited-by__entry__author">Peta-Gay Jackson-Booth, </li><li class="list-inline-item cited-by__entry__author">Michael Jacobs, </li><li class="list-inline-item cited-by__entry__author">Colleen Jacobsen, </li><li class="list-inline-item cited-by__entry__author">Jeffrey M. Jacobson, </li><li class="list-inline-item cited-by__entry__author">Jeffry Jacqmein, </li><li class="list-inline-item cited-by__entry__author">Kate Jaegle, </li><li class="list-inline-item cited-by__entry__author">Shireen H. Jaffer, </li><li class="list-inline-item cited-by__entry__author">Maryam Jahromi, </li><li class="list-inline-item cited-by__entry__author">Manish Jain, </li><li class="list-inline-item cited-by__entry__author">Frank James, </li><li class="list-inline-item cited-by__entry__author">Holly Janes, </li><li class="list-inline-item cited-by__entry__author">Melanie Jay, </li><li class="list-inline-item cited-by__entry__author">Robert Jeanfreau, </li><li class="list-inline-item cited-by__entry__author">Susan Jeanfreau, </li><li class="list-inline-item cited-by__entry__author">William Jennings, </li><li class="list-inline-item cited-by__entry__author">Natasa Jenson, </li><li class="list-inline-item cited-by__entry__author">Keith R. Jerome, </li><li class="list-inline-item cited-by__entry__author">Jennifer A. Johnson, </li><li class="list-inline-item cited-by__entry__author">John Johnson, </li><li class="list-inline-item cited-by__entry__author">Danyel Johnson, </li><li class="list-inline-item cited-by__entry__author">Diane H. Johnson, </li><li class="list-inline-item cited-by__entry__author">Maria Johnson, </li><li class="list-inline-item cited-by__entry__author">Lisa Johnson, </li><li class="list-inline-item cited-by__entry__author">Erica Johnson, </li><li class="list-inline-item cited-by__entry__author">Kristen Johnson, </li><li class="list-inline-item cited-by__entry__author">Jennie Johnson, </li><li class="list-inline-item cited-by__entry__author">Carrie Johnston, </li><li class="list-inline-item cited-by__entry__author">William H. Jones, </li><li class="list-inline-item cited-by__entry__author">Kathleen S. Jones, </li><li class="list-inline-item cited-by__entry__author">Edward C. Jones-López, </li><li class="list-inline-item cited-by__entry__author">Bailey Jordan, </li><li class="list-inline-item cited-by__entry__author">Michal Juraska, </li><li class="list-inline-item cited-by__entry__author">Jarek Juraszek, </li><li class="list-inline-item cited-by__entry__author">Jessica E. Justman, </li><li class="list-inline-item cited-by__entry__author">Seyram Kaali, </li><li class="list-inline-item cited-by__entry__author">Scott Kahney, </li><li class="list-inline-item cited-by__entry__author">Spyros A. Kalams, </li><li class="list-inline-item cited-by__entry__author">Satoshi Kamidani, </li><li class="list-inline-item cited-by__entry__author">Sheetal Kandiah, </li><li class="list-inline-item cited-by__entry__author">Pamela Kane, </li><li class="list-inline-item cited-by__entry__author">Piush Kanodia, </li><li class="list-inline-item cited-by__entry__author">Shashi Kapadia, </li><li class="list-inline-item cited-by__entry__author">Lois Katz, </li><li class="list-inline-item cited-by__entry__author">Melinda Katz, </li><li class="list-inline-item cited-by__entry__author">Carol Kauffman, </li><li class="list-inline-item cited-by__entry__author">Daniel Kaul, </li><li class="list-inline-item cited-by__entry__author">Margaret Kautz, </li><li class="list-inline-item cited-by__entry__author">Westly Keating, </li><li class="list-inline-item cited-by__entry__author">Jia Jin&nbsp; Kee, </li><li class="list-inline-item cited-by__entry__author">Michael C. Keefer, </li><li class="list-inline-item cited-by__entry__author">Wendy A. Keitel, </li><li class="list-inline-item cited-by__entry__author">Colleen F. Kelley, </li><li class="list-inline-item cited-by__entry__author">Amy Kelley, </li><li class="list-inline-item cited-by__entry__author">Kary Kelly, </li><li class="list-inline-item cited-by__entry__author">Elizabeth J. Kelly, </li><li class="list-inline-item cited-by__entry__author">Sandra Kelman, </li><li class="list-inline-item cited-by__entry__author">Gerald Kelty, </li><li class="list-inline-item cited-by__entry__author">Ashley Kennedy, </li><li class="list-inline-item cited-by__entry__author">Christina Kennelly, </li><li class="list-inline-item cited-by__entry__author">Maryam Keshtkar-Jahromi, </li><li class="list-inline-item cited-by__entry__author">Jill Kessler, </li><li class="list-inline-item cited-by__entry__author">Nzeera Ketter, </li><li class="list-inline-item cited-by__entry__author">Najat Khan, </li><li class="list-inline-item cited-by__entry__author">Nitin Khandelwal, </li><li class="list-inline-item cited-by__entry__author">Shishir K. Khetan, </li><li class="list-inline-item cited-by__entry__author">Saadia Khizer, </li><li class="list-inline-item cited-by__entry__author">Hannah Kibuuka, </li><li class="list-inline-item cited-by__entry__author">Kristen Kiersey, </li><li class="list-inline-item cited-by__entry__author">Paul Kilgore, </li><li class="list-inline-item cited-by__entry__author">Anthony Kim, </li><li class="list-inline-item cited-by__entry__author">Kami Kim, </li><li class="list-inline-item cited-by__entry__author">Murray A. Kimmel, </li><li class="list-inline-item cited-by__entry__author">Michelle King, </li><li class="list-inline-item cited-by__entry__author">Jeffrey K. Kingsley, </li><li class="list-inline-item cited-by__entry__author">William Kirby, </li><li class="list-inline-item cited-by__entry__author">John A. Kirby, </li><li class="list-inline-item cited-by__entry__author">Beth D. Kirkpatrick, </li><li class="list-inline-item cited-by__entry__author">Judith L. Kirstein, </li><li class="list-inline-item cited-by__entry__author">Cissy Kityo Mutuluuza, </li><li class="list-inline-item cited-by__entry__author">Noah Kiwanuka, </li><li class="list-inline-item cited-by__entry__author">Francis Kiweewa, </li><li class="list-inline-item cited-by__entry__author">John S. Kizer, </li><li class="list-inline-item cited-by__entry__author">Terry D. Klein, </li><li class="list-inline-item cited-by__entry__author">Thomas C. Klein, </li><li class="list-inline-item cited-by__entry__author">Tracy R. Klein, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Klein, </li><li class="list-inline-item cited-by__entry__author">Susan Kline, </li><li class="list-inline-item cited-by__entry__author">David Kline, </li><li class="list-inline-item cited-by__entry__author">Jennifer Knishinsky, </li><li class="list-inline-item cited-by__entry__author">Jennifer Knowles, </li><li class="list-inline-item cited-by__entry__author">Laura Kogelman, </li><li class="list-inline-item cited-by__entry__author">Sharon Kohrs, </li><li class="list-inline-item cited-by__entry__author">Susan L. Koletar, </li><li class="list-inline-item cited-by__entry__author">James Kopp, </li><li class="list-inline-item cited-by__entry__author">Michael J. Koren, </li><li class="list-inline-item cited-by__entry__author">Chalit Kosolsak, </li><li class="list-inline-item cited-by__entry__author">Karen L. Kotloff, </li><li class="list-inline-item cited-by__entry__author">Angelica Kottkamp, </li><li class="list-inline-item cited-by__entry__author">Marguerite Koutsoukos, </li><li class="list-inline-item cited-by__entry__author">Jayasree Krishnankutty, </li><li class="list-inline-item cited-by__entry__author">Mara Kryvicky, </li><li class="list-inline-item cited-by__entry__author">James G. Kublin, </li><li class="list-inline-item cited-by__entry__author">Kristine J. Kucera, </li><li class="list-inline-item cited-by__entry__author">Darshna Kukian, </li><li class="list-inline-item cited-by__entry__author">Marcy Kulic, </li><li class="list-inline-item cited-by__entry__author">Rebecca J. Kurnat, </li><li class="list-inline-item cited-by__entry__author">Kelly Kush, </li><li class="list-inline-item cited-by__entry__author">Jitendra Singh Kushwaha, </li><li class="list-inline-item cited-by__entry__author">Mark E. Kutner, </li><li class="list-inline-item cited-by__entry__author">Ben Ladner, </li><li class="list-inline-item cited-by__entry__author">Cathy Laflan, </li><li class="list-inline-item cited-by__entry__author">Maryrose Laguio-Vila, </li><li class="list-inline-item cited-by__entry__author">Sherry Lamberth, </li><li class="list-inline-item cited-by__entry__author">Raphael J. Landovitz, </li><li class="list-inline-item cited-by__entry__author">Dakotah C. Lane, </li><li class="list-inline-item cited-by__entry__author">Thelma Laot, </li><li class="list-inline-item cited-by__entry__author">Anyela Lara, </li><li class="list-inline-item cited-by__entry__author">Matthew Laurens, </li><li class="list-inline-item cited-by__entry__author">Andrew Lauria, </li><li class="list-inline-item cited-by__entry__author">Daniel T. Lawler, </li><li class="list-inline-item cited-by__entry__author">Nga Le, </li><li class="list-inline-item cited-by__entry__author">Mathieu Le Gars, </li><li class="list-inline-item cited-by__entry__author">Vickie Leathers, </li><li class="list-inline-item cited-by__entry__author">Brett Leav, </li><li class="list-inline-item cited-by__entry__author">Logan Ledbetter, </li><li class="list-inline-item cited-by__entry__author">Julie E. Ledgerwood, </li><li class="list-inline-item cited-by__entry__author">Kia Lee, </li><li class="list-inline-item cited-by__entry__author">Jessica L. Lee, </li><li class="list-inline-item cited-by__entry__author">Marina Lee, </li><li class="list-inline-item cited-by__entry__author">Angela Lee, </li><li class="list-inline-item cited-by__entry__author">Mark Leibowitz, </li><li class="list-inline-item cited-by__entry__author">Natalia Leistner, </li><li class="list-inline-item cited-by__entry__author">Mark Lerman, </li><li class="list-inline-item cited-by__entry__author">Michael L. Levin, </li><li class="list-inline-item cited-by__entry__author">Brendan Levy, </li><li class="list-inline-item cited-by__entry__author">Phillip Levy, </li><li class="list-inline-item cited-by__entry__author">Wendell Lewis, </li><li class="list-inline-item cited-by__entry__author">Michael Lewis, </li><li class="list-inline-item cited-by__entry__author">Derek Lewis, </li><li class="list-inline-item cited-by__entry__author">Wendell Lewis, </li><li class="list-inline-item cited-by__entry__author">Maggie Lewis, </li><li class="list-inline-item cited-by__entry__author">Paola Lichtenberger, </li><li class="list-inline-item cited-by__entry__author">Amanda Lilienthal, </li><li class="list-inline-item cited-by__entry__author">Kathleen Linder, </li><li class="list-inline-item cited-by__entry__author">Carol Ann Linebarger, </li><li class="list-inline-item cited-by__entry__author">Kendra Lisec, </li><li class="list-inline-item cited-by__entry__author">Ryan Little, </li><li class="list-inline-item cited-by__entry__author">Susan J. Little, </li><li class="list-inline-item cited-by__entry__author">Albert Liu, </li><li class="list-inline-item cited-by__entry__author">Anna S. Lok, </li><li class="list-inline-item cited-by__entry__author">Evelyn Lomasney, </li><li class="list-inline-item cited-by__entry__author">James Longe, </li><li class="list-inline-item cited-by__entry__author">Carlos Lopez, </li><li class="list-inline-item cited-by__entry__author">Eduardo Lopez-Medina, </li><li class="list-inline-item cited-by__entry__author">Julia Lord, </li><li class="list-inline-item cited-by__entry__author">James Lovell, </li><li class="list-inline-item cited-by__entry__author">Ronald Lubelchek, </li><li class="list-inline-item cited-by__entry__author">John Lucaj, </li><li class="list-inline-item cited-by__entry__author">Njira Lucia Lugogo, </li><li class="list-inline-item cited-by__entry__author">Gary Luckasen, </li><li class="list-inline-item cited-by__entry__author">Gregg H. Lucksinger, </li><li class="list-inline-item cited-by__entry__author">Annie Luetkemeyer, </li><li class="list-inline-item cited-by__entry__author">Benjamin J. Luft, </li><li class="list-inline-item cited-by__entry__author">Rafael Lupercio, </li><li class="list-inline-item cited-by__entry__author">Alisha Lutat, </li><li class="list-inline-item cited-by__entry__author">Jill Maaske, </li><li class="list-inline-item cited-by__entry__author">Rosa MacBryde, </li><li class="list-inline-item cited-by__entry__author">Nolan Mackey, </li><li class="list-inline-item cited-by__entry__author">Rebecca P. Madan, </li><li class="list-inline-item cited-by__entry__author">Janine Maenza, </li><li class="list-inline-item cited-by__entry__author">Siham Mahgoub, </li><li class="list-inline-item cited-by__entry__author">Mamodikoe Makhene, </li><li class="list-inline-item cited-by__entry__author">Hussain Malbari, </li><li class="list-inline-item cited-by__entry__author">Elissa Malkin, </li><li class="list-inline-item cited-by__entry__author">Carlos Malvestutto, </li><li class="list-inline-item cited-by__entry__author">Stephanie Mamod, </li><li class="list-inline-item cited-by__entry__author">Millie Manalo, </li><li class="list-inline-item cited-by__entry__author">Jose C. Mancilla, </li><li class="list-inline-item cited-by__entry__author">Kishorchandra Mandaliya, </li><li class="list-inline-item cited-by__entry__author">Somnath Mangarule, </li><li class="list-inline-item cited-by__entry__author">Padma N. Mangu, </li><li class="list-inline-item cited-by__entry__author">Mary Beth Manning, </li><li class="list-inline-item cited-by__entry__author">Rickey D. Manning, </li><li class="list-inline-item cited-by__entry__author">Deb Manzo, </li><li class="list-inline-item cited-by__entry__author">Horacio Marafioti, </li><li class="list-inline-item cited-by__entry__author">Kristin Marks, </li><li class="list-inline-item cited-by__entry__author">Mary A. Marovich, </li><li class="list-inline-item cited-by__entry__author">Adrienna Marquez, </li><li class="list-inline-item cited-by__entry__author">Richard P. Marshall, </li><li class="list-inline-item cited-by__entry__author">Judith Martin, </li><li class="list-inline-item cited-by__entry__author">Troy Martin, </li><li class="list-inline-item cited-by__entry__author">Becky Martinez, </li><li class="list-inline-item cited-by__entry__author">Reuben Martinez, </li><li class="list-inline-item cited-by__entry__author">Javier Martínez, </li><li class="list-inline-item cited-by__entry__author">Silvano Omar Martínez Pérez, </li><li class="list-inline-item cited-by__entry__author">Catherine Mary Healy, </li><li class="list-inline-item cited-by__entry__author">John Mascola, </li><li class="list-inline-item cited-by__entry__author">Robin Mason, </li><li class="list-inline-item cited-by__entry__author">Roger Masotti, </li><li class="list-inline-item cited-by__entry__author">Paul G. Matherne, </li><li class="list-inline-item cited-by__entry__author">Christopher Matich, </li><li class="list-inline-item cited-by__entry__author">Monica Mauri, </li><li class="list-inline-item cited-by__entry__author">Ryan C. Maves, </li><li class="list-inline-item cited-by__entry__author">Michelle Maxwell, </li><li class="list-inline-item cited-by__entry__author">Celia Maxwell, </li><li class="list-inline-item cited-by__entry__author">Kenneth H. Mayer, </li><li class="list-inline-item cited-by__entry__author">Monica A. McArthur, </li><li class="list-inline-item cited-by__entry__author">Jennifer McCarter, </li><li class="list-inline-item cited-by__entry__author">Michael J. McCartney, </li><li class="list-inline-item cited-by__entry__author">R. Scott McClelland, </li><li class="list-inline-item cited-by__entry__author">Bruce McClenathan, </li><li class="list-inline-item cited-by__entry__author">Rachael McClennen, </li><li class="list-inline-item cited-by__entry__author">Andrew McConnell, </li><li class="list-inline-item cited-by__entry__author">Margaret E. McCort, </li><li class="list-inline-item cited-by__entry__author">M. Juliana McElrath, </li><li class="list-inline-item cited-by__entry__author">Charlene McEvoy, </li><li class="list-inline-item cited-by__entry__author">Alice McGarry, </li><li class="list-inline-item cited-by__entry__author">John W. McGettigan, </li><li class="list-inline-item cited-by__entry__author">Jonlyn McGettigan, </li><li class="list-inline-item cited-by__entry__author">Lora J. McGill, </li><li class="list-inline-item cited-by__entry__author">Eric McGrath, </li><li class="list-inline-item cited-by__entry__author">Mark M. McKenzie, </li><li class="list-inline-item cited-by__entry__author">Cecilia McKeown-Bragas, </li><li class="list-inline-item cited-by__entry__author">Irene McKnight, </li><li class="list-inline-item cited-by__entry__author">Morgan McLaughlin, </li><li class="list-inline-item cited-by__entry__author">Meredith McNairy, </li><li class="list-inline-item cited-by__entry__author">Kelly McQuarrie, </li><li class="list-inline-item cited-by__entry__author">Andrew McWilliams, </li><li class="list-inline-item cited-by__entry__author">Jodi Meck, </li><li class="list-inline-item cited-by__entry__author">Surisday Mederos, </li><li class="list-inline-item cited-by__entry__author">Amy Medina, </li><li class="list-inline-item cited-by__entry__author">Carmen Medina, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Meier, </li><li class="list-inline-item cited-by__entry__author">Thomas Mellman, </li><li class="list-inline-item cited-by__entry__author">Jessica M. Mena, </li><li class="list-inline-item cited-by__entry__author">Lisa Menard, </li><li class="list-inline-item cited-by__entry__author">Kathleen Menasche, </li><li class="list-inline-item cited-by__entry__author">Janet Mendez, </li><li class="list-inline-item cited-by__entry__author">Jorge F. Méndez Galván, </li><li class="list-inline-item cited-by__entry__author">Rafael Mendoza, </li><li class="list-inline-item cited-by__entry__author">Erika Mendoza, </li><li class="list-inline-item cited-by__entry__author">Sandra Mendoza, </li><li class="list-inline-item cited-by__entry__author">Rajan Merchant, </li><li class="list-inline-item cited-by__entry__author">Fernando L. Merino, </li><li class="list-inline-item cited-by__entry__author">David Metzger, </li><li class="list-inline-item cited-by__entry__author">Jay Meyer, </li><li class="list-inline-item cited-by__entry__author">Robert Meyer, </li><li class="list-inline-item cited-by__entry__author">Eric A. Meyerowitz, </li><li class="list-inline-item cited-by__entry__author">Nelson L. Michael, </li><li class="list-inline-item cited-by__entry__author">Randle Middleton, </li><li class="list-inline-item cited-by__entry__author">Maria Mileno, </li><li class="list-inline-item cited-by__entry__author">Matthew Miles, </li><li class="list-inline-item cited-by__entry__author">Chelsea Miles, </li><li class="list-inline-item cited-by__entry__author">Eric Miller, </li><li class="list-inline-item cited-by__entry__author">Jacqueline Miller, </li><li class="list-inline-item cited-by__entry__author">Vicki E. Miller, </li><li class="list-inline-item cited-by__entry__author">Meagan Miller, </li><li class="list-inline-item cited-by__entry__author">Paulina Miller, </li><li class="list-inline-item cited-by__entry__author">Jason Milligan, </li><li class="list-inline-item cited-by__entry__author">Ann M. Milliken, </li><li class="list-inline-item cited-by__entry__author">Jill Miracle, </li><li class="list-inline-item cited-by__entry__author">Vincent Mirkil, </li><li class="list-inline-item cited-by__entry__author">Mehdi Mirsaeidi, </li><li class="list-inline-item cited-by__entry__author">Carol L. Mitchell, </li><li class="list-inline-item cited-by__entry__author">Kazuyuki Mizuyama, </li><li class="list-inline-item cited-by__entry__author">Gowdhami Mohan, </li><li class="list-inline-item cited-by__entry__author">Satyajit Mohapatra, </li><li class="list-inline-item cited-by__entry__author">Sharzhaad Molina Guizar, </li><li class="list-inline-item cited-by__entry__author">Florence Momplaisir, </li><li class="list-inline-item cited-by__entry__author">Cynthia L. Monaco, </li><li class="list-inline-item cited-by__entry__author">Cynthia Montano-Pereira, </li><li class="list-inline-item cited-by__entry__author">Natasha Montoya, </li><li class="list-inline-item cited-by__entry__author">Candice Montros, </li><li class="list-inline-item cited-by__entry__author">Amaran Moodley, </li><li class="list-inline-item cited-by__entry__author">Fernanda Morales, </li><li class="list-inline-item cited-by__entry__author">Caitlin Moran, </li><li class="list-inline-item cited-by__entry__author">Catherine Moreau, </li><li class="list-inline-item cited-by__entry__author">Stephen Morris, </li><li class="list-inline-item cited-by__entry__author">Victoria Mosteller, </li><li class="list-inline-item cited-by__entry__author">Stefanie Mott, </li><li class="list-inline-item cited-by__entry__author">Connie Moya, </li><li class="list-inline-item cited-by__entry__author">Terri Moye, </li><li class="list-inline-item cited-by__entry__author">Kimberly Mueller, </li><li class="list-inline-item cited-by__entry__author">Nancy Mueller, </li><li class="list-inline-item cited-by__entry__author">Jacqueline Muenzner, </li><li class="list-inline-item cited-by__entry__author">Nelly Mugo, </li><li class="list-inline-item cited-by__entry__author">Sauda Muhammad, </li><li class="list-inline-item cited-by__entry__author">Kathleen M. Mullane, </li><li class="list-inline-item cited-by__entry__author">Mark J. Mulligan, </li><li class="list-inline-item cited-by__entry__author">Gysella Muniz, </li><li class="list-inline-item cited-by__entry__author">Sigridh Muñoz-Gómez, </li><li class="list-inline-item cited-by__entry__author">Sonal Munsiff, </li><li class="list-inline-item cited-by__entry__author">Deborah Murray, </li><li class="list-inline-item cited-by__entry__author">Monica Murray, </li><li class="list-inline-item cited-by__entry__author">Linda Murray, </li><li class="list-inline-item cited-by__entry__author">David B. Musante, </li><li class="list-inline-item cited-by__entry__author">Sharon Nachman, </li><li class="list-inline-item cited-by__entry__author">Shinya Nagamatsu, </li><li class="list-inline-item cited-by__entry__author">Sherif Naguib, </li><li class="list-inline-item cited-by__entry__author">Jerome G. Naifeh, </li><li class="list-inline-item cited-by__entry__author">S. Hasan Naqvi, </li><li class="list-inline-item cited-by__entry__author">Marshall Nash, </li><li class="list-inline-item cited-by__entry__author">Julio Nasim, </li><li class="list-inline-item cited-by__entry__author">Martha Nason, </li><li class="list-inline-item cited-by__entry__author">Videlis Nduba, </li><li class="list-inline-item cited-by__entry__author">Paul Nee, </li><li class="list-inline-item cited-by__entry__author">Rosa Negron, </li><li class="list-inline-item cited-by__entry__author">Marguerite Neill, </li><li class="list-inline-item cited-by__entry__author">Joy Nelson, </li><li class="list-inline-item cited-by__entry__author">Taylor Nelson, </li><li class="list-inline-item cited-by__entry__author">Tiffany Nemecek, </li><li class="list-inline-item cited-by__entry__author">Lori Nesbitt, </li><li class="list-inline-item cited-by__entry__author">Sonja Neumeister, </li><li class="list-inline-item cited-by__entry__author">Kathleen Neuzil, </li><li class="list-inline-item cited-by__entry__author">Hannah Nevarez, </li><li class="list-inline-item cited-by__entry__author">Joseph L. Newberg, </li><li class="list-inline-item cited-by__entry__author">Lauren Newhouse, </li><li class="list-inline-item cited-by__entry__author">Patrick Newingham, </li><li class="list-inline-item cited-by__entry__author">Fred E. Newton, </li><li class="list-inline-item cited-by__entry__author">Lucy Ng-Price, </li><li class="list-inline-item cited-by__entry__author">Kimberly Nieves, </li><li class="list-inline-item cited-by__entry__author">Chimeremma Nnadi, </li><li class="list-inline-item cited-by__entry__author">Kimberly Nofz, </li><li class="list-inline-item cited-by__entry__author">Nicole L. Nollen, </li><li class="list-inline-item cited-by__entry__author">Asif Noor, </li><li class="list-inline-item cited-by__entry__author">Fernando Noriega, </li><li class="list-inline-item cited-by__entry__author">Richard M. Novak, </li><li class="list-inline-item cited-by__entry__author">Patricia Nahirya Ntege, </li><li class="list-inline-item cited-by__entry__author">Paul J. Nugent, </li><li class="list-inline-item cited-by__entry__author">Claudio Nuñez Lagos, </li><li class="list-inline-item cited-by__entry__author">Cheryl Nuss, </li><li class="list-inline-item cited-by__entry__author">Chelsie Nutsch, </li><li class="list-inline-item cited-by__entry__author">Amesika Nyaku, </li><li class="list-inline-item cited-by__entry__author">Allison O'Brien, </li><li class="list-inline-item cited-by__entry__author">Enrique Ocaña, </li><li class="list-inline-item cited-by__entry__author">Amanda Occhino, </li><li class="list-inline-item cited-by__entry__author">Kimberly Offergeld, </li><li class="list-inline-item cited-by__entry__author">Brenda Okech, </li><li class="list-inline-item cited-by__entry__author">Tracy Okonya, </li><li class="list-inline-item cited-by__entry__author">Jason F. Okulicz, </li><li class="list-inline-item cited-by__entry__author">Oyebisi Olanrewaju, </li><li class="list-inline-item cited-by__entry__author">Shelby Olds, </li><li class="list-inline-item cited-by__entry__author">Marcia O'Leary, </li><li class="list-inline-item cited-by__entry__author">Patrick A. Oliver, </li><li class="list-inline-item cited-by__entry__author">Odette Olivieri, </li><li class="list-inline-item cited-by__entry__author">Jocelyn Zuleica Olmos Vega, </li><li class="list-inline-item cited-by__entry__author">Sarah Omodele, </li><li class="list-inline-item cited-by__entry__author">Allie Oplinger, </li><li class="list-inline-item cited-by__entry__author">Emily Oppenheim, </li><li class="list-inline-item cited-by__entry__author">Yaa D. Oppong, </li><li class="list-inline-item cited-by__entry__author">Jessica Ortega, </li><li class="list-inline-item cited-by__entry__author">Sandra Janeth Ortega Domínguez, </li><li class="list-inline-item cited-by__entry__author">Maricruz E. Ortegón, </li><li class="list-inline-item cited-by__entry__author">Masaru Oshita, </li><li class="list-inline-item cited-by__entry__author">Erica Osmundsen, </li><li class="list-inline-item cited-by__entry__author">Jaleh Ostovar, </li><li class="list-inline-item cited-by__entry__author">Quito Osuna&nbsp;Carr, </li><li class="list-inline-item cited-by__entry__author">Maria Otero, </li><li class="list-inline-item cited-by__entry__author">Janet Otto, </li><li class="list-inline-item cited-by__entry__author">Samuel Gurrion Ouma, </li><li class="list-inline-item cited-by__entry__author">Jeffrey S. Overcash, </li><li class="list-inline-item cited-by__entry__author">Temitope Oyedele, </li><li class="list-inline-item cited-by__entry__author">Janet Oyieko, </li><li class="list-inline-item cited-by__entry__author">Janeth Pacheco-Flores, </li><li class="list-inline-item cited-by__entry__author">Carmen A. Paez, </li><li class="list-inline-item cited-by__entry__author">Barbara A. Pahud, </li><li class="list-inline-item cited-by__entry__author">Ruth Paiano, </li><li class="list-inline-item cited-by__entry__author">Rolando Pajon, </li><li class="list-inline-item cited-by__entry__author">Yogesh K. Paliwal, </li><li class="list-inline-item cited-by__entry__author">Amit Paliwal, </li><li class="list-inline-item cited-by__entry__author">Steven Palmer, </li><li class="list-inline-item cited-by__entry__author">David Pampe, </li><li class="list-inline-item cited-by__entry__author">Menelas N. Pangalos, </li><li class="list-inline-item cited-by__entry__author">Lalitha Parameswaran, </li><li class="list-inline-item cited-by__entry__author">Erwin Pardo, </li><li class="list-inline-item cited-by__entry__author">Mercedes Paredes, </li><li class="list-inline-item cited-by__entry__author">Purvi Parikh, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Parker, </li><li class="list-inline-item cited-by__entry__author">Susan Parker, </li><li class="list-inline-item cited-by__entry__author">Kevin Parks, </li><li class="list-inline-item cited-by__entry__author">Reza Parungao, </li><li class="list-inline-item cited-by__entry__author">Alpa Patel, </li><li class="list-inline-item cited-by__entry__author">Priti Patel, </li><li class="list-inline-item cited-by__entry__author">Thomas Patterson, </li><li class="list-inline-item cited-by__entry__author">Jan Patterson, </li><li class="list-inline-item cited-by__entry__author">Walter Patton, </li><li class="list-inline-item cited-by__entry__author">Leena Paul, </li><li class="list-inline-item cited-by__entry__author">Corrina Pavetto, </li><li class="list-inline-item cited-by__entry__author">Juana R. Pavie, </li><li class="list-inline-item cited-by__entry__author">James Peacock, </li><li class="list-inline-item cited-by__entry__author">Michele Peake-Andrasik, </li><li class="list-inline-item cited-by__entry__author">Laura Pearlman, </li><li class="list-inline-item cited-by__entry__author">Alyssa-Kay Peay, </li><li class="list-inline-item cited-by__entry__author">David Pekala, </li><li class="list-inline-item cited-by__entry__author">Alison Pellecchia, </li><li class="list-inline-item cited-by__entry__author">Issac Pena-Renteria, </li><li class="list-inline-item cited-by__entry__author">Penny Peng, </li><li class="list-inline-item cited-by__entry__author">Noris Peraita, </li><li class="list-inline-item cited-by__entry__author">Henry Peralta, </li><li class="list-inline-item cited-by__entry__author">Donna Percy, </li><li class="list-inline-item cited-by__entry__author">Isabel Pereira, </li><li class="list-inline-item cited-by__entry__author">Ashley Perez, </li><li class="list-inline-item cited-by__entry__author">James T. Peterson, </li><li class="list-inline-item cited-by__entry__author">Jennifer Petts, </li><li class="list-inline-item cited-by__entry__author">Taryn Petty, </li><li class="list-inline-item cited-by__entry__author">Mai Pham, </li><li class="list-inline-item cited-by__entry__author">Sharine Phan, </li><li class="list-inline-item cited-by__entry__author">Amanda Philyaw, </li><li class="list-inline-item cited-by__entry__author">Sikhongi Phungwayo, </li><li class="list-inline-item cited-by__entry__author">Judy Pi, </li><li class="list-inline-item cited-by__entry__author">Shelby Pickle, </li><li class="list-inline-item cited-by__entry__author">Paul Pickrell, </li><li class="list-inline-item cited-by__entry__author">Terry Piedra, </li><li class="list-inline-item cited-by__entry__author">Kristen K. Pierce, </li><li class="list-inline-item cited-by__entry__author">Daniela Pineda Méndez, </li><li class="list-inline-item cited-by__entry__author">Ruth S. Pinilla, </li><li class="list-inline-item cited-by__entry__author">Simmy Pinto, </li><li class="list-inline-item cited-by__entry__author">Rebecca Pitotti, </li><li class="list-inline-item cited-by__entry__author">David Pitrak, </li><li class="list-inline-item cited-by__entry__author">April Pixler, </li><li class="list-inline-item cited-by__entry__author">Stanford Plavin, </li><li class="list-inline-item cited-by__entry__author">Laura Polakowski, </li><li class="list-inline-item cited-by__entry__author">Terry L. Poling, </li><li class="list-inline-item cited-by__entry__author">Philip Ponce, </li><li class="list-inline-item cited-by__entry__author">Laura Porterfield, </li><li class="list-inline-item cited-by__entry__author">Svitlana Postol, </li><li class="list-inline-item cited-by__entry__author">Amy Potts, </li><li class="list-inline-item cited-by__entry__author">Richard Powell, </li><li class="list-inline-item cited-by__entry__author">Margaret Powers-Fletcher, </li><li class="list-inline-item cited-by__entry__author">E. Javier Pretell Alva, </li><li class="list-inline-item cited-by__entry__author">Patty Price-Abbott, </li><li class="list-inline-item cited-by__entry__author">Veronica Procasky, </li><li class="list-inline-item cited-by__entry__author">John Pullman, </li><li class="list-inline-item cited-by__entry__author">Lawrence J. Purpura, </li><li class="list-inline-item cited-by__entry__author">Marie-Laure Py, </li><li class="list-inline-item cited-by__entry__author">Evelyn Quevedo, </li><li class="list-inline-item cited-by__entry__author">Kim Quillin, </li><li class="list-inline-item cited-by__entry__author">Donald Quinn, </li><li class="list-inline-item cited-by__entry__author">Jalima Quintero, </li><li class="list-inline-item cited-by__entry__author">Vanessa Raabe, </li><li class="list-inline-item cited-by__entry__author">Frederick Raiser, </li><li class="list-inline-item cited-by__entry__author">Sabina Raja, </li><li class="list-inline-item cited-by__entry__author">Vivek Rajasekhar, </li><li class="list-inline-item cited-by__entry__author">Danielle Raley, </li><li class="list-inline-item cited-by__entry__author">Mayur Ramesh, </li><li class="list-inline-item cited-by__entry__author">Natalie Ramirez, </li><li class="list-inline-item cited-by__entry__author">Shelly Ramirez, </li><li class="list-inline-item cited-by__entry__author">Wanda Ramon, </li><li class="list-inline-item cited-by__entry__author">James Ramsey, </li><li class="list-inline-item cited-by__entry__author">Bruce G. Rankin, </li><li class="list-inline-item cited-by__entry__author">Heather Rattenbury-Shaw, </li><li class="list-inline-item cited-by__entry__author">Paulina Rebolledo, </li><li class="list-inline-item cited-by__entry__author">Sergio E. Recuenco, </li><li class="list-inline-item cited-by__entry__author">Chinthaparthi Prabhakar Reddy, </li><li class="list-inline-item cited-by__entry__author">Patty Reed, </li><li class="list-inline-item cited-by__entry__author">Maria M. Regalado, </li><li class="list-inline-item cited-by__entry__author">Malina Regalado, </li><li class="list-inline-item cited-by__entry__author">María José Reyes Fentanes, </li><li class="list-inline-item cited-by__entry__author">Humberto Reynales, </li><li class="list-inline-item cited-by__entry__author">Michele D. Reynolds, </li><li class="list-inline-item cited-by__entry__author">Trina L. Reynolds, </li><li class="list-inline-item cited-by__entry__author">Michelle Reynolds, </li><li class="list-inline-item cited-by__entry__author">Margaret Rhee, </li><li class="list-inline-item cited-by__entry__author">Tamara Richards, </li><li class="list-inline-item cited-by__entry__author">Sha-Wanda Richmond, </li><li class="list-inline-item cited-by__entry__author">Sharon A. Riddler, </li><li class="list-inline-item cited-by__entry__author">Robert A. Riesenberg, </li><li class="list-inline-item cited-by__entry__author">Dolores Rijos, </li><li class="list-inline-item cited-by__entry__author">Joshua Rindt, </li><li class="list-inline-item cited-by__entry__author">Enrique Rivas, </li><li class="list-inline-item cited-by__entry__author">Juan J. Rivera, </li><li class="list-inline-item cited-by__entry__author">María I. Rivera, </li><li class="list-inline-item cited-by__entry__author">Juana Rivera, </li><li class="list-inline-item cited-by__entry__author">Gina Rivero, </li><li class="list-inline-item cited-by__entry__author">Rafael Rivero, </li><li class="list-inline-item cited-by__entry__author">Zainab Rizvi, </li><li class="list-inline-item cited-by__entry__author">Barbara Rizzardi, </li><li class="list-inline-item cited-by__entry__author">Denise Roadman, </li><li class="list-inline-item cited-by__entry__author">Merlin L. Robb, </li><li class="list-inline-item cited-by__entry__author">Afsoon Roberts, </li><li class="list-inline-item cited-by__entry__author">Toni Robinson, </li><li class="list-inline-item cited-by__entry__author">Dawn Robison, </li><li class="list-inline-item cited-by__entry__author">Elizabeth E. Robison, </li><li class="list-inline-item cited-by__entry__author">Shannon Rodman, </li><li class="list-inline-item cited-by__entry__author">Jessica Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Carina A. Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Edith Rodriguez, </li><li class="list-inline-item cited-by__entry__author">Rachel Rokser, </li><li class="list-inline-item cited-by__entry__author">Charlotte-Paige Rolle, </li><li class="list-inline-item cited-by__entry__author">Stephanie Rolsma, </li><li class="list-inline-item cited-by__entry__author">Peter Ronco, </li><li class="list-inline-item cited-by__entry__author">Melody Ronk, </li><li class="list-inline-item cited-by__entry__author">Adam Rosen, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Rosen, </li><li class="list-inline-item cited-by__entry__author">David Rosenberg, </li><li class="list-inline-item cited-by__entry__author">A. Lina Rosengren, </li><li class="list-inline-item cited-by__entry__author">Christiana A. Rostad, </li><li class="list-inline-item cited-by__entry__author">Joan Rothenberg, </li><li class="list-inline-item cited-by__entry__author">Rambod Rouhbakhsh, </li><li class="list-inline-item cited-by__entry__author">Nadine Rouphael, </li><li class="list-inline-item cited-by__entry__author">Crystal Rowell, </li><li class="list-inline-item cited-by__entry__author">Pavitra Roychoudhury, </li><li class="list-inline-item cited-by__entry__author">Rola G. Rucker, </li><li class="list-inline-item cited-by__entry__author">Monica Ruiz, </li><li class="list-inline-item cited-by__entry__author">Vida Veronica Ruiz Herrera, </li><li class="list-inline-item cited-by__entry__author">Javier Ruiz-Guiñazú, </li><li class="list-inline-item cited-by__entry__author">Guillermo M. Ruiz-Palacios, </li><li class="list-inline-item cited-by__entry__author">Karen Ruperto, </li><li class="list-inline-item cited-by__entry__author">Richard Rupp, </li><li class="list-inline-item cited-by__entry__author">Sarah E. Rutstein, </li><li class="list-inline-item cited-by__entry__author">Natasha Rybak, </li><li class="list-inline-item cited-by__entry__author">Martin F. Ryser, </li><li class="list-inline-item cited-by__entry__author">Jerald Sadoff, </li><li class="list-inline-item cited-by__entry__author">Michelle Saemann, </li><li class="list-inline-item cited-by__entry__author">Beth E. Safirstein, </li><li class="list-inline-item cited-by__entry__author">Nafisa Saleem, </li><li class="list-inline-item cited-by__entry__author">Jamshid Saleh, </li><li class="list-inline-item cited-by__entry__author">Mansoor Saleh, </li><li class="list-inline-item cited-by__entry__author">Kacie Sales, </li><li class="list-inline-item cited-by__entry__author">Amy Salzl, </li><li class="list-inline-item cited-by__entry__author">Denise Sample, </li><li class="list-inline-item cited-by__entry__author">Robert Samuels, </li><li class="list-inline-item cited-by__entry__author">Rosario Sanchez, </li><li class="list-inline-item cited-by__entry__author">Martha Sanchez, </li><li class="list-inline-item cited-by__entry__author">Erica Sanchez, </li><li class="list-inline-item cited-by__entry__author">Pedro Sánchez, </li><li class="list-inline-item cited-by__entry__author">Laura Ruy Sanchez Guerrero, </li><li class="list-inline-item cited-by__entry__author">Nelia Sanchez-Crespo, </li><li class="list-inline-item cited-by__entry__author">John Sanders, </li><li class="list-inline-item cited-by__entry__author">Lisa J. Sanders, </li><li class="list-inline-item cited-by__entry__author">Rica Santiago, </li><li class="list-inline-item cited-by__entry__author">Fredric Santiago, </li><li class="list-inline-item cited-by__entry__author">María E. Santolaya, </li><li class="list-inline-item cited-by__entry__author">Nessryne Sater, </li><li class="list-inline-item cited-by__entry__author">Stephen Savarino, </li><li class="list-inline-item cited-by__entry__author">Fredrick Sawe, </li><li class="list-inline-item cited-by__entry__author">Carolyn Scatamacchia, </li><li class="list-inline-item cited-by__entry__author">Timothy W. Schacker, </li><li class="list-inline-item cited-by__entry__author">Gert Scheper, </li><li class="list-inline-item cited-by__entry__author">Linda M. Schipani, </li><li class="list-inline-item cited-by__entry__author">Christy Schmeck, </li><li class="list-inline-item cited-by__entry__author">Robert Schmidt, </li><li class="list-inline-item cited-by__entry__author">William Schnitz, </li><li class="list-inline-item cited-by__entry__author">Florian Schödel, </li><li class="list-inline-item cited-by__entry__author">Debra B. Schroeck, </li><li class="list-inline-item cited-by__entry__author">Lode Schuerman, </li><li class="list-inline-item cited-by__entry__author">Hanneke Schuitemaker, </li><li class="list-inline-item cited-by__entry__author">Howard I. Schwartz, </li><li class="list-inline-item cited-by__entry__author">Adam Schwartz, </li><li class="list-inline-item cited-by__entry__author">Howard Schwartz, </li><li class="list-inline-item cited-by__entry__author">Jennifer Schwartz, </li><li class="list-inline-item cited-by__entry__author">Tiffany Schwasinger-Schmidt, </li><li class="list-inline-item cited-by__entry__author">Michael Sciaudone, </li><li class="list-inline-item cited-by__entry__author">Hyman Scott, </li><li class="list-inline-item cited-by__entry__author">Tameika Scott, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Secord, </li><li class="list-inline-item cited-by__entry__author">Nathan Segall, </li><li class="list-inline-item cited-by__entry__author">William Seger, </li><li class="list-inline-item cited-by__entry__author">Shannen Seversen, </li><li class="list-inline-item cited-by__entry__author">Beverly E. Sha, </li><li class="list-inline-item cited-by__entry__author">Mitul Shah, </li><li class="list-inline-item cited-by__entry__author">Jinen Shah, </li><li class="list-inline-item cited-by__entry__author">Samira Shairi, </li><li class="list-inline-item cited-by__entry__author">Shivanjali Shankaran, </li><li class="list-inline-item cited-by__entry__author">Amie Shannon, </li><li class="list-inline-item cited-by__entry__author">Adrienne E. Shapiro, </li><li class="list-inline-item cited-by__entry__author">Stephan C. Sharp, </li><li class="list-inline-item cited-by__entry__author">Marian E. Shaw, </li><li class="list-inline-item cited-by__entry__author">Rozeli Shelly, </li><li class="list-inline-item cited-by__entry__author">Sandra Shelton, </li><li class="list-inline-item cited-by__entry__author">Lawrence Sher, </li><li class="list-inline-item cited-by__entry__author">Amy Sherman, </li><li class="list-inline-item cited-by__entry__author">Neil P. Sheth, </li><li class="list-inline-item cited-by__entry__author">Steven Shinn, </li><li class="list-inline-item cited-by__entry__author">Tammi L. Shlotzhauer, </li><li class="list-inline-item cited-by__entry__author">Kathryn Shoemaker, </li><li class="list-inline-item cited-by__entry__author">Timothy Shope, </li><li class="list-inline-item cited-by__entry__author">Bo Shopsin, </li><li class="list-inline-item cited-by__entry__author">Steven Shoptaw, </li><li class="list-inline-item cited-by__entry__author">Rajeev Shrestha, </li><li class="list-inline-item cited-by__entry__author">Georgi Shukarev, </li><li class="list-inline-item cited-by__entry__author">Farhan Siddiqui, </li><li class="list-inline-item cited-by__entry__author">Marc Siegel, </li><li class="list-inline-item cited-by__entry__author">Silva Sieger, </li><li class="list-inline-item cited-by__entry__author">Dianca Sierra, </li><li class="list-inline-item cited-by__entry__author">Abraham Siika, </li><li class="list-inline-item cited-by__entry__author">William P. Silver, </li><li class="list-inline-item cited-by__entry__author">Todd Simmons, </li><li class="list-inline-item cited-by__entry__author">Gary Simon, </li><li class="list-inline-item cited-by__entry__author">Matthew D. Sims, </li><li class="list-inline-item cited-by__entry__author">Leonard Singer, </li><li class="list-inline-item cited-by__entry__author">Chandramani Singh, </li><li class="list-inline-item cited-by__entry__author">Veer Bahadur Singh, </li><li class="list-inline-item cited-by__entry__author">Justin Singletary, </li><li class="list-inline-item cited-by__entry__author">Nuchra Sirisuphmitr, </li><li class="list-inline-item cited-by__entry__author">Stephanie Skipper, </li><li class="list-inline-item cited-by__entry__author">Stacy Slechta, </li><li class="list-inline-item cited-by__entry__author">Teresa S. Sligh, </li><li class="list-inline-item cited-by__entry__author">William B. Smith, </li><li class="list-inline-item cited-by__entry__author">Mary Smith, </li><li class="list-inline-item cited-by__entry__author">Derek M. Smith, </li><li class="list-inline-item cited-by__entry__author">Michael J. Smith, </li><li class="list-inline-item cited-by__entry__author">Katherine Smith, </li><li class="list-inline-item cited-by__entry__author">Candace Smith, </li><li class="list-inline-item cited-by__entry__author">Kimberly Snell, </li><li class="list-inline-item cited-by__entry__author">M. Mahdee Sobhanie, </li><li class="list-inline-item cited-by__entry__author">Magdalena E. Sobieszczyk, </li><li class="list-inline-item cited-by__entry__author">Obiageli Sogbetun, </li><li class="list-inline-item cited-by__entry__author">Joel Solis, </li><li class="list-inline-item cited-by__entry__author">Cora Sonnier, </li><li class="list-inline-item cited-by__entry__author">Carrie Sopher, </li><li class="list-inline-item cited-by__entry__author">Adriana Sordo Duran, </li><li class="list-inline-item cited-by__entry__author">Brit Sovic, </li><li class="list-inline-item cited-by__entry__author">Stephen A. Spector, </li><li class="list-inline-item cited-by__entry__author">Steven Sperber, </li><li class="list-inline-item cited-by__entry__author">Bart Spiessens, </li><li class="list-inline-item cited-by__entry__author">Stephanie&nbsp; Sproule, </li><li class="list-inline-item cited-by__entry__author">Saranya Sridhar, </li><li class="list-inline-item cited-by__entry__author">Jonathan Staben, </li><li class="list-inline-item cited-by__entry__author">Jessica Stahl, </li><li class="list-inline-item cited-by__entry__author">Amber Stanford, </li><li class="list-inline-item cited-by__entry__author">Lisa Stangl, </li><li class="list-inline-item cited-by__entry__author">Ariana C. Stanton, </li><li class="list-inline-item cited-by__entry__author">Katherine Stapleton, </li><li class="list-inline-item cited-by__entry__author">Jack Stapleton, </li><li class="list-inline-item cited-by__entry__author">Thomas Starkey, </li><li class="list-inline-item cited-by__entry__author">Richard Starlin, </li><li class="list-inline-item cited-by__entry__author">Amy Starr, </li><li class="list-inline-item cited-by__entry__author">Ryan P. Starr, </li><li class="list-inline-item cited-by__entry__author">Kenneth Steil, </li><li class="list-inline-item cited-by__entry__author">Carolene Stephenson, </li><li class="list-inline-item cited-by__entry__author">Kathryn E. Stephenson, </li><li class="list-inline-item cited-by__entry__author">Stephanie Sterling, </li><li class="list-inline-item cited-by__entry__author">Lisa Stevens Rameaka, </li><li class="list-inline-item cited-by__entry__author">Brittany Stewart, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Stoddard, </li><li class="list-inline-item cited-by__entry__author">Robert Striker, </li><li class="list-inline-item cited-by__entry__author">Frank Struyf, </li><li class="list-inline-item cited-by__entry__author">Suzanna Studdard, </li><li class="list-inline-item cited-by__entry__author">Laura Stulken, </li><li class="list-inline-item cited-by__entry__author">Mildred Stull, </li><li class="list-inline-item cited-by__entry__author">Rodney E. Sturgeon, </li><li class="list-inline-item cited-by__entry__author">May-Yin Suen, </li><li class="list-inline-item cited-by__entry__author">Danny Sugimoto, </li><li class="list-inline-item cited-by__entry__author">Amit Suresh&nbsp;Bhate, </li><li class="list-inline-item cited-by__entry__author">Janice Suyehira, </li><li class="list-inline-item cited-by__entry__author">Kazuo Suzuki, </li><li class="list-inline-item cited-by__entry__author">Shobha Swaminathan, </li><li class="list-inline-item cited-by__entry__author">Suzanne Swan, </li><li class="list-inline-item cited-by__entry__author">Edith Swann, </li><li class="list-inline-item cited-by__entry__author">Austin Swanson, </li><li class="list-inline-item cited-by__entry__author">Christy Sweet, </li><li class="list-inline-item cited-by__entry__author">Elisa Swieboda, </li><li class="list-inline-item cited-by__entry__author">Scott N. Syndergaard, </li><li class="list-inline-item cited-by__entry__author">Karla Beatriz Tafur Bances, </li><li class="list-inline-item cited-by__entry__author">Therese Takas, </li><li class="list-inline-item cited-by__entry__author">Zudi-Mwak Takizala, </li><li class="list-inline-item cited-by__entry__author">Simbarashe G. Takuva, </li><li class="list-inline-item cited-by__entry__author">Kawsar R. Talaat, </li><li class="list-inline-item cited-by__entry__author">Dipesh Tamrakar, </li><li class="list-inline-item cited-by__entry__author">Chen S. Tan, </li><li class="list-inline-item cited-by__entry__author">Cayce Tangemen, </li><li class="list-inline-item cited-by__entry__author">Tamzin Tanner, </li><li class="list-inline-item cited-by__entry__author">Milagritos Tapia, </li><li class="list-inline-item cited-by__entry__author">Denis Tarakjian, </li><li class="list-inline-item cited-by__entry__author">Karen Tashima, </li><li class="list-inline-item cited-by__entry__author">David Tatelbaum, </li><li class="list-inline-item cited-by__entry__author">Fernanda Tavares Da-Silva, </li><li class="list-inline-item cited-by__entry__author">Edward M. Tavel, </li><li class="list-inline-item cited-by__entry__author">Kimberly L. Taylor, </li><li class="list-inline-item cited-by__entry__author">Brandie Taylor, </li><li class="list-inline-item cited-by__entry__author">Barbara S. Taylor, </li><li class="list-inline-item cited-by__entry__author">David Taylor, </li><li class="list-inline-item cited-by__entry__author">Sharita Tedder-Edwards, </li><li class="list-inline-item cited-by__entry__author">Meghan Teherani, </li><li class="list-inline-item cited-by__entry__author">Leslie Tharenos, </li><li class="list-inline-item cited-by__entry__author">Jeffrey Thessing, </li><li class="list-inline-item cited-by__entry__author">Meagan Thomas, </li><li class="list-inline-item cited-by__entry__author">LaTeshia Thomas-Seaton, </li><li class="list-inline-item cited-by__entry__author">Amy Thompson, </li><li class="list-inline-item cited-by__entry__author">Karl M. Thompson, </li><li class="list-inline-item cited-by__entry__author">Teri Thompson-Seim, </li><li class="list-inline-item cited-by__entry__author">Isaac Thomsen, </li><li class="list-inline-item cited-by__entry__author">Hong V Tieu, </li><li class="list-inline-item cited-by__entry__author">Lucas Otieno Tina, </li><li class="list-inline-item cited-by__entry__author">Ramy J. Toma, </li><li class="list-inline-item cited-by__entry__author">Joanne E. Tomassini, </li><li class="list-inline-item cited-by__entry__author">Christian Tomaszewski, </li><li class="list-inline-item cited-by__entry__author">Lee Tomatsu, </li><li class="list-inline-item cited-by__entry__author">Ryan Tomlinson, </li><li class="list-inline-item cited-by__entry__author">Xiaomi Tong, </li><li class="list-inline-item cited-by__entry__author">Tina Tong, </li><li class="list-inline-item cited-by__entry__author">Juan P. Torres, </li><li class="list-inline-item cited-by__entry__author">Julian A. Torres, </li><li class="list-inline-item cited-by__entry__author">Dalia Tovar, </li><li class="list-inline-item cited-by__entry__author">Carolyn Tran, </li><li class="list-inline-item cited-by__entry__author">John J. Treanor, </li><li class="list-inline-item cited-by__entry__author">Carla Truyers, </li><li class="list-inline-item cited-by__entry__author">Sade Tukuru, </li><li class="list-inline-item cited-by__entry__author">Christine B. Turley, </li><li class="list-inline-item cited-by__entry__author">Mark A. Turner, </li><li class="list-inline-item cited-by__entry__author">Stefanie Tyson, </li><li class="list-inline-item cited-by__entry__author">Akiyoshi Uchiyama, </li><li class="list-inline-item cited-by__entry__author">Robert J. Ulrich, </li><li class="list-inline-item cited-by__entry__author">Lisa S. Usdan, </li><li class="list-inline-item cited-by__entry__author">Gregory C. Utz, </li><li class="list-inline-item cited-by__entry__author">Timothy P. Vachris, </li><li class="list-inline-item cited-by__entry__author">Bruno Valenti, </li><li class="list-inline-item cited-by__entry__author">Insiya Valika, </li><li class="list-inline-item cited-by__entry__author">Mimi Van Der Leden, </li><li class="list-inline-item cited-by__entry__author">Ilse Van Dromme, </li><li class="list-inline-item cited-by__entry__author">Wesley Van Ever, </li><li class="list-inline-item cited-by__entry__author">Johan Van Hoof, </li><li class="list-inline-item cited-by__entry__author">Griet Van Roey, </li><li class="list-inline-item cited-by__entry__author">An Vandebosch, </li><li class="list-inline-item cited-by__entry__author">Sergio L. Vargas, </li><li class="list-inline-item cited-by__entry__author">Tilly Varughese, </li><li class="list-inline-item cited-by__entry__author">Eduardo Gabriel Vázquez Saldaña, </li><li class="list-inline-item cited-by__entry__author">Norma Vega, </li><li class="list-inline-item cited-by__entry__author">Karen Sofia Vega Orozco, </li><li class="list-inline-item cited-by__entry__author">Diana Vegas, </li><li class="list-inline-item cited-by__entry__author">Hector Velasquez, </li><li class="list-inline-item cited-by__entry__author">Michele Vertucci, </li><li class="list-inline-item cited-by__entry__author">Veronica Viar, </li><li class="list-inline-item cited-by__entry__author">Roberto A. Viau Colindres, </li><li class="list-inline-item cited-by__entry__author">Nicholas A. Viens, </li><li class="list-inline-item cited-by__entry__author">Tonya Villafana, </li><li class="list-inline-item cited-by__entry__author">Sandra M. Villagómez Martínez, </li><li class="list-inline-item cited-by__entry__author">Marysol Villegas, </li><li class="list-inline-item cited-by__entry__author">Johan Vingerhoets, </li><li class="list-inline-item cited-by__entry__author">Mary Vogler, </li><li class="list-inline-item cited-by__entry__author">Mandy Vowell, </li><li class="list-inline-item cited-by__entry__author">Keith W. Vrbicky, </li><li class="list-inline-item cited-by__entry__author">Deo Wabwire, </li><li class="list-inline-item cited-by__entry__author">Larkin T. Wadsworth, </li><li class="list-inline-item cited-by__entry__author">Tami Wahlin, </li><li class="list-inline-item cited-by__entry__author">Anne Wajja, </li><li class="list-inline-item cited-by__entry__author">Paul H. Wakefield, </li><li class="list-inline-item cited-by__entry__author">Anna Wald, </li><li class="list-inline-item cited-by__entry__author">Shannon Walker, </li><li class="list-inline-item cited-by__entry__author">James Walker, </li><li class="list-inline-item cited-by__entry__author">Stephen R. Walsh, </li><li class="list-inline-item cited-by__entry__author">Edward E. Walsh, </li><li class="list-inline-item cited-by__entry__author">Mary C. Walsh, </li><li class="list-inline-item cited-by__entry__author">Emmanuel B. Walter, </li><li class="list-inline-item cited-by__entry__author">Ayanna Walters, </li><li class="list-inline-item cited-by__entry__author">Tina Wang, </li><li class="list-inline-item cited-by__entry__author">Ashley Warden, </li><li class="list-inline-item cited-by__entry__author">T. Anh Wartel, </li><li class="list-inline-item cited-by__entry__author">Michael Waters, </li><li class="list-inline-item cited-by__entry__author">Breanz Watkins, </li><li class="list-inline-item cited-by__entry__author">Angella Webb, </li><li class="list-inline-item cited-by__entry__author">Hala Webster, </li><li class="list-inline-item cited-by__entry__author">Jessica L. Weidler, </li><li class="list-inline-item cited-by__entry__author">Thomas Weiss, </li><li class="list-inline-item cited-by__entry__author">Margaret Wells, </li><li class="list-inline-item cited-by__entry__author">Andrea Wendrow, </li><li class="list-inline-item cited-by__entry__author">Melody Werne, </li><li class="list-inline-item cited-by__entry__author">Whitney West, </li><li class="list-inline-item cited-by__entry__author">Jordan L. Whatley, </li><li class="list-inline-item cited-by__entry__author">Jennifer A. Whitaker, </li><li class="list-inline-item cited-by__entry__author">Julie White, </li><li class="list-inline-item cited-by__entry__author">Jewel J. White, </li><li class="list-inline-item cited-by__entry__author">Toni White, </li><li class="list-inline-item cited-by__entry__author">Priyantha N. Wijewardane, </li><li class="list-inline-item cited-by__entry__author">Timothy Wilkin, </li><li class="list-inline-item cited-by__entry__author">Bethanie Wilkinson, </li><li class="list-inline-item cited-by__entry__author">Samantha Williams, </li><li class="list-inline-item cited-by__entry__author">Barton G. Williams, </li><li class="list-inline-item cited-by__entry__author">Hayes Williams, </li><li class="list-inline-item cited-by__entry__author">Greg Wilson, </li><li class="list-inline-item cited-by__entry__author">Christine Wilson, </li><li class="list-inline-item cited-by__entry__author">Natasha Wilson, </li><li class="list-inline-item cited-by__entry__author">Clint Wilson, </li><li class="list-inline-item cited-by__entry__author">Jennifer Winbigler, </li><li class="list-inline-item cited-by__entry__author">Peter J. Winkle, </li><li class="list-inline-item cited-by__entry__author">Patricia L. Winokur, </li><li class="list-inline-item cited-by__entry__author">John Witbeck, </li><li class="list-inline-item cited-by__entry__author">David Wohl, </li><li class="list-inline-item cited-by__entry__author">Wayne Woo, </li><li class="list-inline-item cited-by__entry__author">Leana Woodside, </li><li class="list-inline-item cited-by__entry__author">Glenn Wortman, </li><li class="list-inline-item cited-by__entry__author">Yi H. Wu, </li><li class="list-inline-item cited-by__entry__author">Paul E. Wylie, </li><li class="list-inline-item cited-by__entry__author">Kinara S. Yang, </li><li class="list-inline-item cited-by__entry__author">Fan Yang, </li><li class="list-inline-item cited-by__entry__author">Anelgine C. Yoon, </li><li class="list-inline-item cited-by__entry__author">Jill York, </li><li class="list-inline-item cited-by__entry__author">Cheryl Young, </li><li class="list-inline-item cited-by__entry__author">Juan Luis Yrivarren Giorza, </li><li class="list-inline-item cited-by__entry__author">Joseph Yusin, </li><li class="list-inline-item cited-by__entry__author">Luz Zapata, </li><li class="list-inline-item cited-by__entry__author">Zindy Yazmín Zárate Hinojosa, </li><li class="list-inline-item cited-by__entry__author">Rebecca Zash, </li><li class="list-inline-item cited-by__entry__author">Elodie Zaworski, </li><li class="list-inline-item cited-by__entry__author">Arthur L. Zemanek, </li><li class="list-inline-item cited-by__entry__author">Kate Zenlea, </li><li class="list-inline-item cited-by__entry__author">Karla Zepeda, </li><li class="list-inline-item cited-by__entry__author">Marcus J. Zervos, </li><li class="list-inline-item cited-by__entry__author">Nan Zhai, </li><li class="list-inline-item cited-by__entry__author">Kevin Zhang, </li><li class="list-inline-item cited-by__entry__author">Nianxian Zhang, </li><li class="list-inline-item cited-by__entry__author">Honghong Zhou, </li><li class="list-inline-item cited-by__entry__author">James Zhou, </li><li class="list-inline-item cited-by__entry__author">Andrea Zimmer, </li><li class="list-inline-item cited-by__entry__author">Barry S. Zingman, </li><li class="list-inline-item cited-by__entry__author">Carmen D. Zorrilla, </li></ul><span class="cited-by__entry__title">Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data, </span><span class="cited-by__entry__series-title">JAMA Network Open, </span><span class="cited-by__entry__volume"><strong>8</strong>, </span><span class="cited-by__entry__issue">5, </span><span class="cited-by__entry__page-range">(e2512763), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1001/jamanetworkopen.2025.12763" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1001/jamanetworkopen.2025.12763</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1001/jamanetworkopen.2025.12763" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Chang Liu, </li><li class="list-inline-item cited-by__entry__author">Tim K. Tsang, </li><li class="list-inline-item cited-by__entry__author">Sheena G. Sullivan, </li><li class="list-inline-item cited-by__entry__author">Benjamin J. Cowling, </li><li class="list-inline-item cited-by__entry__author">Bingyi Yang, </li></ul><span class="cited-by__entry__title">Comparative duration of neutralizing responses and protections of COVID-19 vaccination and correlates of protection, </span><span class="cited-by__entry__series-title">Nature Communications, </span><span class="cited-by__entry__volume"><strong>16</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1038/s41467-025-60024-9" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1038/s41467-025-60024-9</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1038/s41467-025-60024-9" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Kyle Fahrbach, </li><li class="list-inline-item cited-by__entry__author">Allie Cichewicz, </li><li class="list-inline-item cited-by__entry__author">Haitao Chu, </li><li class="list-inline-item cited-by__entry__author">Manuela Di Fusco, </li><li class="list-inline-item cited-by__entry__author">Heather Burnett, </li><li class="list-inline-item cited-by__entry__author">Hannah R. Volkman, </li><li class="list-inline-item cited-by__entry__author">Morodoluwa Akin-Fajiye, </li><li class="list-inline-item cited-by__entry__author">Carlos Fernando Mendoza, </li><li class="list-inline-item cited-by__entry__author">Joseph C. Cappelleri, </li></ul><span class="cited-by__entry__title">Comparative effectiveness of Omicron XBB 1.5-adapted COVID-19 vaccines: a systematic literature review and network meta-analysis, </span><span class="cited-by__entry__series-title">Expert Review of Vaccines, </span><span class="cited-by__entry__volume"><strong>24</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__page-range">(416-432), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1080/14760584.2025.2505754" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1080/14760584.2025.2505754</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1080/14760584.2025.2505754" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Jordan R. Willis, </li><li class="list-inline-item cited-by__entry__author">Madhu Prabhakaran, </li><li class="list-inline-item cited-by__entry__author">Michelle Muthui, </li><li class="list-inline-item cited-by__entry__author">Ansuya Naidoo, </li><li class="list-inline-item cited-by__entry__author">Troy Sincomb, </li><li class="list-inline-item cited-by__entry__author">Weiwei Wu, </li><li class="list-inline-item cited-by__entry__author">Christopher A. Cottrell, </li><li class="list-inline-item cited-by__entry__author">Elise Landais, </li><li class="list-inline-item cited-by__entry__author">Allan C. deCamp, </li><li class="list-inline-item cited-by__entry__author">Nahid R. Keshavarzi, </li><li class="list-inline-item cited-by__entry__author">Oleksandr Kalyuzhniy, </li><li class="list-inline-item cited-by__entry__author">Jeong Hyun Lee, </li><li class="list-inline-item cited-by__entry__author">Linda M. Murungi, </li><li class="list-inline-item cited-by__entry__author">Wilfrida A Ogonda, </li><li class="list-inline-item cited-by__entry__author">Nicole L. Yates, </li><li class="list-inline-item cited-by__entry__author">Martin M. Corcoran, </li><li class="list-inline-item cited-by__entry__author">Swastik Phulera, </li><li class="list-inline-item cited-by__entry__author">Joel Musando, </li><li class="list-inline-item cited-by__entry__author">Amanda Tsai, </li><li class="list-inline-item cited-by__entry__author">Gabrielle Lemire, </li><li class="list-inline-item cited-by__entry__author">Yiakon Sein, </li><li class="list-inline-item cited-by__entry__author">Michael Muteti, </li><li class="list-inline-item cited-by__entry__author">Praveen Alamuri, </li><li class="list-inline-item cited-by__entry__author">Jennifer A. Bohl, </li><li class="list-inline-item cited-by__entry__author">Drienna Holman, </li><li class="list-inline-item cited-by__entry__author">Sunny Himansu, </li><li class="list-inline-item cited-by__entry__author">Brett Leav, </li><li class="list-inline-item cited-by__entry__author">Caroline Reuter, </li><li class="list-inline-item cited-by__entry__author">Li-An Lin, </li><li class="list-inline-item cited-by__entry__author">Baoyu Ding, </li><li class="list-inline-item cited-by__entry__author">Chunla He, </li><li class="list-inline-item cited-by__entry__author">Walter L. Straus, </li><li class="list-inline-item cited-by__entry__author">Kellie J. MacPhee, </li><li class="list-inline-item cited-by__entry__author">Isabel Regadas, </li><li class="list-inline-item cited-by__entry__author">Diana V. Nyabundi, </li><li class="list-inline-item cited-by__entry__author">Ruth Chirchir, </li><li class="list-inline-item cited-by__entry__author">Aggrey Anzala, </li><li class="list-inline-item cited-by__entry__author">John N. Kimotho, </li><li class="list-inline-item cited-by__entry__author">Caleb Kibet, </li><li class="list-inline-item cited-by__entry__author">Kelli Greene, </li><li class="list-inline-item cited-by__entry__author">Hongmei Gao, </li><li class="list-inline-item cited-by__entry__author">Erica Beatman, </li><li class="list-inline-item cited-by__entry__author">Kiara Benson, </li><li class="list-inline-item cited-by__entry__author">Dominick Laddy, </li><li class="list-inline-item cited-by__entry__author">David M. Brown, </li><li class="list-inline-item cited-by__entry__author">Rhianna Bronson, </li><li class="list-inline-item cited-by__entry__author">Jalen Baptiste, </li><li class="list-inline-item cited-by__entry__author">Suprabhath Gajjala, </li><li class="list-inline-item cited-by__entry__author">Zahra Rikhtegaran-Tehrani, </li><li class="list-inline-item cited-by__entry__author">Alison Benner, </li><li class="list-inline-item cited-by__entry__author">Mukundhan Ramaswami, </li><li class="list-inline-item cited-by__entry__author">Danny Lu, </li><li class="list-inline-item cited-by__entry__author">Nushin Alavi, </li><li class="list-inline-item cited-by__entry__author">Sonya Amirzehni, </li><li class="list-inline-item cited-by__entry__author">Michael Kubitz, </li><li class="list-inline-item cited-by__entry__author">Ryan Tingle, </li><li class="list-inline-item cited-by__entry__author">Erik Georgeson, </li><li class="list-inline-item cited-by__entry__author">Nicole Phelps, </li><li class="list-inline-item cited-by__entry__author">Yumiko Adachi, </li><li class="list-inline-item cited-by__entry__author">Alessia Liguori, </li><li class="list-inline-item cited-by__entry__author">Claudia Flynn, </li><li class="list-inline-item cited-by__entry__author">Katherine McKenney, </li><li class="list-inline-item cited-by__entry__author">Xiaoya Zhou, </li><li class="list-inline-item cited-by__entry__author">D. Collins Owuor, </li><li class="list-inline-item cited-by__entry__author">Sharon Owuor, </li><li class="list-inline-item cited-by__entry__author">Soo-Young Kim, </li><li class="list-inline-item cited-by__entry__author">Michael Duff, </li><li class="list-inline-item cited-by__entry__author">Ju Yeong Kim, </li><li class="list-inline-item cited-by__entry__author">Grace Gibson, </li><li class="list-inline-item cited-by__entry__author">Sabyasachi Baboo, </li><li class="list-inline-item cited-by__entry__author">Jolene Diedrich, </li><li class="list-inline-item cited-by__entry__author">Torben Schiffner, </li><li class="list-inline-item cited-by__entry__author">Marisa Shields, </li><li class="list-inline-item cited-by__entry__author">Mabela Matsoso, </li><li class="list-inline-item cited-by__entry__author">Jennifer Santos, </li><li class="list-inline-item cited-by__entry__author">Kristen Syvertsen, </li><li class="list-inline-item cited-by__entry__author">Allison Kennedy, </li><li class="list-inline-item cited-by__entry__author">Melissa Schroeter, </li><li class="list-inline-item cited-by__entry__author">Johan Vekemans, </li><li class="list-inline-item cited-by__entry__author">John Yates, </li><li class="list-inline-item cited-by__entry__author">James C. Paulson, </li><li class="list-inline-item cited-by__entry__author">Ollivier Hyrien, </li><li class="list-inline-item cited-by__entry__author">Adrian B. McDermott, </li><li class="list-inline-item cited-by__entry__author">Pholo Maenetje, </li><li class="list-inline-item cited-by__entry__author">Julien Nyombayire, </li><li class="list-inline-item cited-by__entry__author">Etienne Karita, </li><li class="list-inline-item cited-by__entry__author">Rosine Ingabire, </li><li class="list-inline-item cited-by__entry__author">Vinodh Edward, </li><li class="list-inline-item cited-by__entry__author">Vincent Muturi-Kioi, </li><li class="list-inline-item cited-by__entry__author">Janine Maenza, </li><li class="list-inline-item cited-by__entry__author">Adrienne E. Shapiro, </li><li class="list-inline-item cited-by__entry__author">M. Juliana McElrath, </li><li class="list-inline-item cited-by__entry__author">Srilatha Edupuganti, </li><li class="list-inline-item cited-by__entry__author">Barbara S. Taylor, </li><li class="list-inline-item cited-by__entry__author">David Diemert, </li><li class="list-inline-item cited-by__entry__author">Gabriel Ozorowski, </li><li class="list-inline-item cited-by__entry__author">Richard A. Koup, </li><li class="list-inline-item cited-by__entry__author">David Montefiori, </li><li class="list-inline-item cited-by__entry__author">Andrew B. Ward, </li><li class="list-inline-item cited-by__entry__author">Gunilla Karlsson Hedestam, </li><li class="list-inline-item cited-by__entry__author">Georgia Tomaras, </li><li class="list-inline-item cited-by__entry__author">Devin J. Hunt, </li><li class="list-inline-item cited-by__entry__author">Daniel Muema, </li><li class="list-inline-item cited-by__entry__author">Devin Sok, </li><li class="list-inline-item cited-by__entry__author">Dagna S. Laufer, </li><li class="list-inline-item cited-by__entry__author">Sarah F. Andrews, </li><li class="list-inline-item cited-by__entry__author">Eunice W. Nduati, </li><li class="list-inline-item cited-by__entry__author">William R. Schief, </li></ul><span class="cited-by__entry__title">Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans, </span><span class="cited-by__entry__series-title">Science, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1126/science.adr8382" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1126/science.adr8382</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1126/science.adr8382" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Yongjun Huang, </li><li class="list-inline-item cited-by__entry__author">Haley R. Fonseca, </li><li class="list-inline-item cited-by__entry__author">Leonardo Acuna, </li><li class="list-inline-item cited-by__entry__author">Wensong Wu, </li><li class="list-inline-item cited-by__entry__author">Xuexia Wang, </li><li class="list-inline-item cited-by__entry__author">Samantha Gonzales, </li><li class="list-inline-item cited-by__entry__author">Manuel Barbieri, </li><li class="list-inline-item cited-by__entry__author">David R. Brown, </li><li class="list-inline-item cited-by__entry__author">Marianna K. Baum, </li></ul><span class="cited-by__entry__title">SARS-CoV-2 Antibodies in Response to COVID-19 Vaccination in Underserved Racial/Ethnic Minority People Living with HIV, </span><span class="cited-by__entry__series-title">Vaccines, </span><span class="cited-by__entry__volume"><strong>13</strong>, </span><span class="cited-by__entry__issue">5, </span><span class="cited-by__entry__page-range">(517), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3390/vaccines13050517" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/vaccines13050517</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/vaccines13050517" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Aviraj K. S, </li><li class="list-inline-item cited-by__entry__author">Apoorva Wasnik, </li><li class="list-inline-item cited-by__entry__author">Lalima Gupta, </li><li class="list-inline-item cited-by__entry__author">Ayushi Ranjan, </li><li class="list-inline-item cited-by__entry__author">Harshini Suresh, </li></ul><span class="cited-by__entry__title">Effectiveness of interventions to improve vaccine efficacy: a systematic review and meta-analysis, </span><span class="cited-by__entry__series-title">Systematic Reviews, </span><span class="cited-by__entry__volume"><strong>14</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1186/s13643-025-02856-6" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1186/s13643-025-02856-6</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1186/s13643-025-02856-6" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Tobias Monschein, </li><li class="list-inline-item cited-by__entry__author">Tobias Zrzavy, </li><li class="list-inline-item cited-by__entry__author">Paulus S. Rommer, </li><li class="list-inline-item cited-by__entry__author">Sven G. Meuth, </li><li class="list-inline-item cited-by__entry__author">Andrew Chan, </li><li class="list-inline-item cited-by__entry__author">Thomas Berger, </li><li class="list-inline-item cited-by__entry__author">Hans-Peter Hartung, </li></ul><span class="cited-by__entry__title">SARS-CoV-2 Vaccines and Multiple Sclerosis, </span><span class="cited-by__entry__series-title">Neurology Neuroimmunology &amp; Neuroinflammation, </span><span class="cited-by__entry__volume"><strong>12</strong>, </span><span class="cited-by__entry__issue">3, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1212/NXI.0000000000200393" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1212/NXI.0000000000200393</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1212/NXI.0000000000200393" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Dalton W. Staller, </li><li class="list-inline-item cited-by__entry__author">Flobater I. Gawargi, </li><li class="list-inline-item cited-by__entry__author">Sanjali S. Panigrahi, </li><li class="list-inline-item cited-by__entry__author">Paras K. Mishra, </li><li class="list-inline-item cited-by__entry__author">Ram I. Mahato, </li></ul><span class="cited-by__entry__title">Pharmaceutical Perspectives on Oligonucleotide Therapeutics and Delivery Systems, </span><span class="cited-by__entry__series-title">Pharmacological Reviews, </span><span class="cited-by__entry__page-range">(100065), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.pharmr.2025.100065" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.pharmr.2025.100065</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.pharmr.2025.100065" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry--see-more"><a href="javascript:void(0)" data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2021.385.issue-19%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2113017%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" class="cited-by__see-more">See more</a></li></ol></div><div class="cited-by__spinner justify-content-center align-items-center d-none"><div role="status" class="spinner-border text-gray"><span class="sr-only">Loading...</span></div></div></div></section>

        </div>
    

</section></section></div><div id="core-collateral-fulltext-options" role="tabpanel" data-core-tabs="core-collateral-fulltext-options" tabindex="-1" aria-labelledby="pane-core-collateral-fulltext-options"><header><h2 id="pane-core-collateral-fulltext-options"><i class="icon-eye" aria-hidden="true"></i>View Options</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div class="section--wrapper"><h3>View options</h3><section class="format--pdf"><h4> <abbr title="Portable Document Format">PDF</abbr></h4><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2113017" class="btn btn--pdf" aria-label="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2113017" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2113017.pdf"><i aria-hidden="true" class="icon-pdf"></i><span>View PDF</span></a></section></div><!-- Its needed to duplicate this for PB check Collateral.js as well--></div><div id="core-collateral-media" role="tabpanel" data-core-tabs="core-collateral-media" tabindex="-1" aria-labelledby="pane-core-collateral-media"><header><h2 id="pane-core-collateral-media"><i class="icon-photo" aria-hidden="true"></i>Media</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-figures" role="tab" id="tab-figures-label" aria-selected="true" class="active">Figures</button><button aria-controls="tab-other" role="tab" id="tab-other-label" tabindex="-1" aria-selected="false" class="inactive" aria-disabled="true">Other</button></div><section id="tab-figures" aria-labelledby="tab-figures-label" role="tabpanel" tabindex="0"><h3>Figures</h3><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#figures"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-f0"><figure class="graphic"><a class="open-in-viewer" href="#f0" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f0.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/cd9a6d07-b425-4d9f-8d58-c18c4c45e968/assets/images/large/nejmoa2113017_f0.jpg" height="3416" width="2640" aria-labelledby="f0" loading="lazy"></a><figcaption>Download a PDF of the <a href="#ap0">Research Summary</a>.</figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f0"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f0.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f1"><figure class="graphic"><a class="open-in-viewer" href="#f1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f1.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/1a7b1e11-6e57-48e5-9a1e-f2f1c9e8b5be/assets/images/large/nejmoa2113017_f1.jpg" height="2115" width="2640" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Randomization and Analysis Populations.</div><div class="notes"><div role="doc-footnote">Eight participants, including six with major protocol deviations and two who erroneously underwent randomization twice, were excluded from the original randomization population (30,423 participants) and from all analysis sets. The full analysis population comprised all participants who had undergone randomization and received at least one injection; the modified intention-to-treat population included participants in the full analysis population who had no immunologic or virologic evidence of previous Covid-19 (i.e., had both a negative nasopharyngeal swab specimen and a negative anti-nucleocapsid antibody test result) at day 1 before the first injection; and the per-protocol population consisted of all participants in the modified intent-to-treat population who received planned injections according to the schedule and had no major protocol deviations that affected key trial data. The safety population included all participants who had undergone randomization and received at least one injection; this population was used for all safety analyses except the analysis for solicited adverse events. For safety analyses, participants were evaluated according to the injection received. Three participants assigned to the mRNA-1273 group received two doses of placebo and were included in the placebo safety population, and seven participants assigned to the placebo group received one or two doses of mRNA-1273 and were included in the mRNA-1273 safety population. The data cutoff date was March 26, 2021.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f1"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f2"><figure class="graphic"><a class="open-in-viewer" href="#f2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f2.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/4652d527-7163-470e-8421-106217b707e0/assets/images/large/nejmoa2113017_f2.jpg" height="3438" width="2629" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Efficacy of the mRNA-1273 Vaccine in Preventing Covid-19.</div><div class="notes"><div role="doc-footnote">In Panels A and C, the dashed vertical line denotes the adjudicated assessment beginning at day 42 (14 days after the second injection of vaccine or placebo). Tick marks in all three panels indicate censored data. Vaccine efficacy was defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional-hazards model with Efron’s method of tie handling and with treatment group as a covariate, adjusted for stratification factor. The data cutoff date was March 26, 2021.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f2"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f3"><figure class="graphic"><a class="open-in-viewer" href="#f3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f3.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/4657f5e8-6a33-4d2f-8dd2-1b050955e2b2/assets/images/large/nejmoa2113017_f3.jpg" height="1015" width="2640" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Vaccine Efficacy for Primary and Secondary End Points.</div><div class="notes"><div role="doc-footnote">Vaccine efficacy was defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo), and 95% confidence intervals were estimated using a stratified Cox proportional-hazards model with Efron’s method of tie handling and with the treatment group as a covariate, adjusted for stratification factor. The P value for the vaccine efficacy against Covid-19 (upper right corner) is P&lt;0.001. The dashed vertical line represents a vaccine efficacy of 30%, based on the null hypothesis that the primary efficacy of the mRNA-1273 vaccine is 30% or less. In the Covid-19 rows, censoring rules for efficacy analyses (Covid-19 cases based on eligible symptoms and positive reverse-transcriptase–polymerase-chain-reaction [RT-PCR] assay within 14 days before the second injection) were applied, except for deaths from Covid-19. If a participant had a positive RT-PCR assay at the visit before the second dose (day 29) without eligible symptoms within the previous 14 days, or a positive anti-nucleocapsid antibody test at a scheduled visit before Covid-19 was diagnosed, the participant’s data were censored at the date of the positive RT-PCR assay or anti-nucleocapsid antibody test. Covid-19 diagnoses were based on adjudication committee assessments. The data for Covid-19 regardless of previous SARS-CoV-2 status were based on the number of participants in the full analysis population (15,166 participants in the placebo group and 15,180 participants in the mRNA-1273 group). Data for the asymptomatic subgroup include data from the participant-decision visit. Asymptomatic was defined as the absence of symptoms (according to either the primary efficacy end point of Covid-19 or the secondary definition of Covid-19 [the Centers for Disease Control and Prevention definition, requiring only one symptom]) and of infection as detected by RT-PCR assay (at scheduled visits) or seroconversion (anti-nucleocapsid antibody test). In the primary approach, documented asymptomatic infection was counted beginning 14 days after the second injection, which required seroconversion at month 2 (day 57 through the participant-decision visit). Asymptomatic seroconversion excludes infections confirmed by RT-PCR assay only and includes infections confirmed by seroconversion and those confirmed by both RT-PCR and seroconversion (Table S28). Vaccine efficacy and 95% confidence intervals for asymptomatic SARS-CoV-2 infection were estimated with Fine and Gray’s subdistribution hazard model, with disease cases as competing events and with treatment group as a covariate, adjusted for stratification factor. Results for additional end points are summarized in Table S27. The data cutoff date was March 26, 2021. NE indicates that the lower bound of the 95% confidence interval could not be estimated.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f3"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f3.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f4"><figure class="graphic"><a class="open-in-viewer" href="#f4" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f4.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/19887e6e-08b6-4722-af2e-661850da3213/assets/images/large/nejmoa2113017_f4.jpg" height="3084" width="2640" aria-labelledby="f4" loading="lazy"></a><figcaption><div class="caption">Efficacy of the mRNA-1273 Vaccine in Preventing Covid-19 in Subgroups.</div><div class="notes"><div role="doc-footnote">Analysis of the vaccine efficacy of mRNA-1273 in the prevention of Covid-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the second injection. Vaccine efficacy, defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional-hazards model with Efron’s method of tie-handling and with the treatment group as a covariate, adjusted for stratification factor if applicable. The total number of events for race includes 38 placebo recipients and 3 mRNA-1273 recipients who were in “Multiple,” “Other,” or not reported or unknown categories, and the total number for ethnicity includes 4 placebo recipients and no mRNA-1273 recipients who were in not reported or unknown categories (not shown). Race and ethnic group were reported by the participant. The body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters. Additional subgroup data are provided in Table S29. The data cutoff date was March 26, 2021. HIV denotes human immunodeficiency virus.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f4"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f4" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f4.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f5"><figure class="graphic"><a class="open-in-viewer" href="#f5" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f5.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/53b693ff-6179-441a-bf13-001595ad6b83/assets/images/large/nejmoa2113017_f5.jpg" height="1135" width="2640" aria-labelledby="f5" loading="lazy"></a><figcaption><div class="caption">Incidence of Covid-19 According to Time Periods in the Per-Protocol Population.</div><div class="notes"><div role="doc-footnote">The incidence rate based on adjudicated Covid-19 cases was defined as the number of participants with an event during the period divided by the number of participants at risk at the beginning of each period and adjusted by person-years (total time at risk) in each treatment group. The dashed vertical line represents a vaccine efficacy of 30% based on the null hypothesis that the primary efficacy of the mRNA-1273 vaccine is 30% or less. The number of person-years was calculated from randomization to the date of onset of Covid-19, the end of each time period, the last date of participation in the trial, or the efficacy data cutoff date, whichever date was the earliest. For the analysis of time intervals starting from 14 days after the first injection, starting from the second injection, and starting 14 days after the second injection, assessed every 2 months, person-years for each time period were defined starting from the beginning of each time interval and truncating at the end of the interval (if there was an ending time). Vaccine efficacy was defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo). The 95% confidence interval for the ratio was calculated with the exact method, conditional on the total number of cases and adjusted for person-years for the time period. The data cutoff date was March 26, 2021.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f5"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f5" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f5.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></section><section id="tab-other" aria-labelledby="tab-other-label" role="tabpanel" tabindex="-1"><h3>Other</h3></section></div><div id="core-collateral-tables" role="tabpanel" data-core-tabs="core-collateral-tables" tabindex="-1" aria-labelledby="pane-core-collateral-tables"><header><h2 id="pane-core-collateral-tables"><i class="icon-tables" aria-hidden="true"></i>Tables</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><!-- There is no content. --></div><div id="core-collateral-share" role="tabpanel" data-core-tabs="core-collateral-share" tabindex="-1" aria-labelledby="pane-core-collateral-share"><header><h2 id="pane-core-collateral-share"><i class="icon-share" aria-hidden="true"></i>Share</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>Share</h3><div class="section--wrapper"><section><h4>CONTENT LINK</h4><div id="share-self"><p data-id="article-share-self-link" class="share-self__source">https://www.nejm.org/doi/full/10.1056/NEJMoa2113017</p><button data-id="article-share-access" aria-label="CONTENT LINK" class="share-self__action btn btn--inverse"><i aria-hidden="true" class="icon-copy-o"></i><span>Copy Link</span></button><div aria-live="polite" class="share-self__status"><p class="share-self__success"><i aria-hidden="true" class="icon-check_circle"></i><span>Copied!</span></p><p class="share-self__failed"><i aria-hidden="true" class="icon-x_btnclose"></i><span>Copying failed.</span></p></div></div></section><section data-location="share_tools_article"><h4>Share</h4><div class="share-buttons a2a a2a_kit" style="line-height: 16px;"><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i><span>Facebook</span></a><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i><span>X (formerly Twitter)</span></a><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i><span>LinkedIn</span></a><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i><span>email</span></a><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i><span>Bluesky</span></a></div></section></div></div><div data-location="references_article" id="core-collateral-references" role="tabpanel" aria-labelledby="pane-core-collateral-references" data-core-tabs="core-collateral-references" tabindex="-1"><header><h2 id="pane-core-collateral-references"><i aria-hidden="true" class="icon-references"></i>References</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>References</h3><div role="list" class="section--wrapper"><div role="listitem" data-has="label"><div class="label">1.</div><div id="core-r1" class="citations"><div class="citation"><div class="citation-content">Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. <em>N Engl J Med</em> 2021;384:403-416.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r1-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_2_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2035389&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33378609/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000629333200009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+the+mRNA-1273+SARS-CoV-2+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=403-416&amp;doi=10.1056%2FNEJMoa2035389&amp;pmid=33378609" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r1-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] follow-up of 2 months after vaccination. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] after a median follow-up of 64 days. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] enrolled at 99 sites in the United States. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] at high risk for severe disease (or both). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] and vaccine have been described previously. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] the second dose, were described previously </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-7" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>g [...] and Fig. S2). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-8" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>h [...] group and the mRNA-1273 group (Table S5). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r1-9" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>i [...] consistent with those reported previously, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r17" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>j [...] Given the high efficacies of the vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="core-r2" class="citations"><div class="citation"><div class="citation-content">Johnson &amp; Johnson COVID-19 vaccine authorized by U.S. FDA for emergency use — first single-shot vaccine in fight against global pandemic. New Brunswick, NJ: <em>Johnson &amp; Johnson</em>, February 27, 2021 (<a href="https://www.jnj.com/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic">https://www.jnj.com/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Johnson+%26+Johnson+COVID-19+vaccine+authorized+by+U.S.+FDA+for+emergency+use+%E2%80%94+first+single-shot+vaccine+in+fight+against+global+pandemic&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="core-r3" class="citations"><div class="citation"><div class="citation-content">Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. <em>N Engl J Med</em> 2020;383:2603-2615.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2034577&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33301246/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000605648000010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+the+BNT162b2+mRNA+Covid-19+vaccine.&amp;publication_year=2020&amp;journal=N+Engl+J+Med&amp;pages=2603-2615&amp;doi=10.1056%2FNEJMoa2034577&amp;pmid=33301246" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] follow-up of 2 months after vaccination. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r17" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] Given the high efficacies of the vaccines </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="core-r4" class="citations"><div class="citation"><div class="citation-content">Sadoff J, Le Gars M, Shukarev G, et al. Interim results of a phase 1–2a trial of Ad26.COV2.S Covid-19 vaccine. <em>N Engl J Med</em> 2021;384:1824-1835.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_5_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2034201&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33440088/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640382300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+results+of+a+phase+1%E2%80%932a+trial+of+Ad26.COV2.S+Covid-19+vaccine.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1824-1835&amp;doi=10.1056%2FNEJMoa2034201&amp;pmid=33440088" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="core-r5" class="citations"><div class="citation"><div class="citation-content">Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. <em>N Engl J Med</em> 2021;384:1412-1423.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_6_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2101765&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33626250/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640554500008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BNT162b2+mRNA+Covid-19+vaccine+in+a+nationwide+mass+vaccination+setting.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1412-1423&amp;doi=10.1056%2FNEJMoa2101765&amp;pmid=33626250" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="core-r6" class="citations"><div class="citation"><div class="citation-content">Maternal, neonatal, and child health services during COVID-19. Atlanta: Centers for Disease Control and Prevention, November 5, 2020 (<a href="https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/pregnancy-services.html">https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/pregnancy-services.html</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Maternal%2C+neonatal%2C+and+child+health+services+during+COVID-19&amp;publication_year=2020" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="core-r7" class="citations"><div class="citation"><div class="citation-content">Thompson MG, Burgess JL, Naleway AL, et al. Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines. <em>N Engl J Med</em> 2021;385:320-329.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_8_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2107058&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34192428/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000669589200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Prevention+and+attenuation+of+Covid-19+with+the+BNT162b2+and+mRNA-1273+vaccines.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=320-329&amp;doi=10.1056%2FNEJMoa2107058&amp;pmid=34192428" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="core-r8" class="citations"><div class="citation"><div class="citation-content">Thompson MG, Burgess JL, Naleway AL, et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers — eight U.S. locations, December 2020–March 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:495-500.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r8-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7013e3" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33793460/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000636784900007" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Interim+estimates+of+vaccine+effectiveness+of+BNT162b2+and+mRNA-1273+COVID-19+vaccines+in+preventing+SARS-CoV-2+infection+among+health+care+personnel%2C+first+responders%2C+and+other+essential+and+frontline+workers+%E2%80%94+eight+U.S.+locations%2C+December+2020%E2%80%93March+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=495-500&amp;doi=10.15585%2Fmmwr.mm7013e3&amp;pmid=33793460" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r8-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] deployment in the general population. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r15" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] (beta) and B.1.617.2 (delta) variants. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="core-r9" class="citations"><div class="citation"><div class="citation-content">Tenforde MW, Olson SM, Self WH, et al. Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged ≥65 years — United States, January–March 2021. <em>MMWR Morb Mortal Wkly Rep</em> 2021;70:674-679.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.15585/mmwr.mm7018e1" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33956782/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647643800003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Pfizer-BioNTech+and+Moderna+vaccines+against+COVID-19+among+hospitalized+adults+aged+%E2%89%A565+years+%E2%80%94+United+States%2C+January%E2%80%93March+2021.&amp;publication_year=2021&amp;journal=MMWR+Morb+Mortal+Wkly+Rep&amp;pages=674-679&amp;doi=10.15585%2Fmmwr.mm7018e1&amp;pmid=33956782" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r10" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] deployment in the general population. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r20" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] infection, regardless of race and age. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="core-r10" class="citations"><div class="citation"><div class="citation-content">Pawlowski C, Lenehan P, Puranik A, et al. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. <em>Med (N Y)</em> 2021;2(8):979-992.e8.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.medj.2021.06.007" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34223401/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000686159800011" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=FDA-authorized+mRNA+COVID-19+vaccines+are+effective+per+real-world+evidence+synthesized+across+a+multi-state+health+system.&amp;publication_year=2021&amp;journal=Med+%28N+Y%29&amp;pages=979-992.e8&amp;doi=10.1016%2Fj.medj.2021.06.007&amp;pmid=34223401" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="core-r11" class="citations"><div class="citation"><div class="citation-content">Corbett KS, Edwards D, Leist SR, et al. SARS-CoV-2 mRNA vaccine development enabled by prototype pathogen preparedness. June 11, 2020 (<a href="https://www.biorxiv.org/content/10.1101/2020.06.11.145920v1">https://www.biorxiv.org/content/10.1101/2020.06.11.145920v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+mRNA+vaccine+development+enabled+by+prototype+pathogen+preparedness.&amp;publication_year=2020" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="core-r12" class="citations"><div class="citation"><div class="citation-content">Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. <em>Lancet</em> 2021;397:1819-1829.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r12-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)00947-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33964222/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000651041900028" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Impact+and+effectiveness+of+mRNA+BNT162b2+vaccine+against+SARS-CoV-2+infections+and+COVID-19+cases%2C+hospitalisations%2C+and+deaths+following+a+nationwide+vaccination+campaign+in+Israel%3A+an+observational+study+using+national+surveillance+data.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=1819-1829&amp;doi=10.1016%2FS0140-6736%2821%2900947-8&amp;pmid=33964222" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r12-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r15" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] (beta) and B.1.617.2 (delta) variants. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r20" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] infection, regardless of race and age. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="core-r13" class="citations"><div class="citation"><div class="citation-content">Planas D, Bruel T, Grzelak L, et al. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. <em>Nat Med</em> 2021;27:917-924.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-021-01318-5" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33772244/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000633281900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Sensitivity+of+infectious+SARS-CoV-2+B.1.1.7+and+B.1.351+variants+to+neutralizing+antibodies.&amp;publication_year=2021&amp;journal=Nat+Med&amp;pages=917-924&amp;doi=10.1038%2Fs41591-021-01318-5&amp;pmid=33772244" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="core-r14" class="citations"><div class="citation"><div class="citation-content">Abu-Raddad LJ, Chemaitelly H, Butt AA. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants. <em>N Engl J Med</em> 2021;385:187-189.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_15_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMc2104974&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33951357/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000647808600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+the+BNT162b2+Covid-19+vaccine+against+the+B.1.1.7+and+B.1.351+variants.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=187-189&amp;doi=10.1056%2FNEJMc2104974&amp;pmid=33951357" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="core-r15" class="citations"><div class="citation"><div class="citation-content">Bernal JL, Andrews N, Gower C, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant. May 24, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.05.22.21257658v1">https://www.medrxiv.org/content/10.1101/2021.05.22.21257658v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+COVID-19+vaccines+against+the+B.1.617.2+variant.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="core-r16" class="citations"><div class="citation"><div class="citation-content">Marshall M, Ferguson ID, Lewis P, et al. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. <em>Pediatrics</em> 2021;148(3):e2021052478-e2021052478.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1542/peds.2021-052478" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34088762/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000755048000072" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Symptomatic+acute+myocarditis+in+7+adolescents+after+Pfizer-BioNTech+COVID-19+vaccination.&amp;publication_year=2021&amp;journal=Pediatrics&amp;pages=e2021052478-e2021052478&amp;doi=10.1542%2Fpeds.2021-052478&amp;pmid=34088762" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="core-r17" class="citations"><div class="citation"><div class="citation-content">Thomas SJ, Moreira ED, Kitchin N, et al. Six month safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. July 28, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1">https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Six+month+safety+and+efficacy+of+the+BNT162b2+mRNA+COVID-19+vaccine.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="core-r18" class="citations"><div class="citation"><div class="citation-content">Tenforde MW, Patel MM, Ginde AA, et al. Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States. <em>Clin Infect Dis</em> 2021 August 6 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34358310/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000756472600001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+SARS-CoV-2+mRNA+vaccines+for+preventing+Covid-19+hospitalizations+in+the+United+States.&amp;publication_year=2021&amp;journal=Clin+Infect+Dis&amp;pmid=34358310" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="core-r19" class="citations"><div class="citation"><div class="citation-content">Jones NK, Rivett L, Seaman S, et al. Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection. <em>Elife</em> 2021;10:e68808-e68808.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.7554/eLife.68808" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33830018/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000644424200001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Single-dose+BNT162b2+vaccine+protects+against+asymptomatic+SARS-CoV-2+infection.&amp;publication_year=2021&amp;journal=Elife&amp;pages=e68808-e68808&amp;doi=10.7554%2FeLife.68808&amp;pmid=33830018" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="core-r20" class="citations"><div class="citation"><div class="citation-content">Tande AJ, Pollock BD, Shah ND, et al. Impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening. <em>Clin Infect Dis</em> 2021 March 10 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/cid/ciab229" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33704435/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000780096300009" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Impact+of+the+COVID-19+vaccine+on+asymptomatic+infection+among+patients+undergoing+pre-procedural+COVID-19+molecular+screening.&amp;publication_year=2021&amp;journal=Clin+Infect+Dis&amp;doi=10.1093%2Fcid%2Fciab229&amp;pmid=33704435" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="core-r21" class="citations"><div class="citation"><div class="citation-content">Collier AY, McMahan K, Yu J, et al. Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. <em>JAMA</em> 2021;325:2370-2380.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jama.2021.7563" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33983379/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000650215800001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+COVID-19+mRNA+vaccines+in+pregnant+and+lactating+women.&amp;publication_year=2021&amp;journal=JAMA&amp;pages=2370-2380&amp;doi=10.1001%2Fjama.2021.7563&amp;pmid=33983379" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="core-r22" class="citations"><div class="citation"><div class="citation-content">Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. <em>N Engl J Med</em> 2021;384:2273-2282.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_23_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2104983&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33882218/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000642261100001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Preliminary+findings+of+mRNA+Covid-19+vaccine+safety+in+pregnant+persons.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=2273-2282&amp;doi=10.1056%2FNEJMoa2104983&amp;pmid=33882218" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="core-r23" class="citations"><div class="citation"><div class="citation-content">Ali K, Berman G, Zhou H, et al. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. <em>N Engl J Med</em>.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_24_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2109522&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34379915/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000685294300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Evaluation+of+mRNA-1273+SARS-CoV-2+vaccine+in+adolescents.&amp;journal=N+Engl+J+Med&amp;doi=10.1056%2FNEJMoa2109522&amp;pmid=34379915" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="core-r24" class="citations"><div class="citation"><div class="citation-content">Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. <em>N Engl J Med</em> 2021;385:239-250.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r24"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_25_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2113017&amp;key=10.1056%2FNEJMoa2107456&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34043894/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000657049900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety%2C+immunogenicity%2C+and+efficacy+of+the+BNT162b2+Covid-19+vaccine+in+adolescents.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=239-250&amp;doi=10.1056%2FNEJMoa2107456&amp;pmid=34043894" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="core-r25" class="citations"><div class="citation"><div class="citation-content">Haidar G, Agha M, Lukanski A, et al. Immunogenicity of COVID-19 vaccination in immunocompromised patients: an observational, prospective cohort study interim analysis. June 30, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.06.28.21259576v1">https://www.medrxiv.org/content/10.1101/2021.06.28.21259576v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+COVID-19+vaccination+in+immunocompromised+patients%3A+an+observational%2C+prospective+cohort+study+interim+analysis.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="core-r26" class="citations"><div class="citation"><div class="citation-content">Hadjadj J, Planas D, Ouedrani A, et al. Immunogenicity of BNT162b2 vaccine against the alpha and delta variants in immunocompromised patients. August 9, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.08.08.21261766v1">https://www.medrxiv.org/content/10.1101/2021.08.08.21261766v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+BNT162b2+vaccine+against+the+alpha+and+delta+variants+in+immunocompromised+patients.&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div></div></div></div><aside data-core-aside="right-rail">



        
        <div id="DTM_Position_MedRectangle" class="ad">
 <!--emptycomment-->
</div>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="relatedArticlesWidget" data-widget-id="8206d5cd-cb8c-4ff9-8c46-3d22e0dee215" data-location="recirc_curatedRelated_article">
        



        
        

        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <div id="nejm_jobs" class="nejm_jobs"> <!-- top red rectangle --><div id="nejm-widget" class="nejm-widget" style="display: block;"><div class="nejm-widget_logo">	<a target="nejm-win" href="https://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" src="https://apps1.nejmcareercenter.org/images/nejmCCID-JobsWidget.gif" width="140" height="36">	</a></div><div class="nejm-widget_cont"> <!-- content --><div class="nejm-widget_title">PHYSICIAN JOBS</div><div class="nejm-widget_date">June 10, 2025</div><div class="nejm-widget_item"><div><span> West Hartford, Connecticut</span></div><div><span>Hematology / Oncology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/886963/hematologist-oncologist-regional-cancer-care-associates-west-hartford/?query=fjwp&amp;rid=5696">Hematologist/Oncologist - Regional Cancer Care Associates West Hartford</a></div></div><div class="nejm-widget_item"><div><span> Newburyport, Massachusetts</span></div><div><span>Internal Medicine</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/885449/primary-care-physician-newburyport-ma/?query=fjwp&amp;rid=428606">Primary Care Physician, Newburyport, MA</a></div></div><div class="nejm-widget_item"><div><span> San Francisco, California</span></div><div><span>Obstetrics &amp; Gynecology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/880019/swbmg-physician-ob-gyn-maternal-and-fetal-medicine/?query=fjwf&amp;rid=845672">SWBMG Physician, OB/GYN: Maternal and Fetal Medicine</a></div></div><div class="nejm-widget_item"><div><span> Modesto, California</span></div><div><span>Dermatology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/889300/physician-dermatology-mohs-surgery-modesto-ca-/?query=fjwf&amp;rid=845677">Physician, Dermatology, Mohs Surgery (Modesto, CA)</a></div></div><div class="nejm-widget_item"><div><span> Connecticut</span></div><div><span>Surgery, Orthopedic</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/890846/orthopedic-foot-and-ankle-opening-in-southwestern-connecticut-partnership-track/?query=fjwf&amp;rid=5127">Orthopedic Foot &amp; Ankle Opening in Southwestern Connecticut - Partnership Track</a></div></div><div class="nejm-widget_item"><div><span> Las Vegas, Nevada</span></div><div><span>Hospitalist</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/883845/post-acute-hospitalist-physician/?query=fjwf&amp;rid=751">Post-Acute, Hospitalist Physician</a></div></div></div> <!-- content --> <!-- footer --></div> <!-- nejm-widget --></div><script src="https://apps1.nejmcareercenter.org/?width=300&amp;sp=all"></script>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="literatumAd" data-widget-id="001e4aa7-b6fe-4b21-9d5b-5bde81227c67" id="ad-article-right-rail-300x250-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <a href="/action/clickThrough?id=128129&amp;url=https%3A%2F%2Fstore.nejm.org%2Fsignup%2Fnejm%2Fregister%2Falerts%3Fpromo%3DONFQSR51%26query%3Dcm_rr%26utm_source%3Dnejm%26utm_medium%3Dcm%26utm_campaign%3Dalerts23&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2113017&amp;pubId=41290416&amp;placeholderId=101337&amp;productId=1035"><img src="/sda/128129/rightRail--SpecialtyUpdates23-001.jpg" width="300" height="250"></a>
            
        </div>
    

    

    



        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <script src="https://widgets.nejm.org/onepub-widgets/loader/webcomponents-loader.js" async="" nonce="94d6a59084c8e7d5-SJC">
<script src="https://widgets.nejm.org/onepub-widgets/loader/polyfill-support.js"  nonce="94d6a59084c8e7d5-SJC"></script>
<script src="https://widgets.nejm.org/onepub-widgets/more-like-this.js" type="module" nonce="94d6a59084c8e7d5-SJC"></script>

<more-like-this class="onepub-widget" dataid="onepub-more-like-this" collections="catalyst-article, clinician-article, evidence-article, nejm-ai-article, nejm-article" headertitle="More Like This" maxitems="5"><!----><div class="more-like-this onepub-more-like-this_"><!--?lit$163528146$--><onepub-fonts><wc-fetch></wc-fetch><!--?lit$163528146$--><div class="mlt-wrapper"><div class="mlt-header-container"><div class="mlt-header-content-left"><div class="mlt-header-title-container"><span class="mlt-header-title">More Like This</span></div><!--?lit$163528146$--></div></div><div class="mlt-body"><!--?lit$163528146$--><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$163528146$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$163528146$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$163528146$-->Apr 21, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2119451?query=recirc_Semantic" target="_self">Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant</a></div><div class="mlt-article-authors"><!--?lit$163528146$-->N. Andrews and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$163528146$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$163528146$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$163528146$-->Mar 10, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2117128?query=recirc_Semantic" target="_self">Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina</a></div><div class="mlt-article-authors"><!--?lit$163528146$-->D.-Y. Lin and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$163528146$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$163528146$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$163528146$-->Jan 27, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2115481?query=recirc_Semantic" target="_self">Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines</a></div><div class="mlt-article-authors"><!--?lit$163528146$-->N. Andrews and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$163528146$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$163528146$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$163528146$-->Jan 13, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2116063?query=recirc_Semantic" target="_self">Covid-19 Vaccine Effectiveness in New York State</a></div><div class="mlt-article-authors"><!--?lit$163528146$-->E.S. Rosenberg and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$163528146$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$163528146$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$163528146$-->Dec 16, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2106599?query=recirc_Semantic" target="_self">Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel</a></div><div class="mlt-article-authors"><!--?lit$163528146$-->T. Pilishvili and Others</div></div><!----></div><div class="mlt-footer"></div></div></onepub-fonts><style>:host{display:block}@keyframes fadeIn{0%{opacity:0}100%{opacity:1}}.more-like-this{max-width:25rem}.more-like-this *{font-variant-numeric:lining-nums}.mlt-wrapper{animation:fadeIn 1s}.mlt-header-container{border-bottom:#4d4d4d solid .0625rem;border-top:#4d4d4d solid .125rem}.mlt-header-title{color:#1a1a1a;display:block;font-family:var(--sans-serif);font-size:1rem;font-weight:700;letter-spacing:.02rem;line-height:1.5rem;padding-bottom:.94rem;padding-top:.94rem;text-transform:uppercase}.mlt-header-description{color:#333;display:block;font-family:ff-scala-sans-pro;font-size:.75rem;letter-spacing:.05rem;margin-top:-.5rem;padding-bottom:1rem;text-transform:uppercase}.mlt-article-container{border-bottom:#e5e5e5 solid .0625rem;margin-top:1.38rem}.mlt-article-container-header{font-family:var(--sans-serif);font-size:.6875rem;letter-spacing:.04em;line-height:1.125rem;margin:0 0 1rem;text-transform:uppercase}.mlt-article-type{font-weight:700;line-height:1.25rem;letter-spacing:.04rem;text-decoration:none}.mlt-article-type:hover{text-decoration:underline}.nejm{color:#f30}.nejm-ai{color:#006197}.nejm-catalyst{color:#5708a6}.nejm-evidence{color:#69a323}.mlt-article-site-label::after,.mlt-article-type::after{border-right:1px solid #e5e5e5;content:'';display:inline;padding:.1875rem .375rem .125rem 0;margin:0 .375rem 0 0}.mlt-article-pubdate{color:#666;font-style:normal;font-weight:700;line-height:1.25rem;letter-spacing:.04em}.mlt-article-authors{color:#666;font-family:var(--sans-serif);font-size:1rem;font-style:normal;font-weight:400;letter-spacing:normal;line-height:1.5rem;margin-bottom:1.38rem}.mlt-article-site-label{color:#666;font-style:normal;font-weight:700;letter-spacing:.04em}.mlt-article-title{margin-bottom:.5rem}.mlt-article-title>a{background-image:linear-gradient(#f30,#f30);background-position:0 90%;background-repeat:no-repeat;background-size:0 0;color:#1a1a1a;font-family:var(--quadraat-web);font-size:1.25rem;font-style:normal;font-weight:700;letter-spacing:normal;line-height:1.8rem;margin:1.5rem 0 .35rem 0;text-decoration:none;transition:background .25s ease-in-out}.mlt-article-title>a:hover{background-position:0 98%;background-size:100% .125rem;text-decoration:none}.skeleton-card{box-shadow:0 0 4px 1px rgba(0,0,0,.1);margin:1rem 0;padding:1rem}</style></div></more-like-this>




        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>










    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="ad06db99-f228-4c92-9ad7-c4ae0fdbdbf1" id="bc-web-rec">
        



        
        <!-- BlueConic TEST empty HTML widget with DIV wrapper with id=bc-web-rec -->

        </div>
    

</aside></article><div data-extent="article-wrapper"><div class="core-container"></div><div class="after-credits"><div class="core-container"><a href="/doi/pdf/10.1056/NEJMoa2113017?download=true" id="downloadPdfUrl" data-doi="10.1056/NEJMoa2113017" data-behavior="trackDownloadEvent" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2113017.pdf"><span>Download PDF</span></a></div></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1056/NEJMoa2113017"}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><div class="articles-nav"></div><template id="figure_nav_template"><nav><a href="#" title="Open in viewer" class="open-in-viewer"><i aria-hidden="true" class="icon-expand"></i></a></nav></template><template id="fv_panel_template" data-sharesocial="Share"><div class="fv__panel js--hidden"><div class="fv__panel__text"><div class="fv__panel__contentTitle"></div><div class="fv__panel__contentText"></div></div></div></template>
<template id="fv_directory_template" data-overlay="View figure"><div class="fv__directory"><div class="fv__header"><nav class="tab__nav"></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"></div></div></template><template id="fv_directory_tabItem_template" data-figures="Figures" data-others="Others" data-tables="Tables"><button role="tab" data-toggle="tab" class="tab__nav__item"></button></template>
<template id="fv_lightbox_template" data-sr-back="Go to figure location within the article" data-sr-closealt="Close" data-sr-download="Toggle download panel" data-sr-download-pptx="Download PPT" data-sr-info="Toggle information panel" data-sr-panel="Close panel" data-sr-share="Toggle share panel" data-sr-zoom="Zoom" data-text-close="Back to article" data-text-nav-figures="All figures" data-text-nav-others="All others" data-text-nav-tables="All tables" data-text-viewall="View all material" data-title-back="Back to article" data-title-closealt="Close" data-title-download="Download" data-title-download-pptx="Download PPT" data-title-info="Info" data-title-share="Share" data-title-zoom="Zoom"></template>
<template id="fv_toolbar_template"><div class="fv__toolbar__info"><strong class="fv__toolbar__contentTitle uppercase"></strong><p class="fv__toolbar__contentText"></p></div></template><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-references="References" data-figure="Go to Figure" data-media="Go to Media" data-more="More" data-original="Go to original" data-table="Go to Table" data-inviewer="Open in Viewer" data-allinviewer="Open all in viewer"><svg data-tags="copyright" viewBox="0 0 24 24"><path d="M12 20.016q3.281 0 5.648-2.368T20.016 12t-2.368-5.648T12 3.984 6.352 6.352 3.984 12t2.368 5.648T12 20.016zm0-18q4.125 0 7.055 2.93T21.985 12t-2.93 7.055T12 21.985t-7.055-2.93T2.015 12t2.93-7.055T12 2.015zm-.14 7.125q-1.876 0-1.876 2.718v.282q0 2.718 1.875 2.718.704 0 1.172-.398t.469-1.008h1.781q0 1.172-1.031 2.063-.984.843-2.39.843-1.876 0-2.86-1.125t-.984-3.093v-.282q0-1.921.937-3 1.125-1.265 2.906-1.265 1.547 0 2.438.89.984.985.984 2.297H13.5q0-.328-.14-.61-.235-.468-.329-.562-.469-.468-1.172-.468z"></path></svg><span>Request permissions</span><i aria-hidden="true" class="icon-open_in_new"></i></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template>

        <div role="navigation" aria-label="Sticky Navigation" class="st-header"><div class="st-header__content"><div class="st-header__item st-header__menu"></div><div class="st-header__current st-header__item"><div class="st-header__label">Now Reading:</div><div class="st-header__title">Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase</div></div><div class="st-header__share st-header__item"><div class="share-dropblock dropdown"><a id="sticky-header-dropBlock" href="#" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="dropdown-toggle"><span title="" data-toggle="tooltip" data-trigger="hover" data-original-title="Share options"><span class="sr-only">Share</span><i aria-hidden="true" class="icon-share"></i></span></a><div aria-labelledby="sticky-header-dropBlock" data-location="share_tools_article" class="dropdown-menu"><ul class="rlist--inline a2a a2a_kit" style="line-height: 16px;"><li><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i></a></li><li><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i></a></li><li><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i></a></li><li><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i></a></li><li><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i></a></li></ul></div></div></div><div class="st-header__nav st-header__item"><div class="content-navigation"><a href="/doi/full/10.1056/NEJMoa2110345" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>PREVIOUS ARTICLE</h6><div>Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months</div></div></div><i aria-hidden="true" class="icon-arrow-left"></i><span>Previous</span></a><a href="/doi/full/10.1056/NEJMra2100152" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>NEXT ARTICLE</h6><div>Peritoneal Dialysis</div></div></div><span>Next</span><i aria-hidden="true" class="icon-arrow-right"></i></a></div></div></div><div class="st-header__track"><div id="progress-tracker" class="st-header__tracker" style="width: 0px;"></div></div></div><div class="fv figureViewer js--has-focus-mode"><div class="fv__directory" data-core-tabs="default" style="display: flex;"><div class="fv__header"><nav class="tab__nav" role="tablist"><button role="tab" data-toggle="tab" class="tab__nav__item active" aria-controls="#tab-pane-figures" aria-selected="true">Figures</button><button role="tab" data-toggle="tab" class="tab__nav__item inactive" aria-controls="#tab-pane-tables" tabindex="-1" aria-selected="false" aria-disabled="true">Tables</button></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"><div class="tab__pane fv__list fv__list--figures" id="tab-pane-figures" aria-label="All figures" tabindex="0" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f0" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f0.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/cd9a6d07-b425-4d9f-8d58-c18c4c45e968/assets/images/large/nejmoa2113017_f0.jpg" height="3416" width="2640" aria-labelledby="f0" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title"></div><div class="fv__item__description"><figcaption>Download a PDF of the <a href="#ap0">Research Summary</a>.</figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f1" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f1.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/1a7b1e11-6e57-48e5-9a1e-f2f1c9e8b5be/assets/images/large/nejmoa2113017_f1.jpg" height="2115" width="2640" aria-labelledby="f1" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 1</div><div class="fv__item__description"><figcaption><div class="caption">Randomization and Analysis Populations.</div><div class="notes"><div role="doc-footnote">Eight participants, including six with major protocol deviations and two who erroneously underwent randomization twice, were excluded from the original randomization population (30,423 participants) and from all analysis sets. The full analysis population comprised all participants who had undergone randomization and received at least one injection; the modified intention-to-treat population included participants in the full analysis population who had no immunologic or virologic evidence of previous Covid-19 (i.e., had both a negative nasopharyngeal swab specimen and a negative anti-nucleocapsid antibody test result) at day 1 before the first injection; and the per-protocol population consisted of all participants in the modified intent-to-treat population who received planned injections according to the schedule and had no major protocol deviations that affected key trial data. The safety population included all participants who had undergone randomization and received at least one injection; this population was used for all safety analyses except the analysis for solicited adverse events. For safety analyses, participants were evaluated according to the injection received. Three participants assigned to the mRNA-1273 group received two doses of placebo and were included in the placebo safety population, and seven participants assigned to the placebo group received one or two doses of mRNA-1273 and were included in the mRNA-1273 safety population. The data cutoff date was March 26, 2021.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f2" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f2.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/4652d527-7163-470e-8421-106217b707e0/assets/images/large/nejmoa2113017_f2.jpg" height="3438" width="2629" aria-labelledby="f2" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 2</div><div class="fv__item__description"><figcaption><div class="caption">Efficacy of the mRNA-1273 Vaccine in Preventing Covid-19.</div><div class="notes"><div role="doc-footnote">In Panels A and C, the dashed vertical line denotes the adjudicated assessment beginning at day 42 (14 days after the second injection of vaccine or placebo). Tick marks in all three panels indicate censored data. Vaccine efficacy was defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional-hazards model with Efron’s method of tie handling and with treatment group as a covariate, adjusted for stratification factor. The data cutoff date was March 26, 2021.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f3" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f3.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/4657f5e8-6a33-4d2f-8dd2-1b050955e2b2/assets/images/large/nejmoa2113017_f3.jpg" height="1015" width="2640" aria-labelledby="f3" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 3</div><div class="fv__item__description"><figcaption><div class="caption">Vaccine Efficacy for Primary and Secondary End Points.</div><div class="notes"><div role="doc-footnote">Vaccine efficacy was defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo), and 95% confidence intervals were estimated using a stratified Cox proportional-hazards model with Efron’s method of tie handling and with the treatment group as a covariate, adjusted for stratification factor. The P value for the vaccine efficacy against Covid-19 (upper right corner) is P&lt;0.001. The dashed vertical line represents a vaccine efficacy of 30%, based on the null hypothesis that the primary efficacy of the mRNA-1273 vaccine is 30% or less. In the Covid-19 rows, censoring rules for efficacy analyses (Covid-19 cases based on eligible symptoms and positive reverse-transcriptase–polymerase-chain-reaction [RT-PCR] assay within 14 days before the second injection) were applied, except for deaths from Covid-19. If a participant had a positive RT-PCR assay at the visit before the second dose (day 29) without eligible symptoms within the previous 14 days, or a positive anti-nucleocapsid antibody test at a scheduled visit before Covid-19 was diagnosed, the participant’s data were censored at the date of the positive RT-PCR assay or anti-nucleocapsid antibody test. Covid-19 diagnoses were based on adjudication committee assessments. The data for Covid-19 regardless of previous SARS-CoV-2 status were based on the number of participants in the full analysis population (15,166 participants in the placebo group and 15,180 participants in the mRNA-1273 group). Data for the asymptomatic subgroup include data from the participant-decision visit. Asymptomatic was defined as the absence of symptoms (according to either the primary efficacy end point of Covid-19 or the secondary definition of Covid-19 [the Centers for Disease Control and Prevention definition, requiring only one symptom]) and of infection as detected by RT-PCR assay (at scheduled visits) or seroconversion (anti-nucleocapsid antibody test). In the primary approach, documented asymptomatic infection was counted beginning 14 days after the second injection, which required seroconversion at month 2 (day 57 through the participant-decision visit). Asymptomatic seroconversion excludes infections confirmed by RT-PCR assay only and includes infections confirmed by seroconversion and those confirmed by both RT-PCR and seroconversion (Table S28). Vaccine efficacy and 95% confidence intervals for asymptomatic SARS-CoV-2 infection were estimated with Fine and Gray’s subdistribution hazard model, with disease cases as competing events and with treatment group as a covariate, adjusted for stratification factor. Results for additional end points are summarized in Table S27. The data cutoff date was March 26, 2021. NE indicates that the lower bound of the 95% confidence interval could not be estimated.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f4" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f4.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/19887e6e-08b6-4722-af2e-661850da3213/assets/images/large/nejmoa2113017_f4.jpg" height="3084" width="2640" aria-labelledby="f4" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 4</div><div class="fv__item__description"><figcaption><div class="caption">Efficacy of the mRNA-1273 Vaccine in Preventing Covid-19 in Subgroups.</div><div class="notes"><div role="doc-footnote">Analysis of the vaccine efficacy of mRNA-1273 in the prevention of Covid-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the second injection. Vaccine efficacy, defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional-hazards model with Efron’s method of tie-handling and with the treatment group as a covariate, adjusted for stratification factor if applicable. The total number of events for race includes 38 placebo recipients and 3 mRNA-1273 recipients who were in “Multiple,” “Other,” or not reported or unknown categories, and the total number for ethnicity includes 4 placebo recipients and no mRNA-1273 recipients who were in not reported or unknown categories (not shown). Race and ethnic group were reported by the participant. The body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters. Additional subgroup data are provided in Table S29. The data cutoff date was March 26, 2021. HIV denotes human immunodeficiency virus.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f5" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2113017_f5.jpg"><img src="/cms/10.1056/NEJMoa2113017/asset/53b693ff-6179-441a-bf13-001595ad6b83/assets/images/large/nejmoa2113017_f5.jpg" height="1135" width="2640" aria-labelledby="f5" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 5</div><div class="fv__item__description"><figcaption><div class="caption">Incidence of Covid-19 According to Time Periods in the Per-Protocol Population.</div><div class="notes"><div role="doc-footnote">The incidence rate based on adjudicated Covid-19 cases was defined as the number of participants with an event during the period divided by the number of participants at risk at the beginning of each period and adjusted by person-years (total time at risk) in each treatment group. The dashed vertical line represents a vaccine efficacy of 30% based on the null hypothesis that the primary efficacy of the mRNA-1273 vaccine is 30% or less. The number of person-years was calculated from randomization to the date of onset of Covid-19, the end of each time period, the last date of participation in the trial, or the efficacy data cutoff date, whichever date was the earliest. For the analysis of time intervals starting from 14 days after the first injection, starting from the second injection, and starting 14 days after the second injection, assessed every 2 months, person-years for each time period were defined starting from the beginning of each time interval and truncating at the end of the interval (if there was an ending time). Vaccine efficacy was defined as 1 minus the hazard ratio (mRNA-1273 vs. placebo). The 95% confidence interval for the ratio was calculated with the exact method, conditional on the total number of cases and adjusted for person-years for the time period. The data cutoff date was March 26, 2021.</div></div></figcaption></div></div></div><div class="tab__pane fv__list fv__list--tables" id="tab-pane-tables" aria-label="All tables" tabindex="-1" role="tabpanel"></div></div></div></div><div class="references-pop-up fade" aria-hidden="true"><div class="references-pop-up__heading text-dark d-flex align-items-center"><div class="references-pop-up__title flex-grow-1">Reference <span class="references-pop-up__heading-number">1</span></div><a class="references-pop-up__close text-dark" href="#" title="close pop-up" tabindex="-1" aria-hidden="true"><i class="icon-close" aria-hidden="true"></i></a></div><div class="references-pop-up__items citations to-citation__accordion external-links"></div></div></main>
    

</div>

                    
                        



        
        <div class="ng-page_layout ng-page_layout-fullWidth"><div class="container-fluid"><div class="row"><div class="col-12">



        
        




        
        <div class="ng-page_layout-contentSpacing"></div>










    
    
        <div data-widget-def="oneSearchMultiSearch" data-widget-id="778b3ad8-1a8d-43d8-8196-63b03df4a138" data-location="recirc_inIssue_bottom_article">
        



        
        <div class="os-ms os-ms-more-from-issue"><h3 class="ng-subsection-title"><a href="/toc/nejm/385/19" class="ng-subsection-title_link animation-icon-shift"><span class="ng-subsection-title_text">More from Vol. 385 No. 19</span><span class="ng-subsection-title_icon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-longArrowRight"></use></svg></span></span></a></h3><ul class="os-ms-more-from-issue_list"><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Nov 04, 2021</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2110345" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">S.J. Thomas and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Nov 04, 2021</span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2102953" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">L.A. Inker and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Nov 04, 2021</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2103753" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Race, Genetic Ancestry, and Estimating Kidney Function in CKD</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">C. Hsu and Others</span></div></div></div></div></div></li></ul></div>

        </div>
    

</div></div></div></div>

                    
                        



        
        <div class="ng-page_layout-bottomAd"><div class="container-fluid"><div class="row"><div class="col-12">









    
    
        <div data-widget-def="literatumAd" data-widget-id="7e022d0d-4a48-44a7-af66-033cf5c13eb8" id="ad-article-bottom-FULLx320-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <!-- START: Circulation Footer 3 -->
<aside class="g-cta-subscribe">
	<style>
.bads_footer-banner24-ONJQNRF1{background:url(/pb-assets/contextual_messaging/footer-yel-background-2x-1513629627453.jpg) center center no-repeat;padding:20px;display:block;margin:0;min-height:inherit;background-size:cover;text-decoration:none!important;color:#1a1a1a;text-align:left}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:42px;line-height:44px;letter-spacing:.2px;margin:0 0 20px;font-family:ff-quadraat-web-pro,sans-serif;font-weight:600}.bads_footer-banner24-ONJQNRF1-inner{max-width:1300px;margin:0 auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions .a-btn{width:130px;padding-left:12px}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{position:static;color:#000;font-size:18px;line-height:27px;border:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:20px 0 20px 0;list-style-type:none;padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login a{color:#0a68ad}.bads_clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.bads_clearfix{display:block}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{float:left;width:50%;padding:30px 0}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{float:left;padding-left:30px;width:50%}.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{display:block;max-width:100%;height:auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:18px;text-transform:uppercase;line-height:24px;font-weight:600;margin:-15px 0 0;letter-spacing:.2px}@media only screen and (max-width:480px){.bads_footer-banner24-ONJQNRF1-inner .bads_device-img,.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{width:100%;float:none}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{padding-left:0}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:27px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding-top:0;padding-bottom:0}.bads_footer-banner24-ONJQNRF1{height:auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:0 0 12px;list-style-type:none}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{line-height:25px;font-size:15px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1 .bads_device-img{width:280px!important;margin:0 auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 3px;font-size:14px}}@media only screen and (min-width:480px) and (max-width:1024px){.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:30px;margin-bottom:15px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{font-size:14px}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:13px;margin-top:0}}@media only screen and (min-width:1025px) and (max-width:1200px){.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:10px 0}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 5px}}@media only screen and (min-width:1401px){.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{float:right}}
	</style>
	<div class="bads_footer-banner24-ONJQNRF1">
	  <div class="bads_footer-banner24-ONJQNRF1-inner bads_clearfix">
		 <div class="bads_subs-btn">
			<p class="g-cta-subscribe__title">Tap into groundbreaking research and clinically relevant insights</p>
			<ul class="g-cta-subscribe__actions">
				<li class="g-cta-subscribe__actions-primary">
				  <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2113017%26promo%3DONFQNRF1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2113017&amp;pubId=41290416&amp;placeholderId=101336&amp;productId=1035" class="ng-btn_primary ng-btn_iconRight"><span class="ng-btn_text">Subscribe </span><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#arrows-longArrowRight"></use></svg></span></a>
				</li>
			</ul>
			<p class="g-cta-subscribe__login">Already a subscriber? <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dactivate%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2113017%26promo%3DONFQANR4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2113017&amp;pubId=41290416&amp;placeholderId=101336&amp;productId=1035">Activate</a> your online access.</p>
		 </div>

		<div class="bads_device-img">
		   <img src="/sda/127716/footer-devices-2x.png" alt="Devices">
		</div>
	   </div>
	</div>
</aside>
<!--/END: Circulation Footer 3 -->
            
        </div>
    

    

    



        </div>
    

</div></div></div></div>

                    
                        



        
        <footer class="ng-footer footer__top" style="position: relative;"><div data-location="footer" class="ng-footer_columns"><div class="container-fluid"><div class="row"><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">ARTICLE CATEGORIES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item">
        <a href="/browse/nejm-article-category/research" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Research</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/review" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reviews</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/clinical-cases" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Clinical Cases</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/perspective" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Perspective</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/commentary" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Commentary</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/other" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Other</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/medical-article-index" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Browse all Articles</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/toc/nejm/current" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Current Issue</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/loi/nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Issue Index</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">RESOURCES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Authors &amp; Reviewers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Submit a Manuscript</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Subscribers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://tools.ovid.com/ovidtools/nejm.html" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Administrators</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/media" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Media</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/how-to-advertise" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertisers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/information-for-subscription-agents" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Agents</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/permissions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Permissions &amp; Licensing</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/reprints" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reprints</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a>
    </li>
</ul>
</div></div></div><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="About us">ABOUT US</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/about-nejm/about-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">About NEJM</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmgroup.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM Group</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Products &amp; Services</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/editors-and-publishers" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Editors &amp; Publishers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/advertising-policies" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertising Policies</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/contact-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text" aria-label="Contact us">Contact Us</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions?#Accessibility" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Accessibility</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">FAQs</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/help" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Help</span></a></li>
    <li class="ng-footer_column-list-item"><a href="mailto:sitefeedback@nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Site Feedback</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">SUBSCRIPTIONS</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Subscribe</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=renew&amp;product=nejm&amp;promo=ONFLNRR3&amp;prc=ONFARN52" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Renew</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=activate&amp;promo=ONFLNAA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Activate Subscription</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC4" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Manage Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=paybill&amp;product=nejm&amp;promo=BNFLPBA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Pay Bill</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.wolterskluwer.com/en/solutions/ovid/nejm-complete-collection" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Sales</span></a></li>    
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/special-content" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Special Content</span></a></li>
</ul>
</div></div></div><div class="col-lg-4 col-md-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">STAY CONNECTED</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/emails?section=NEJM" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Email Alerts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Apps</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Podcasts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">RSS Feed</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/institutional-access" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Remote Access</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="Follow us">FOLLOW US</h4>
<ul class="ng-footer_column-list">
<li class="ng-footer_column-list-item"><a href="https://www.facebook.com/TheNewEnglandJournalofMedicine" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-facebook"></use></svg></span></span><span class="ng-footer_column-link-text">Facebook</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://twitter.com/nejm" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-twitter"></use></svg></span></span><span class="ng-footer_column-link-text">X (formerly Twitter)</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.instagram.com/nejm/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-instagram"></use></svg></span></span><span class="ng-footer_column-link-text">Instagram</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.youtube.com/user/NEJMvideo" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-youtube"></use></svg></span></span><span class="ng-footer_column-link-text">Youtube</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.linkedin.com/company/nejm-group" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-linkedin"></use></svg></span></span><span class="ng-footer_column-link-text">LinkedIn</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://bsky.app/profile/nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-bluesky"></use></svg></span></span><span class="ng-footer_column-link-text">Bluesky</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.tiktok.com/@nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-tiktok"></use></svg></span></span><span class="ng-footer_column-link-text">TikTok</span></a></li>
</ul>
</div></div></div></div></div></div><div data-location="footer" class="ng-footer_journals"><div class="container-fluid"><div class="row"><div class="col-12">



        
        <h4 class="ng-footer_journals-label">JOURNALS</h4>
<ul class="ng-footer_journals-list">
<li class="ng-footer_journals-item"><a href="https://www.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">The New England Journal of Medicine</a></li>
<li class="ng-footer_journals-item"><a href="https://catalyst.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Catalyst Innovations in Care Delivery</a></li>
<li class="ng-footer_journals-item"><a href="https://evidence.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Evidence</a></li>
<li class="ng-footer_journals-item"><a href="https://ai.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM AI</a></li>
</ul>
</div></div></div></div><div data-location="legal" class="ng-footer_bottom"><div class="container-fluid"><div class="row"><div class="col-lg-7 col-md-6 ng-footer_bottom-left">



        
        <p>Copyright © 2025 <a href="https://www.massmed.org/" target="_blank" rel="noopener" class="ng-footer_bottom-link"><b>Massachusetts Medical Society</b></a>. All rights reserved, including those for text and data mining, AI training, and similar technologies. Electronic ISSN 1533-4406. Print ISSN 0028-4793.The content of this site is intended for health care professionals.</p>
</div><div class="col-lg-5 col-md-6 ng-footer_bottom-right">



        
        <style>
  #teconsent a {
    color: #666;
    text-decoration: none;
  }
  #teconsent a:hover {
    color: #666;
    text-decoration: underline;
  }
</style>
<ul class="ng-footer_bottom-list">
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/copyright-information.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Copyright</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/terms-of-use.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Terms</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/privacy-policy.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Privacy Policy</a></li>
<li class="ng-footer_bottom-list-item"><span id="teconsent" consent="undefined" aria-label="Open Cookie Preferences Modal" role="complementary"><a role="link" id="icon-id047246073067241556" tabindex="0" lang="en" aria-haspopup="dialog" aria-label="Cookie Preferences, opens a dedicated popup modal window" class="truste_cursor_pointer">Cookie Preferences</a></span></li>
</ul>
<a href="https://www.nejmgroup.org/" title="NEJM Group" target="_blank" rel="noopener" class="ng-footer_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/logo_group.svg" alt="NEJM Group logo" class="ng-footer_logo" loading="lazy" width="103" height="40"></a>
</div></div></div></div><div data-show-after="400" class="back-to-top back-to-top--align-right  "><button data-snap="footer__top" class="back-to-top__action position-relative p-0 m-0 border-0 d-flex flex-column align-items-center justify-content-center"><svg viewBox="0 0 36 36" class="position-relative"><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" class="back-to-top__action__ring-bg"></path><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" stroke-dasharray="0, 100" class="back-to-top__action__ring"></path></svg><span class="back-to-top__action-icon position-absolute d-flex"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-up"></use></svg></span></span><span class="sr-only">Back to top</span></button></div></footer>

                    
                        



        
        <!-- TrustArc: Banner -->
<div id="consent_blackbar"><style>  #consent_blackbar{    position:relative;    width:100%;    z-index: 999999;  }    #trustarc-banner-overlay {  background-color: rgb(0, 0, 0);   opacity: 0.3;   position: fixed;   z-index: 1000000;   width: 100%;  height: 100%;   top: 0px;   left: 0px;   overflow: hidden;}.truste-title {  /*font-family: "Source Sans Pro", sans-serif;  font-size: 23px;  font-style: normal;  font-stretch: normal;*/  color: #222;  margin-bottom: 20px;  text-align: center;/*  font-weight:bold;*/}.truste-footer {  margin: 0 auto;      }.truste-left {  margin: 0px 0px 15px 15px;/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;    */}.truste-banner { margin: 0 auto; }.truste-messageColumn {/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;*/  color: #666666;  margin: 0px;}#truste-consent-button, #truste-consent-required {    background-color: #FF1E00;    color: #F2F1F1;    padding: 5px 10px;    border: 1px solid #FF1E00;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }      #truste-show-consent {    background-color: #FF1E00;    color: #F2F1F1;    border: 1px solid #FF1E00;    padding: 5px 10px;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }div.truste-consent-track-class {  position: fixed;  z-index:9999999;   background: #666;   border: 1px solid #333;    /*padding: 10px 60px;*/    bottom:0px;    right:0px;    left:0px;    margin: 10px;}.truste-left {  margin: 0;}div.text-content {  display: flex;  flex-direction: column;  align-self: baseline;}#truste-consent-text {    /*font-family: "Source Sans Pro", sans-serif;    font-size: 16px;*/    color: #fff;    margin: 15px 0px;}.truste-footer {  padding-top: 15px;}#truste-consent-content {  margin: 0 auto;    padding: 0 10px;    max-width: 1366px;}.truste-consent-footer {  display: none;}.flex-container {  display: block;  align-items: center;  justify-content: space-between;}#truste-consent-buttons {  float: right;  margin: 10px 5px 10px 0px;}#truste-show-consent { background: #F30 !important;}#truste-consent-button, #truste-consent-required { background: #F30 !important; } /* MEDIA QUERIES */  @media screen and (max-width: 500px) {  #truste-consent-track {    padding: 5px 20px;  }  }@media screen and (max-width: 375px) {  .truste-buttonsColumn {    float: none;    margin: 0;  }  #truste-consent-button, #truste-consent-required, #truste-show-consent {    width: 100%;    margin-bottom: 5px;  }          #truste-consent-buttons {  float: none;  margin: 10px 0px 10px 0px;	}}</style><div id="truste-consent-track" style="display: block; opacity: 1;">  <div id="trustarc-banner-overlay"></div>  <div class="truste-consent-track-class">    <div id="truste-consent-content" class="truste-banner">        <div class="flex-container">          <div class="text-content">            <div id="truste-consent-text" class="truste-messageColumn">This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or manage your own preferences.                       </div>          </div>          <div id="truste-consent-buttons" class="truste-buttonsColumn">            <button id="truste-show-consent" aria-haspopup="dialog">Manage Settings</button>      <button id="truste-consent-button">Accept</button>      <!-- <button id="truste-consent-required">Decline All</button> -->          </div>        </div>                <div style="clear:both;"></div>    </div>  </div></div><!--emptycomment--></div>
<!-- /TrustArc: Banner -->

                    
                        



        
        <link rel="stylesheet" href="https://cssjs.nejm.org/mmsWidgets.css"><script nonce="94d6a59084c8e7d5-SJC" type="text/javascript" src="https://cssjs.nejm.org/mmsWidgets.js"></script><script nonce="94d6a59084c8e7d5-SJC" type="text/javascript">var litSSO = {
    "ucid": null,
    "accessToken": null,
    "authState": null
};

var loginUri = '/action/doSsoLogin';
var logoutUri = '/action/doLogout';

displayAuthenticatedMessage();

mmsWidgets.init({
    clientId: 'qsra7g4d6jwdsgn3zbe6udp6r6278mr9',
    origin: 'NEJM',
    xdReceiver: 'http://www.nejm.org/pb-assets/sso/xd.html',
    isFullPageSignIn: isSignInPage(),
    debug: true,

    onReady: function (e) {
        console.log('<<<<<<<<<< client: received onReady event.');
        $("A.litSsoLogin").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0) {
                mmsWidgets.signIn(e);
                return false;
            }
        });
        $("A.litSsoLogout").click(function (e) {
            mmsWidgets.signOut(e);
            return false;
        });
        $("A.litSsoCreate").click(function (e) {
            mmsWidgets.showRegModal(e);
            return false;
        });
        $("A.litSsoSubscribe").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0)
                location.assign(e.currentTarget.href);
            return false;
        });
        if (window.doSSOLogin) {
            window.setTimeout(function () {
                mmsWidgets.signIn();
            }, 500);
        }
        ;
    },
    onLoginSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLoginSuccess event.' + JSON.stringify(e));

        const redirectUrl = getRedirectUri(window.location.search, location.href.replace(window.location.origin, ""));
        document.cookie = "skipSso=; expires=; path=/";
        if (!litSSO.ucid || e.ucid != litSSO.ucid || !litSSO.accessToken || e.accessToken != litSSO.accessToken) {
            location.assign(loginUri + "?ucid=" + e.profile.ucid
                + "&accessToken=" + e.accessToken
                + "&authState=" + e.authState
                + "&email=" + encodeURIComponent(e.profile.email)
                + "&givenNames=" + e.profile.givenName
                + "&surname=" + e.profile.familyName
                + "&redirectUri=" + redirectUrl
                + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                + "&rememberMe=" + e.rememberMe);
        }
    },
    onAuthStateReady: function (e) {
        console.log('<<<<<<<<<< client: received onAuthStateReady event.' + JSON.stringify(e))

        var isMmsSsoAuthenticated = (e.authState && e.authState !== "anonymous" && e.authState !== "lead" && e.ucid && e.accessToken) ? true : false;
        var isLitSsoAuthenticated = (litSSO.ucid && litSSO.accessToken && litSSO.authState) ? true : false;
        console.log('           isMmsSsoAuthenticated=' + isMmsSsoAuthenticated + ', isLitSsoAuthenticated=' + isLitSsoAuthenticated);

        if (isMmsSsoAuthenticated) {
            if (!isLitSsoAuthenticated || litSSO.ucid != e.ucid) {
                if (window.skipSso)
                    document.cookie = "skipSso=" + encodeURIComponent(e.ucid) + "; expires=; path=/";

                if (!window.skipSso && document.cookie.indexOf("skipSso=" + encodeURIComponent(e.ucid)) == -1) {
                    location.assign(loginUri + "?ucid=" + e.profile.ucid
                        + "&accessToken=" + e.accessToken
                        + "&authState=" + e.authState
                        + "&email=" + encodeURIComponent(e.profile.email)
                        + "&givenNames=" + e.profile.givenName
                        + "&surname=" + e.profile.familyName
                        + "&redirectUri=" + location.href.replace(window.location.origin, "")
                        + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                        + "&rememberMe=" + e.rememberMe);
                } else
                    console.log('**** client: Skip SSO ****');
            } else if (e.accessToken !== litSSO.accessToken)
                updateLitSession(e.ucid, e.accessToken);
        } else if (isLitSsoAuthenticated)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));

        if (document.getElementById("ssoerr-ucid"))
            document.getElementById("ssoerr-ucid").innerHTML = e.ucid;

    },
    onRegistrationSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onRegistrationSuccess event.' + JSON.stringify(e))
        document.cookie = "skipSso=; expires=; path=/";
        var uccLastUpdatedDate = '1812-01-01 00:00:00.1 +0000';
        location.assign(loginUri + "?ucid=" + e.profile.ucid
            + "&accessToken=" + e.accessToken
            + "&authState=" + e.authState
            + "&email=" + encodeURIComponent(e.profile.email)
            + "&givenNames=" + e.profile.givenName
            + "&surname=" + e.profile.familyName
            + "&redirectUri=" + location.href.replace(window.location.origin, "")
            + "&uccLastUpdatedDate=" + encodeURIComponent(uccLastUpdatedDate)
            + "&rememberMe=" + e.rememberMe);
    },
    onLogoutSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLogoutSuccess event.' + JSON.stringify(e))

        document.cookie = "skipSso=; expires=; path=/";
        location.assign(logoutUri);
    },
});

function updateLitSession(ucid, accessToken) {
    $.ajax({
        method: "GET",
        url: "/action/doSsoSessionUpdate",
        data: {ucid: ucid, accessToken: accessToken},
        success: function (callData, textStatus) {
            console.log("Session accessToken updated")
            litSSO.accessToken = accessToken
        },
        error: function (jqXHR, textStatus, errorThrown) {
            alert("Your website session has expired and will now be reset.")
            console.log("Session update failed: " + jqXHR.responseText)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));
        }
    });
}

function getRedirectUri(location, fallback) {
    const urlParams = new URLSearchParams(location);
    const uriUrlParam = urlParams.get('uri');
    if (uriUrlParam)
        return encodeURIComponent(uriUrlParam);
    else
        return encodeURIComponent(fallback);
}

function isSignInPage() {
    return document.querySelector('meta[name="pbContext"]').content.indexOf("customPage:string:/sign-in") > -1;
}

function displayAuthenticatedMessage() {
    if (isSignInPage()) {
        var div = document.getElementById('authMsg');
        if ("" === "PersonUser") {
            div.innerHTML += "You are already signed in to " + window.location.origin.replace("https://", "").replace("www.", "") + ". If you would like to sign in with a different email address, please use the form below.";
        } else {
            div.innerHTML = '';
        }
    }
}</script>

                    
                
            </div>
        </div><iframe name="trustarc_notice" id="trustarcNoticeFrame" title="Trustarc Cross-Domain Consent Frame" src="https://consent.trustarc.com/get?name=crossdomain.html&amp;domain=nejm.com" style="display: none;"></iframe><script src="https://consent.trustarc.com/asset/notice.js/v/v1.7-1576" async="async" crossorigin="" importance="high" nonce="94d6a59084c8e7d5-SJC"></script>
        


        
        

            <script src="/products/mms-nextgen/mms/releasedAssets/js/build.lazyload.bundle-c8c4e7d20884f81951fb.js" nonce="94d6a59084c8e7d5-SJC"></script>

        <script src="/products/mms-nextgen/mms/releasedAssets/js/main.bundle-3819a02ec7bc2aca01ec.js" nonce="94d6a59084c8e7d5-SJC"></script>
        


<div id="adModal" tabindex="-1" aria-labelledby="exampleModalCenterTitle" class="ng-modal modal" style="display: none;" aria-hidden="true">
    <div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered ad-promoLayer">
        <div class="ng-modal_content modal-content p-0">
            <div class="ng-modal_body modal-body m-0">
                <div class="ng-modal_header modal-header">
                    <button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#close"></use></svg></span></span>
                    </button>
                </div>

            </div>
        </div>
    </div>
</div>
<script type="text/javascript" src="/wro/1125813~product.js" nonce="94d6a59084c8e7d5-SJC"></script>








<input id="showLayers" type="hidden" value="true">

    <!-- placeholder id=null, description=ad-layer-config -->
    <!-- placeholder id=null, description=ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=ad-layer-promo-1 -->

    <input id="firstAd" type="hidden" value="">
    <input id="secondAd" type="hidden" value="">

    
    
    

    
    
    <input id="IsInstitution" type="hidden" value="false">
    <input id="IsSubscriber" type="hidden" value="true">
    <input id="CustomerId" type="hidden" value="">


<script type="text/javascript" nonce="94d6a59084c8e7d5-SJC">
  jQuery.extend(jQuery.mmsLayers.config, {
    rules: [{
      "name": "Launch Layer Ad",
      "frequency": 30,
      "showOnPage": 5,
      "enabled": false,
      "cookieName": "MarketingLaunchLayer",
      "styleClass": "launchLayer"
    },
    {
      "name": "Promo Layer Ad",
      "frequency": 14,
      "enabled": true,
      "cookieName": "PromoLayer",
      "styleClass": "promoLayer"
    },
    {
      "name": "Interstitial Ad",
      "frequency": 7,
      "enabled": false,
      "cookieName": "InterstitialAd"
    },
    {
      "name": "Iperceptions - Ion Layer Ad",
      "showOnPage": 1,
      "enabled": false,
      "test": false,
      "cookieName":"Iperceptions"
    }]
 });
</script>

















    <script type="text/javascript" nonce="94d6a59084c8e7d5-SJC">
        $(document).ready(() => setTimeout(() => {
            let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" "));
            $.get("/resource/lodash?t="+_bnt);
        },4000));
    </script>












    

    
    

    
    
    
    
        
            
                <script type="text/javascript" src="/wro/1125813~article-metrics.js" nonce="94d6a59084c8e7d5-SJC"></script>
            
            
            
        
    




<script type="text/javascript" src="/wro/1125813~full-text-analytics.js" nonce="94d6a59084c8e7d5-SJC"></script>


    


            <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94d6a5907d7ee7d5',t:'MTc0OTUzNTIwOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94d6a5907d7ee7d5&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;f55e150c7a5f4a4ab9ef82f4a1c9c43c&quot;}" crossorigin="anonymous"></script><div style="display:none;" id="signInEmbedded" class="ucc-fullpage-signin ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Sign In</h1>
  </div>    
  <div class="capture_signin">
    {* #signInForm *}
    <div class="ucc-form-inner-wrapper">
      {* signInEmailAddress *}
      {* currentPassword *}
      <div style="padding-top:10px;">
          <div class="capture_form_item capture_form_rememberme">
          <label class="ucc-form-checkbox">                
            <input checked="checked" id="ucc-remember-me-cb-embedded" name="ucc-remember-me-cb-embedded" type="checkbox" value="true">
            <span>Remember Me</span>
          </label>                           
          </div>
          <div class="capture_form_item capture_form_forgotpwd">
            <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
          </div>
      </div>
      <div class="capture_form_item">      
        <button id="ucc-sign-in-submit-embedded" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
      </div>
      <div class="capture_form_item capture_form_footer">
        <div class="ucc-no-acct-msg">Don't have an account?</div>
        <div class="ucc-no-acct-msg-2">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
          <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
        </div>
      </div>
      <div class="capture_form_item capture_form_submit">
        
      </div>      
    </div>
    {* /signInForm *}
  </div>
</div><div style="display:none;" id="forgotPassword" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Forgot Password</h1>
  </div>   
  <div class="ucc-form-inner-wrapper">
  <p style="color:black">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
  </div> 
  <div class="capture_forgotpassword">
    {* #forgotPasswordForm *}      
      <div class="ucc-form-inner-wrapper">
        {* forgotPasswordEmailAddress *}
        {* captcha *}
        <div class="capture_form_item" style="padding-top: 20px;">        
          <input id="ucc-widget-forgotpwd-submit" value="Continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
        </div>
      </div>
    {* /forgotPasswordForm *}
  </div>
  </div><div style="display:none;" id="forgotPasswordSuccess" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Create New Password</h1>
  </div>    
  <div class="capture_forgotpassword">
      <div class="ucc-form-inner-wrapper">
        <p style="padding-top: 30px; padding-bottom: 30px;">We've sent an email with instructions to create a new password. Your existing password has not been changed.</p>        
        <div class="capture_form_item">      
          <button class="capture_btn capture_primary capture-full-width-btn" onclick="janrain.capture.ui.modal.close()">CLOSE</button>
        </div>
      </div>
  </div>
  </div><div style="display:none;" id="resetPassword" class="ucc-widgets-nejm-next">
      <div class="row">      
        <div class="col-md-8 col-md-offset-2 reset-pwd-info"><p>To reset your password, enter a new password twice and click the 'Reset Password' button.</p></div>
      </div>
      <div class="col-md-4 col-md-offset-4">
        {* #changePasswordFormNoAuth *}
          {* newPassword *}
          {* newPasswordConfirm *}     
          <div class="capture_form_item">
            <input value="RESET PASSWORD" type="submit" class="capture_btn capture_primary capture-full-width-btn">
          </div>
          {* /changePasswordFormNoAuth *}
      </div>
    </div><div style="display:none;" id="resetPasswordSuccess">
        <div class="reset-pwd-info">
          <div class="reset-pwd-success-welcome"></div>
          <p class="reset-pwd-success-msg">Your password has been reset. You will need to <a href="/signin" onclick="mmsWidgets.signIn(event)">sign in</a> again using your new password to access site content and features.</p>
          <p class="reset-pwd-success-nav"></p>
        </div>      
    </div><div style="display:none;" id="resetPasswordRequestCode" class="ucc-widgets-nejm-next">
        {* #resetPasswordForm *}
        <div class="capture_form_error">The link that you followed to reset your password has expired.</div>
          <div class="col-md-8 col-md-offset-2">
            <p class="reset-pwd-info">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
          </div>
          <div class="col-md-4 col-md-offset-4">
            {* signInEmailAddress *}
            <div class="capture_form_item">
              <input value="continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
            </div>
          </div>
        {* /resetPasswordForm *}
    </div><div style="display:none;" id="resetPasswordRequestCodeSuccess">
      <div class="reset-pwd-info">
        <p>If the address matches an existing account, you will receive an email with instructions to reset your password.</p>
        <p class="reset-pwd-success-nav"></p>
      </div>
  </div>

        
        
    

<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><jcj-mjijaoagtlfl></jcj-mjijaoagtlfl><script type="text/javascript" src="https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1056/nejmoa2113017?callback=_altmetric.embed_callback&amp;domain=www.nejm.org&amp;cache_until=3-10"></script><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="janrainEngageEmbed" style="display: none;"><div class="janrainContent" style="width: 380px !important; height: 156px !important; padding-left: 5px !important; padding-right: 5px !important; box-sizing: content-box !important; background-color: rgb(255, 255, 255) !important; border: 1px solid rgb(192, 192, 192) !important; border-radius: 10px !important; overflow: hidden !important; position: relative !important;"><div id="janrainView"><div class="janrainHeader" style="background-color: rgb(255, 255, 255) !important; font-size: 14px !important; color: rgb(102, 102, 102) !important; position: relative !important; height: 20px !important; left: -5px !important; padding: 5px 5px 0px !important; white-space: nowrap !important; width: 380px !important; z-index: 100 !important; border-radius: 10px 10px 0px 0px !important; text-align: left !important;"><div style="padding-left: 1px !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important;">Sign in using your account with</div></div><div id="janrainProviderPages" style="padding-top: 5px; left: 5px; position: absolute;"><div class="janrainPage" pageindex="0"><ul class="providers" id="janrainProviders_0" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-aol" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="1" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-aol" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-aol" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">AOL</span></a></li><li id="janrain-openid" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="3" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-openid" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-openid" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">OpenID</span></a></li></ul><ul class="providers" id="janrainProviders_1" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-yahoo" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="2" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-yahoo" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-yahoo" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">Yahoo!</span></a></li></ul></div></div><div style="background-color: rgb(255, 255, 255) !important; width: 380px !important; height: 10px !important; position: absolute !important; left: 0px !important; padding-left: 5px !important; padding-right: 5px !important; padding-bottom: 5px !important; bottom: 0px !important; font-size: 10px !important; text-align: left !important; color: rgb(102, 102, 102) !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; border-radius: 0px 0px 10px 10px !important;"><div style="padding-left: 1px !important;"><a href="http://janrain.com/products/engage/social-login?utm_source=mms.rpxnow.com&amp;utm_medium=Partner&amp;utm_campaign=attribution" target="_blank">Social Login by Janrain</a></div></div></div></div></div><iframe name="captureIFrame_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-transactionid="oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" id="captureIFrame_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" src="about:blank" class="" data-captureiframeloadeventbound="yes" style="display: none;"></iframe><div id="janrainModalOverlay" style="inset: 0px; position: fixed; background-color: rgb(0, 0, 0); opacity: 0.4; display: none; z-index: 1000;"></div><div id="janrainModal" style="width: 380px; height: 131px; position: absolute; z-index: 1000; display: none;"><a href="#" class="janrain_modal_closebutton" style="position: absolute; cursor: pointer; z-index: 1000;">X</a><div style="display: block;" id="signIn" class="ucc-widgets-nejm-next janrain-capture-ui capture-ui-content capture_screen_container" data-capturescreenname="signIn" data-captureventadded="true">
    <div class="capture_header">
      <h1>Sign In</h1>
    </div>    
    <div class="capture_signin">
      <form id="capture_signIn_signInForm" name="signInForm" data-capturefield="signInForm" action="https://mms.us.janraincapture.com/widget/traditional_signin.jsonp" class="capture_form capture_signInForm" method="POST" novalidate="novalidate" data-transactionid="oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" target="captureIFrame_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" accept-charset="UTF-8" next="{&quot;noop&quot;:&quot;&quot;}"><div id="capture_signIn_signInForm_defaultSavedProfileMessage"></div><div id="capture_signIn_signInForm_errorMessages"></div><input id="capture_signIn_utf8" data-capturefield="undefined" value="✓" type="hidden" class="capture_utf8" name="utf8"><input id="capture_signIn_screen_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="signIn" type="hidden" class="capture_screen_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="capture_screen"><input id="capture_signIn_js_version_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="d445bf4" type="hidden" class="capture_js_version_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="js_version"><input id="capture_signIn_transactionId_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" type="hidden" class="capture_transactionId_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="capture_transactionId"><input id="capture_signIn_form_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="signInForm" type="hidden" class="capture_form_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="form"><input id="capture_signIn_flow_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="standard" type="hidden" class="capture_flow_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="flow"><input id="capture_signIn_client_id_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="qsra7g4d6jwdsgn3zbe6udp6r6278mr9" type="hidden" class="capture_client_id_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="client_id"><input id="capture_signIn_redirect_uri_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="https://www.nejm.org" type="hidden" class="capture_redirect_uri_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="redirect_uri"><input id="capture_signIn_response_type_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="code" type="hidden" class="capture_response_type_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="response_type"><input id="capture_signIn_flow_version_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="20240514181256512029" type="hidden" class="capture_flow_version_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="flow_version"><input id="capture_signIn_settings_version_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="" type="hidden" class="capture_settings_version_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="settings_version"><input id="capture_signIn_locale_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="en-US" type="hidden" class="capture_locale_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="locale"><input id="capture_signIn_recaptcha_version_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" data-capturefield="undefined" value="2" type="hidden" class="capture_recaptcha_version_oovuekersiw4te85w9lyoc4zr6s9x3nu5wop8q80" name="recaptchaVersion">
      <div class="ucc-form-inner-wrapper">
        <div id="capture_signIn_form_item_signInEmailAddress" class="capture_form_item capture_email capture_form_item_signInEmailAddress" data-capturefield="undefined"><label for="capture_signIn_signInEmailAddress">Email Address</label><input id="capture_signIn_signInEmailAddress" data-capturefield="signInEmailAddress" value="" type="email" class="capture_signInEmailAddress capture_required capture_text_input" placeholder="Email Address" name="signInEmailAddress"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="signInEmailAddress">Validating</div><div class="capture_tip_error" data-elementname="signInEmailAddress"></div></div>
        <div id="capture_signIn_form_item_currentPassword" class="capture_form_item capture_password capture_form_item_currentPassword" data-capturefield="undefined"><label for="capture_signIn_currentPassword">Password</label><input id="capture_signIn_currentPassword" data-capturefield="currentPassword" value="" type="password" class="capture_currentPassword capture_required capture_text_input" placeholder="Password" name="currentPassword"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="currentPassword">Validating</div><div class="capture_tip_error" data-elementname="currentPassword"></div></div>
        <div style="padding-top:10px;">
            <div class="capture_form_item capture_form_rememberme">
                <label class="ucc-form-checkbox">                
                    <input checked="checked" id="ucc-remember-me-cb" name="ucc-remember-me-cb" type="checkbox" value="true">
                    <span>Remember Me</span>
                </label>          
            </div>
            <div class="capture_form_item capture_form_forgotpwd">
              <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
            </div>
        </div>
        <div class="capture_form_item">
          <button id="ucc-sign-in-submit" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
        </div>
       
        <div class="capture_form_item">
          <div class="ucc-no-acct-msg">Don't have an account?</div>
          <div class="ucc-no-acct-msg-2" id="signInModalCreateAccountLink">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

          <div class="ucc-no-acct-msg-2" id="signInModalCloseLink" style="display:none">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

        </div>
     
        <div class="capture_form_item capture_form_submit">
          
        </div>      
      </div>
      </form>
    </div>
  </div></div></body></html>